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ABSTRACT OF THE DISSERTATION 
ASSESSMENT OF THE OCCURRENCE AND POTENTIAL EFFECTS OF 
PHARMACEUTICALS AND PERSONAL CARE PRODUCTS IN SOUTH 
FLORIDA WATERS AND SEDIMENTS 
by 
Chengtao Wang 
Florida International University, 2012 
Miami, Florida 
Professor Piero R. Gardinali, Major Professor 
A LLE-GC-MS method was developed to detect PPCPs in surface water samples 
from Big Cypress National Park, Everglades National Park and Biscayne 
National Park in South Florida. The most frequently found PPCPs were caffeine, 
DEET and triclosan with detected maximum concentration of 169 ng/L, 27.9 ng/L 
and 10.9 ng/L, respectively. The detection frequencies of hormones were less 
than PPCPs. Detected maximal concentrations of estrone, 17β-estradiol, 
coprostan-3-ol, coprostane and coprostan-3-one were 5.98 ng/L, 3.34 ng/L, 16.5 
ng/L, 13.5 ng/L and 6.79 ng/L, respectively.  
 
An ASE-SPE-GC-MS method was developed and applied to the analysis of  the 
sediment and soil area where reclaimed water was used for irrigation. Most 
analytes were below detection limits, even though some of analytes were 
detected in the reclaimed water at relatively high concentrations corroborating 
the fact that PPCPs do not significantly partition to mineral phases.  
viii 
 
 
An online SPE-HPLC-APPI-MS/MS method and an online SPE-HPLC-HESI-
MS/MS method were developed to analyze reclaimed water and drinking water 
samples. In the reclaimed water study, reclaimed water samples were collected 
from the sprinkler for a year-long period at Florida International University 
Biscayne Bay Campus, where reclaimed water was reused for irrigation. Analysis 
results showed that several analytes were continuously detected in all reclaimed 
water samples. Coprostanol, bisphenol A and DEET’s maximum concentration 
exceeded 10 µg/L (ppb). The four most frequently detected compounds were 
diphenhydramine (100%), DEET (98%), atenolol (98%) and carbamazepine 
(96%). In the study of drinking water, 54 tap water samples were collected from 
the Miami-Dade area. The maximum concentrations of salicylic acid, ibuprofen 
and DEET were 521 ng/L, 301 ng/L and 290 ng/L, respectively. The three most 
frequently detected compounds were DEET (93%), carbamazepine (43%) and 
salicylic acid (37%), respectively. Because the source of drinking water in Miami-
Dade County is the relatively pristine Biscayne aquifer, these findings suggest 
the presence of wastewater intrusions into the delivery system or the onset of 
direct influence of surface waters into the shallow aquifer.  
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CHAPTER 1 
INTRODUCTION 
1.1 What are PPCPs? 
Pharmaceuticals and Personal Care Products (PPCPs) are defined as any 
product used by individuals for personal health or cosmetic reasons or used by 
agribusiness to enhance growth or health of livestock. Pharmaceuticals and 
Personal Care Products comprise a diverse collection of thousands of chemical 
substances, including prescription and nonprescription drugs, veterinary drugs, 
fragrances, and cosmetics (URL1). Pharmaceuticals and Personal Care 
Products are a wide variety of important “unrecognized” or “emerging” pollutants 
in everyday urban activities. The United States Environmental Protection Agency 
(EPA) defines emerging pollutants as new chemicals without regulatory status 
and the influence of emerging pollutants on environmental and human health are 
poorly understood to say the least.  
 
1.2 Why do we need to monitor them? 
 Many pharmaceuticals are not completely eliminated by the human body and 
often are excreted only slightly transformed or even unchanged (Reddersen et al., 
2002). The disposal of unused medication via a household sink or toilet brings 
pharmaceuticals directly to the wastewater treatment plants (WWTPs) in 
relatively high concentrations. Several investigations have shown that current 
wastewater treatment processes (physical and biological) could not remove 
PPCPs completely from effluents of WWTPs (Ingrand et al., 2003; Esperanza et 
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al., 2004; Sui et al., 2010; Lacey et al., 2011; Ryu et al., 2011). The typical rate of 
removal of analgesics, anti-inflammatories and beta-blockers are 30% to 40%. 
The average rate of removal is about 50% for antibiotics and 71% for compounds 
like bisphenol A (Deblonde et al., 2011). More recent research indicates that 
advanced treatment steps (e.g., ultrafiltation, flocculation, ozonation, advanced 
oxidation or osmosis) are usually required to increase removal of micropolluants 
(Fatta-Kassinos et al., 2010). However, these treatment steps are seldom used in 
the WWTPs because of their high costs. Therefore, the effluents of wastewater 
treatment plants bring pharmaceuticals to the surface waters when the effluents 
are discharged into rivers, lakes or oceans. If the effluent is reused for irrigation 
or landscape, PPCPs may be transferred to soil and enter to surface water 
through runoff (Heberer et al., 2002). When active recharge is used, PPCPs may 
also leach into an aquifer and be transported into ground waters, which are 
potential drinking water sources. That is likely the main reason of why PPCPs are 
reported in the ground water and drinking water samples. The presence of 
PPCPs in the ground water may also be caused by the influence of landfill 
leachates. Meanwhile, large use of veterinary drugs may also cause the 
occurrence of PPCPs residues in the environment. Figure 1 shows the possible 
sources and pathways of PPCPs in the environment.  
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Figure 1. Possible sources and pathways for the occurrence of PPCPs residues 
in the environment 
 
One issue about PPCPs present in the environment is that the endocrine 
disrupting effect of some PPCPs may occur even at very low concentration 
(Caliman and Gavrilescu, 2009). Until now, very little is known about the long-
term effect of PPCPs on aquatic organisms. For most human pharmaceuticals, it 
is unlikely that they will have acute effects on aquatic organisms except for the 
cases of a direct spill/disposal. However, understanding the chronic effects and 
toxicity of pharmaceuticals mixtures are more important because many aquatic 
species are continuously exposed to PPCPs over their entire life cycle. Despite 
this, there is very little data about chronic effects of pharmaceuticals on the 
aquatic organisms except for ethynylestradiol (EE2). Ethynylestradiol shows 
estrogenic effects in many fish at extremely low concentrations. For fathead 
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minnows, egg fertilization of female was significantly decreased at extremely low 
concentration of 0.32 ng/L ethynylestradiol. For males, demasculinization 
(decreased male secondary sex characteristic index) happened when males 
exposed to EE2 at a concentration of 0.96 ng/L (Parrott and Blunt, 2005). In 
addition, life exposure of zebrafish to EE2 at a concentration of 0.05 ng/L caused 
the secondary sexual characteristics of males to become significantly feminized 
(Larsen et al., 2008). Very few chronic effect data of analgesics, non-steroid anti-
inflammatories and beta-blockers are available. Diclofenac was found to have 
chronic histopathological effects in rainbow trout at a concentration of 5 µg/L 
(Schwaiger et al., 2004). Propranolol has chronic toxicity for fish not only on the 
cardiovascular system but also on reproduction. Reproduction of C.dubia and H. 
azteca was affected by propranolol at 250 µg/L and 100 µg/L after 14 days of 
exposure, respectively (Huggett et al., 2002). Typically toxicity of single 
compound may show no or only little effects at certain concentration, but 
mixtures of many pharmaceuticals may have effects at the same concentrations 
due to synergistic effects. Study on mixtures of NSAID (diclofenac, ibuprofen, 
naproxen, acetylsalicylic acid) on Daphnia and algae demonstrated the mixture 
followed the concept of concentration addition (Michael, 2003).  Even though the 
reported lowest observed effect concentrations (LOEC) of PPCPs are usually 
higher than measured concentrations in the effluent of WWTPs or surface water, 
monitoring PPCPs in the environment is still an urgent need. The general lack of 
chronic toxicity data on pharmaceuticals requires not only more investigation 
about potential ecotoxicological effects such as endocrine disruption, 
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immunological status, or gene activation and silencing during long-term exposure 
but also the development of robust, low-level, selective, high throughput 
analytical techniques. 
 
Besides aquatic organisms like fish, plants may also be affected, to a lesser 
extent, by PPCPs when treated wastewater is reused for irrigation. It is not clear 
the negative effects on plants are from direct damage of PPCPs to plant or from 
the indirect damage of PPCPs to the soil microorganisms (Sabourin et al., 2009; 
Matamoros and Salvado, 2012).  
 
Another important issue is the presence of chronic levels of antibiotics in the 
environment. Presence of antibiotics is often suggested as a potential link to the 
development of antibiotic-resistant bacteria. The resistant bacteria can be 
transferred to human via water or food if plants are irrigated by reclaimed water, 
surface water or sludge with antibiotic-resistant bacteria which have escaped 
from treatment (Fatta-Kassinos et al., 2010). 
 
1.3 What are the typical procedures to detect them? 
The two key challenges for the detection of emerging microconstituents is 
interference from complex matrices and the relatively low concentration of 
analytes in the environment. However, with the development of sophisticated and 
sensitive analytical protocol, such as more efficient extraction techniques and 
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more sensitive detectors, trace level PPCPs can be detected in the environment. 
Typical analysis procedure for aqueous and solid samples is shown in figure 2. 
 
Figure 2. Typical analysis procedure for aqueous and solid samples 
 
1.3.1 Sample preparation for aqueous samples 
Currently, available extraction techniques for aqueous samples (e.g., tap water, 
surface water and wastewater) include Liquid-liquid extraction (LLE) (Zafra et al., 
2003), solid phase extraction (SPE) (Zaharie, 2006; Gómez et al., 2007; Gros et 
al., 2009) and solid phase microextraction (SPME) (Pablo Lamas et al., 2004) etc.  
Solid phase extraction is the most widely used extraction method. Solid phase 
extraction cartridge sorbents include non-polar phase, ion-exchange phase and 
polymeric phase. Among them, the Oasis HLB (Waters Corp, Hydrophilic-
Lipophilic Balanced phase) cartridge is able to extract both polar and nonpolar 
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analytes under the same conditions and improve simultaneous detection of 
analytes with markedly different chemical properties.  In order to increase the 
capacity of multiple-residues extraction, several researches started to use 
tandem or serial mixed-mode cartridges to increase analyte recoveries (Gros et 
al., 2009; Laven et al., 2009). The development of on-line SPE simplifies the 
extraction procedure and reduces the sample preparation time. Therefore, more 
and more studies begin to focus on on-line SPE method development (Segura et 
al., 2007; Garcia-Ac et al., 2009; Lopez-Serna et al., 2010). Because of the 
repeated use of the SPE mini-cartridges, development of on-line methods require 
many additional optimization of parameters, such as sample size, the sample 
loading flow, and wash step, but the additional work is clearly offset by the gain in 
processing speed as a result of the system automation. 
 
Solid phase microextraction is another extraction technique that starts to attract 
interest for the analysis of many organic compounds in aqueous samples. Solid 
phase microextraction extracts target compounds from sample to an absorptive 
layer of sorbent coated on a fiber. The quantity of target compounds extracted is 
proportional to the concentration of target compounds in the sample. After 
extraction, the fiber can be transferred to the injection port of GC, where 
desorption happens and analysis starts. The advantage of SPME is solvent free 
and very simple sample preparation (Carballa et al., 2004; Pablo Lamas et al., 
2004; Fatta-Kassinos et al., 2010). However, the use of SPME is still limited by 
the fiber activation and cleanup steps and is much more difficult to automate. 
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1.3.2 Sample preparation for solid samples 
For solid matrices (e.g., soils, sediments, sludge and fish tissues), accelerated 
solvent extraction (ASE) or pressurized liquid extraction (PLE), ultrasonic 
assisted extraction (UAE) and microwave-assisted extraction (MEA) have been 
used to enhance extraction efficiency (Löffler and Ternes, 2003; Burkhardt et al., 
2005; Xu et al., 2008; Jelic et al., 2009; Vazquez-Roig et al., 2010).  Usually SPE 
is used as a clean-up step after the extraction mentioned above to reduce the 
interference from environmental samples due to the complexity of matrices.  
 
1.4 Instrumental detection 
Detection and quantification of PPCPs in the environment were a big challenge 
several years ago because of the complexity of matrices and PPCPs’ low 
concentration of occurrence. Currently, gas chromatography (GC), coupled with 
mass spectrometry (MS) and high performance liquid chromatography (HPLC), 
coupled with MS, provide the opportunity to detect PPCPs down to extremely low 
concentrations in the ng/L (parts per trillion) range. The choice of GC or HPLC 
depends on the chemical properties of the target compounds. Generally, GC is 
appropriate for identification and quantification of volatile or volatizable 
compounds, while HPLC is used to determine more polar and less volatile 
compounds.  For the investigation of PPCPs in the environment, GC-MS, GC-
MS2, LC-MS, LC-MS2 have become indispensable tools. Capillary 
electrophoresis (CE) also is used to analyze pharmaceuticals and personal care 
products. However, CE without preconcentration can only reach concentrations 
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in the µg/L range limiting its application. Therefore, GC or LC coupled with MS is 
still the primary tools for analysis of PPCPs in the environment.  
 
1.4.1 GC-MS and GC-MS2 
The use of GC-MS to determine PPCPs in the environment started in the 
nineteen seventies (Garrison et al., 1976). Nowadays, GC-MS and GC-MS2 are 
still the most widely used techniques because of their availability in 
environmental laboratories. The major advantage of GC coupled with MS is that 
the ionization modes like electron impact (EI) or chemical ionization (CI) are 
generally less affected by the sample matrix than electrospray ionization (ESI), 
the main ionization mode used for liquid chromatography mass spectrometry. 
 
A derivatization step is usually needed for highly-polar, thermally-fragile 
compounds to make them suitable for GC analysis. Usually, GC-MS analysis 
after derivatization is an effective alternative to liquid chromatography mass 
spectrometry. Derivatization is usually done by substitution on the polar 
functional group and the most common reactions are alkylation, acylation and 
silylation (Shareef et al., 2006; Schummer et al., 2009). The largest limitation to 
this approach is the derivatization step itself. The efficiency of derivatization is 
influenced by the derivatizing agent and solvent, reaction temperature and 
reaction time. These parameters need to be optimized to increase the signal to 
noise (S/N) for analytes. The most commonly used derivatization technique is 
silylation, and common reagents include trimethylchlorosilane (TMCS),  
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trimiethylsilylimidazole (TMSI), N-methyl-trimethylsilyltrifluoroacetamide (MSTFA), 
N,O-bis-(trimethylsilyl)trifluoroacetamide (BSTFA) and N-(t-butyldimethylsilyl)-N-
methyltrifluoroacetamide (MTBSTFA), where the last two are the most frequently 
reported in the analysis of PPCPs (Boyd et al., 2003; Rice and Mitra, 2007; Xu et 
al., 2008; Durán-Alvarez et al., 2009). 
 
The column used to separate PPCPs in GC analysis includes DB5, DB5-MS, 
HP5-MS and their equivalents.  The dimension of the column is usually 30 m × 
0.25 mm × 0.25 µm and longer columns or thicker film phases can be used to 
improve the separation of PPCPs. Normal injection volume is 1-2 µL. While large 
volume injection has been reported to decrease the method detection limits 
(MDLs) of GC analysis the introduction of co-extractants and residues from the 
derivatizing agents do compromise the column integrity so its use is not 
widespread. Typical temperature program is from 50 °C to 300 °C with a run time 
of 30 - 45 mins (Boyd et al., 2003; Zafra et al., 2003; Weigel et al., 2004; Gibson 
et al., 2007; Gómez et al., 2007).  
 
Most of the publications focused on EI with -70 eV standard ionization energy. 
Electrons are continuously emitted from a heated filament (200-280 °C) and 
collide with analytes that elute from the end of the GC column. Qualification 
analysis of PPCPs and their metabolites can be achieved by full-scan mass 
spectra with the help of computer libraries, which have thousands of standard 
mass spectra. Quantification analysis is usually achieved by compounds 
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molecular ions and fragment ions in selective ion monitoring (SIM). Selective ion 
monitoring improves sensitivity of target compounds by only acquiring data of 
target compounds with no attempt to acquire data of non-target compounds 
(Boyd et al., 2003; Zafra et al., 2003; Weigel et al., 2004; Lishman et al., 2006; 
Gibson et al., 2007). 
  
Gas chromatography tandem mass spectrometry is able to achieve excellent 
selectivity and sensitivity by suppression of matrix backgrounds. The MS2 
experiment can be implemented by ion-trap and triple-quadrupole mass 
analyzers. The precursor ions are selected and the fragmentations are optimized 
to obtain the best S/N ratio. Therefore, MS2 has been used for the detection of 
trace level analytes present in complex matrices like wastewater, sediment and 
sludge (Verenitch et al., 2006; Gómez et al., 2007). 
 
1.4.2 LC-MS and LC-MS2 
Although MS has the ability to simultaneously identify target compounds, LC 
separation is still needed, especially for isomeric chemicals. Reversed-phase 
analytical columns are most commonly used to separate pharmaceuticals and 
personal care products. The typical particle size of analytical columns is between 
1.9 µm and 3 µm. The organic mobile phase includes methanol, acetonitrile or a 
combination of these two solvents, while the aqueous phase is water with the 
addition of formic acid, acetic acid, ammonium hydroxide, ammonium formate or 
ammonium acetate to adjust pH. 
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1.4.3 Ionization techniques 
High performance liquid chromatography mass spectrometry has been shown as 
a valuable alternative for detection of PPCPs and EDCs to overcome the 
drawbacks of GC-MS (Gardinali and Zhao, 2002; Gentili et al., 2002; Ingrand et 
al., 2003; Cahill et al., 2004; Castiglioni et al., 2005; Schlüsener and Bester, 2005; 
Martnez Bueno et al., 2007; Gros et al., 2009; Laven et al., 2009; Huerta-Fontela 
et al., 2010; Jian-lin et al., 2010). Electrospray ionization (ESI), atmospheric 
pressure chemical ionization (APCI) and atmospheric pressure photoionization 
(APPI) are the three most common ionization techniques coupled with liquid 
chromatography (Marchi et al., 2009). Electrospray ionization dominates the field 
of environmental analysis at trace level because of its simplicity and versatility. 
 
Electrospray ionization and atmospheric pressure chemical ionization have both 
been widely used for analysis of polar molecules in the aqueous environmental 
samples in many studies (Cahill et al., 2004; Castiglioni et al., 2005; Gros et al., 
2009). Several studies that described multi-target detection of up to 74 
compounds by ESI have been recently published in the literature (Gros et al., 
2009; Lopez-Serna et al., 2010). However, ESI and APCI also have many critical 
limitations. For example, some steroids, and generally nonpolar compounds, 
such as PAHs, are poorly ionized or cannot be ionized by ESI or APCI (Hanold et 
al., 2004). Therefore, it is not surprising that most of the studies using ESI are 
focused on the most polar, easily ionizable pharmaceuticals. Only a handful of 
studies have tried to detect steroid hormones that are difficult to ionize by ESI or 
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APCI with marginal results (Jeannot et al., 2002; Ingrand et al., 2003). Not 
surprisingly, there is abundant literature for compounds ameanable to ESI but 
reports are scarce for those that present an ionization challenge. The critical 
issue is that the most EDC active compounds are not well ionized by 
electrospray ionization. 
 
Atmospheric pressure photoionization is based on the interaction of a photon 
beam created by a discharge lamp with the vapors of a nebulized liquid solution 
(Marchi et al., 2009). Atmospheric pressure photoionization is a technique that 
has the capability to ionize compounds with a wide range of polarities while being 
remarkably tolerant of matrix components of HPLC additives. The rapidly growing 
number of publications in this area clearly demonstrates the advantages of 
atmospheric pressure photoionization (Raffaelli and Saba, 2003; Bos et al., 2006; 
Marchi et al., 2009). At the beginning, APPI was introduced as a complement of 
ESI and APCI. So far, APPI has been proved to be a valuable tool for analytes 
which are poorly ionized or not ionized by ESI and APCI. In particular APPI was 
shown to be able to detect steroid hormones down to several ng/L and had been 
proven to have much higher sensitivity than ESI. (Yamamoto et al., 2006; Viglino 
et al., 2008). Atmospheric pressure photoionization is the ionization of choice for 
PAHs and showed results comparable to gas chromatography mass 
spectrometry (Itoh et al., 2006; Cai et al., 2009). Indeed, APPI not only gives 
superior performance on nonpolar compounds but also works great for analytes 
which are out of the reach of ESI and APCI. Cai et al. demonstrated that APPI 
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could be considered as a universal ionization method since APPI was able to 
ionize more compounds, with greater structural diversity, than ESI and APCI (Cai 
et al., 2005). Because of APPI’s capacity to ionize compounds with various 
polarities, it has been increasingly applied in the environmental and 
pharmaceutical areas.  
 
1.4.4 Detection techniques 
In single quadrupole MS, SIM is the mode used for qualitative and quantitative 
analysis of target compounds (Cahill et al., 2004). Compared with MS, MS2 can 
reduce more interference from matrix. The unique ability of ion trap-MS (IT-MS) 
for MSn makes it an ideal tool in identification of analytes of interest (Ingrand et 
al., 2003) but because of its space-charge limitations is not generally used for 
quantitation. Triple quadrupole (QqQ) is the most frequently used MS2 detector in 
the muti-residue analysis of pharmaceuticals and EDCs in the environmental 
samples (Trenholm et al., 2008). For quantitative analysis, QqQ is excellent, but 
qualitative information, which is needed for structure identification, is lost. The 
drawback of QqQ can be overcome by using triple quadrupole time of flight 
(QqTOF) or quadrupole linear iontrap (QqLIT). Triple quadrupole time of flight is 
appropriate for identification of unknown compounds or metabolites due to its 
ability of providing exact mass. Quadrupole linear iontrap is excellent for both 
due to the unique capabilities of linear ion traps. LIT can run in two different 
modes, acting as the classical triple quadruple scan or sensitive ion trap scan. 
However, QqTOF and QqLIT are not widely available in environmental analysis 
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so far due to their extremely high cost. Only a few papers reported on their 
application for trace lever determination of emerging contaminants (Gros et al., 
2009; Laven et al., 2009; Huerta-Fontela et al., 2010). 
 
1.5 What is the concentration and fate of PPCPs in the environment? 
With the development of sensitive detection techniques, a wealth of information 
about the occurrence of PPCPs in the complex environment samples have been 
produced in the last decade (Verenitch et al., 2006; Gómez et al., 2007; Durán-
Alvarez et al., 2009; Xu et al., 2009). Pharmaceutical and personal care products 
have been documented in almost every water resource around the world. 
Pharmaceutical and personal care products are generally divided into several 
groups based on their mode of action including anti-inflammatory/analgesics, 
lipid regulators, H2-receptor antagonists, betablockers, personal care products 
and hormones.  
 
1.5.1 Anti-inflammatory/ analgesics 
Pharmaceuticals in this section are primarily used as painkillers. The most 
prominent drugs of this group are aspirin, ibuprofen and naproxen. Large 
amounts of painkillers are sold without prescription as “over-the-counter” (OTC) 
drugs. Because of the diversity of manufacturers it is hard to estimate the amount 
of OTC drugs sold worldwide. Acetaminophen (paracetamol) is one of the most 
frequently used OTC painkillers all over the world. About 140 tons of 
acetaminophen was dispensed in Wales (Kasprzyk-Hordern et al., 2008) and 
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more than 500 tons were sold in Germany (Thomas, 2002). In the investigation of 
139 surface streams in the U.S., acetaminophen was detected in 23.8% of 
samples at a maximum concentration of 10,000 ng/L (Kolpin et al., 2002). 
Acetaminophen is easily degraded and removed by WWTPs but it was still 
frequently detected in the environmental samples because its large usage. For 
example groundwater samples collected from 18 states from the USA, showed 
maximum concentration of acetaminophen of 380 ng/L (Barnes et al., 2008).  
Acetaminophen was even detected in drinking water in France at concentrations 
as high as of 210 ng/L (Mompelat et al., 2009). 
 
Ibuprofen is also a popular painkiller. Ibuprofen was detected in 50% of samples 
from UK estuaries at the maximal concentration of 928 ng/L and the median 
concentration of 48 ng/L.  It was detected in 139 streams in the U.S. at the 
maximum concentration of 1000 ng/L with 9.5% detection frequency. The high 
concentration of ibuprofen in surface water is not surprising because it has been 
reported at a high concentration in effluents of wastewater treatment plants. The 
high concentration of ibuprofen WWTP effluents is because of a combination of 
the high usage and low degree of human metabolism. In the WWTPs, ibuprofen 
was detected at concentrations from 14.3 to 22,700 ng/L in the influent and from 
30 to 12,600 ng/L in the effluent of WWTPs, respectively (Deblonde et al., 2011). 
Ibuprofen has also been detected in drinking water with maximal concentrations 
of 3.0 ng/L, 0.6 ng/L, 8.5 ng/L and 1350 ng/L in Germany, France, Finland and 
the USA, respectively (Mompelat et al., 2009). 
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Other than these compounds mentioned above, naproxen, diclofenac, 
indomethacine, ketoprofen are also in high demand and were also widely 
reported in the wastewaters and surface waters (Mompelat et al., 2009; 
Deblonde et al., 2011). 
 
1.5.2 Lipid regulators 
Clofibric acid, the active metabolite of the blood regulator clofibrate, has been 
widely reported in the effluents of WWTPs and has a removal rate of 40% 
(Metcalfe et al., 2003; Deblonde et al., 2011). Clofibric acid has been reported in 
surface waters at concentrations of 100 ng/L in UK estuaries (Thomas and Hilton, 
2004) and 0.4-18 ng/L in the river samples from Ebro River Basin (Gros et al., 
2009). In tap water, clofibric acid was reported up to 270 ng/L in distribution 
systems in Germany (Mompelat et al., 2009).  
 
The metabolites of fenofibrate—gemfibrozil, bezafibrate and fenofibric acid—
have been routinely detected up to µg/L in WWTPs effluents and surface waters 
(Thomas, 2002; Metcalfe et al., 2003; Kim et al., 2007; Deblonde et al., 2011). In 
drinking water, gemfibrozil was detected up to 70 ng/L in Canada (Mompelat et 
al., 2009). 
 
1.5.3 Antidepressants and anticonvulsants 
Antidepressants are a psychiatric medication used to alleviate mood disorders. 
Fluoxetine is a widely used antidepressant. Although the relative removal of 
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fluoxetine is higher than other pharmaceuticals (~98%) (Deblonde et al., 2011), 
fluoxetine was still reported in many surface water and groundwater samples. In 
national reconnaissance of the USA, the maximum concentration of fluoxetine in 
streams, groundwater and sources of drinking water were 12 ng/L, 56 ng/L and 
ND, respectively (Kolpin et al., 2002; Barnes et al., 2008; Focazio et al., 2008).  
 
Anticonvulsants are used in the treatment of epileptic seizures. Carbamazepine 
is one the most frequently detected anticonvulsants in wastewater, surface 
waters and drinking water. Because of its environmental stability carbamazepine 
is one of the most commonly detected PPCPs in surface waters worldwide. In 
WWTPs, the mean concentrations of carbamazepine in the influent and effluent 
were 732 ng/L and 774 ng/L, respectively, which indicated that carbamazepine 
had an extremely low removal rate in WWTPs (Deblonde et al., 2011). The 
concentrations of carbamazepine had been detected up to 1075 ng/L in surface 
waters in Germany (Heberer et al., 2002). Carbamazepine has even been 
detected in ground waters and drinking waters because of its persistence. The 
maximal concentrations of carbamazepine detected in drinking water were 24 
ng/L, 258 ng/L, 43.2 ng/L and 60 ng/L in Canada, France, Germany and the USA, 
respectively (Mompelat et al., 2009).  
 
1.5.4 H2-receptor antagonists 
The function of H2 receptor antagonists is to block the action of histamine on 
parietal cells in the stomach. Cimetidine, ranitidine, famotidine and nizatidine are 
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the available OCT H2 receptor antagonists in the USA. Ranitidine was detected 
in streams in the USA at a maximum concentration of 10 ng/L with the detection 
frequency of 1.2% (Kolpin et al., 2002). In surface water in South Wales, 
concentrations of ranitidine were reported up to 8 ng/L (Kasprzyk-Hordern et al., 
2008). Until now, ranitidine was not detected in groundwater or sources of 
drinking water in national reconnaissance in the United States (Barnes et al., 
2008; Focazio et al., 2008).  
 
1.5.5 Betablockers 
Betablockers are used to manage cardiac dysrhythmia, cardioprotection after 
heart attack and hypertension. Betablockers are not very widely studied in 
wastewater. Concentration of metoprolol and propranolol in the influent of 
WWTPs ranged from 20 to 4900 ng/L and 36 to 510 ng/L, respectively. In the 
effluent of WWTPs the concentration of metoprolol and propranolol ranged from 
19 to 1700 ng/L and 30 to 180 ng/L, respectively. The removal rate was about 60% 
(Deblonde et al., 2011). Propranolol was detected up to 56 ng/L in UK estuaries 
in 40% of the samples (Thomas and Hilton, 2004). Kasprzyk-Hordern’s study 
suggests that betablockers, like atenolol, propranolol and metoprolol, are very 
persistent in the aqueous environment because they were present in 100% of the 
samples collected downstream from a wastewater discharge point and showing 
very small decreases in concentration with distance from the wastewater 
discharge point (Kasprzyk-Hordern et al., 2008). 
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1.5.6 Industrial chemicals and personal care products 
Bisphenol A is used to make polycarbonate polymers and epoxy resins, which 
are used to make plastic along with other materials. Over six million tons of 
bisphenol A are produced worldwide each year (Welshons et al., 2006). The 
concentration of bisphenol A ranged from 88 to 11800 ng/L in the influent of 
wastewater treatment plants. With the removal rate of 71%, the concentration of 
bisphenol A was between 6 and 4090 ng/L in the effluent (Deblonde et al., 2011). 
Because of the incomplete removal of bisphenol A in the WWTPs, it also been 
detected in surface waters, ground waters and drinking waters. Bisphenol A was 
detected in 41.2% of samples collected from 139 streams in the USA and the 
maximum concentration was 12000 ng/L (Kolpin et al., 2002). In the groundwater 
in the USA, bisphenol A was detected up to 2550 ng/L with 29.8% detection 
frequency (Barnes et al., 2008). In the Australia, bisphenol A was detected up to 
600 ng/L in surface water and 930 ng/L in groundwater. Water samples were 
collected from 27 surface water sites and 59 groundwater sites all across 
Australia (Hohenblum et al., 2004). 
 
Personal care products are used for beautification and in personal hygiene. 
Triclosan is an antimicrobial disinfectant. Triclosan was detected up to 2300 ng/L 
with a very high detection frequency (57.6%) in streams in the United States 
(Kolpin et al., 2002). The removal rate of triclosan was 76.8% (Deblonde et al., 
2011) and the incomplete removal of triclosan from effluents brought triclosan to 
the surface waters or even the drinking water. Triclosan’s maximum 
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concentrations were 95 ng/L in South Wales’ river water (Kasprzyk-Hordern et al., 
2008) and 56.7 ng/L in Romania’s river water (Zaharie, 2006). Triclosan was 
detected in drinking water sample in the USA with the maximal concentration of 
734 ng/L (Mompelat et al., 2009). 
 
1.5.7 Hormones 
A hormone is a chemical released by a cell or a gland in one part of the body, 
which can affect cells of other parts of the body by triggering chemically induced 
messages. Hormones, which can behave as endocrine disruptors in the 
environment, may induce unexpected effect in no-mammalian organism in the 
aqueous environment, such as algae, invertebrate and fish. Disturbance of 
reproductive system and hormone system, immune depression, neurobehavioral 
changes may have effects on the population level (Fent et al., 2006). Estrone 
(E1), 17β-estradiol (E2) and ethynylestradiol (EE2) are the three hormones that 
have been studied most. The natural and environmental concentrations of 
hormones are lower than many other pharmaceuticals, but we still need to pay 
attention to them because they have endocrine disrupting effect at the ng/L level. 
A study of WWTPs located at Galicia, Spain showed that the concentration of E2 
in the influent was 3 ng/L and in the effluent of plant the concentration was below 
detection limit (1 ng/L). The overall removal rate of E2 in WWTPs was around 
65%, but E2 is usually converted to E1 during secondary treatment (conventional 
activated sludge) (Carballa et al., 2004), which explains why sometimes E1 was 
detected at a higher concentration in the effluent of WWTPs than E2 (Kim et al., 
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2007; Ryu et al., 2011).  Estrone was detected in the surface water and ground 
water up to 4.6 ng/L and 1.6 ng/L, respectively, in Australia (Hohenblum et al., 
2004). In the study of U.S. drinking water, the maximum concentrations of E1, E2 
and E3 were 0.9 ng/L, 17 ng/L and 1.4 ng/L in the source water, respectively. But 
none of them were above the detection limit (0.2 ng/L, 0.5 ng/L and 1.0 ng/L, 
respectively) in the finished water (Benotti et al., 2009). 
 
1.6 Control of PPCPs pollution 
More efforts need to be made to decrease the pollution in the environment with 
PPCPs.  Several methods, including segregation of source, improvement of the 
disposal system for expired medicines, application of the pharmaceutical return 
program and the development of “green” pharmaceuticals, can be used to 
prevent the release of PPCPs into the environment. Source segregation can be 
an effective way to prevent pharmaceuticals from entering the environment. 
Wastewater from hospitals can be separated from domestic wastewater and 
advanced treatment can be applied to wastewater form hospitals to remove 
pharmaceutical and personal care products.  Presently, most of the expired 
medicines are disposed of via sinks or toilets, ending up in WWTPs or household 
waste ending up in landfill sites. The US federal prescription drug-disposal 
guidelines (2007) allow flushing certain drugs if it is safe, but suggests returning 
unused, unneeded, or expired medicines to pharmaceutical take-back locations 
for safe disposal (URL2). Development of “green” pharmaceuticals requires more 
efforts and time but would be an effective way to increase the rapid removal of 
23 
 
PPCPs from the environment. Keeping in mind that these compounds are 
produced with an intended biological effect, in the absence of good data 
describing their ecological effects caution should be exerted to prevent their 
chronic release into environmental systems. Because of the lack of an 
environmental regulatory framework continued efforts to document their 
occurrence is still the best approach to keep the discussion going. The work 
presented here is a step in that direction and provides a set of tools and findings 
to advance the knowledge on the environmental occurrence of these chemicals 
in sensitive areas in South Florida.  Water resources in Florida are under 
persistent stress due to the continued expansion of the urban population, the 
constant changes of land use and the competition for good quality water between 
the human population and ecosystem sustainability. 
 
1.7 Objectives 
The overall objective of this study is to monitor the PPCPs and hormones in 
reclaimed waters, surface waters, drinking waters, sediments and soils in South 
Florida in order to provide a general overview of the quality of these resources. 
 
In order to accomplish this task, specific aims include to: 
• Develop a GC-MS method for the detection of PPCPs and hormones in surface 
waters, sediments and soils.  
• Because GC-MS systems are still the most widely used instrument 
in environmental labs. A sensitive GC-MS method is still valuable 
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for the analysis of PPCPs in the environment samples. (Chapters 2 
and 3) 
 
• Develop a fully automated, high throughput online SPE-LC-MS/MS method for 
the detection of PPCPs and hormones in different water matrices to avoid 
sample preparation.  
• The online SPE method simplified sample preparation procedure 
and increased the productivity of analysis. Tandem MS enhanced 
both the selectivity and sensitivity. The online SPE-LC-MS/MS 
method largely increased the efficiency of analysis compared to 
GC-MS method. (Chapters 4 and 5) 
 
• Compare different ionization sources including HESI, APCI and APPI on the 
ionization efficiency for PPCPs and hormones and produce a single, yet 
comprehensive method for the analysis of multiple compounds at 
environmentally relevant concentrations. (Chapters 4 and 5) 
 
• Assess the occurrence of the target compounds in surface, reclaimed and 
drinking waters in South Florida and provide information regarding the present 
state of the quality of water resources with respect to PPCPs.  
• A better understanding of distributions of PPCPs in South Florida 
can be achieved by analyzing the results from surface water 
samples. By analyzing reclaimed water, more information will be 
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provided about the potential effects of water reuse. Results from 
drinking water samples will offer information about current water 
quality in South Florida and the implications for system integrity. 
(Chapters 6 and 7)  
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CHAPTER 2 
Detection of PPCPs and hormones in aqueous samples using GC-MS 
2.1 Introduction    
The wide spread occurrence of pharmaceuticals and personal care products 
(PPCPs) and endocrine disrupting compounds (EDCs) have shifted the attention 
of environmental and toxicological research beyond traditional environmental 
pollutants, such as polychlorinated biphenyls (PCBs), dioxins, and pesticides. 
 
Pharmaceuticals and personal care products are continuously released into the 
environment in vast quantities from many sources but in general municipal 
wastewater has been recognized as one of the main routes bringing human 
pharmaceuticals into the environment. Traditional wastewater treatment 
processes, such as aerated lagoons, conventional activated sludge and filtration, 
do not completely remove drugs and estrogens from their effluents (Lishman et 
al., 2006; Verenitch et al., 2006; Gibson et al., 2007; Gros et al., 2009). Many 
PPCPs and hormones have been detected in the effluent of wastewater 
treatment plants (WWTPs) (Boyd et al., 2003; Gibson et al., 2007) as well as in 
the receiving surface water (Kolpin et al., 2002). The residue of hormones can 
have adverse effects on organisms in the environment at very low concentrations 
(1-10 ng/L). These endocrine disrupting compounds (EDCs) can influence the 
endocrine system under long-term chronic exposure. Synthetic estrogens such 
as mestranol and ethynylestradiol (EE2) have the lowest observable effect level 
(LOEL) on the order of 1 ng/L (Christiansen, 2002). Concentrations above LOEL 
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have already been found in surface water (Kolpin et al., 2002) and current data 
suggests that hormones can travel considerable distance from the source of 
pollution (Barel-Cohen et al., 2006). Therefore, it is essential to monitor 
concentrations of PPCPs and EDCs in the aquatic environment at trace levels to 
provide adequate risk evaluation. 
 
The most common difficulties for the detection of PPCPs are low occurrence 
concentration levels (μg/L or ng/L), which requires highly sensitive instruments 
and the interference coextraction of environment samples, which made it very 
difficult to identify and quantify target compounds. Therefore, proper clean-up 
procedures are required during sample preparation. In addition, there is a need 
for detection of diverse PPCPs in a single run. Therefore, this chapter reviews 
simultaneous detection of PPCPs in the environment. 
 
The analysis of trace level contamination in environmental samples can be 
achieved by sophisticated analytical techniques such as liquid chromatography 
(LC) coupled to tandem mass spectrometry (MS/MS). Ionization sources such as 
electrospray ionization (ESI) and atmospheric chemical ionization (APCI) that are 
coupled to LC can ionize polar and non-volatile compounds (Kolpin et al., 2002; 
Cahill et al., 2004). The high selectivity of tandem mass allows simple sample 
preparation of complex matrix samples such as wastewater (Ingrand et al., 2003; 
Vanderford et al., 2003; Weigel et al., 2004; Castiglioni et al., 2005; Verenitch et 
al., 2006; Gómez et al., 2007; Gros et al., 2009). However, those sophisticated 
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analytical techniques are still not as common as GC-MS because of their high 
cost. In addition, certain steroids such as coprostan-3-ol and coprostanone, are 
very hard to be ionized in ESI or APCI. Gas chromatography mass spectrometry 
is still a very useful common technique to simultaneously detect trace level 
hormones and PPCPs in the environment, despite the fact that GC-MS may 
require an extra derivatization step during sample preparation (Kolpin et al., 2002; 
Boyd et al., 2003; Weigel et al., 2004; Lishman et al., 2006; Gibson et al., 2007). 
 
In my study, I developed a reliable method to simultaneously detect 20 PPCPs in 
surface water using liquid-liquid extraction followed by GC-MS analysis. I 
detected 20 PPCPs of different properties in a single run. The method was used 
to detect compounds in water samples from Big Cypress National Preserve, 
Everglades National Park and Biscayne National Park in south Florida in order to 
understand the current status with respect to PPCPs occurrence and potential 
sources. The research investigates the influence of human activities on the 
surface waters from national parks and provides information on overall water 
quality in South Florida. 
 
2.2 Experimental  
2.2.1 Chemicals 
Caffeine was purchased from Fisher Scientific (Suwannee, GA, USA). N,N-
Diethyl-3-methylbenzamide (DEET), 4-nonylphenol, triclosan, bisphenol A, 
androsterone, 17α-estradiol, estrone, equilin, 17β-estradiol, testosterone, 17α-
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ethynylestradiol, coprostane, progesterone, estriol, coprostan-3-ol, coprostan-3-
one and cholesterol were purchased as solids from Sigma and Aldrich (St. Louis, 
MO, USA). Mestranol and equilenin were purchased as a certified standard 
solution from Dr. Ehrenstorfer (Augsburg, Germany). Caffeine-13C3 used as 
surrogate was purchased from Cambridge Isotope Laboratories, Inc (Andover, 
MA, USA). Deuterated 17β-estradiol (17β-estradiol-d5), bisphenol A (bisphenol 
A-d16), estrone (estrone-d4) and progesterone (progesterone-d9) were 
purchased from CDN Isotopes (Pointe-Claire, Quebec, Canada). All the 
reference standards were >95% purity. Detailed information of selected PPCPs is 
shown in table 1. Intermediate solutions were prepared at concentrations of 200 
ppm in methanol and stored in the dark below 4°C. All laboratory materials were 
either made of glass or Teflon to avoid contamination. Glassware used in 
extraction was cleaned with soap and rinsed with DI water and combustion took 
place at 450 °C for at least six hours. Teflon materials were rinsed with methanol, 
acetone, methylene chloride and hexane before use.  
 
Table 1. Target PPCPs, structure, CAS and intended usage 
Name Structure CAS Use 
DEET 
 
134-62-3 Insect repellant 
Caffeine 
 
58-08-2 Stimulant 
Nonylphenol 
 
104-40-5 
Product formed 
during process 
phenols 
 
N
O
 
N
N N
N
H3C
CH3
CH3
O
O
 
H3C(H2C)7H2C
OH
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Name Structure CAS Use 
Triclosan 
 
3380-34-5 antibiotic 
Bisphenol A 
 
80-05-7 Polymer additive 
Androsterone 
 
53-41-8 androgen 
17α-estradiol 
 
57-91-0 estrogen 
Estrone 
 
53-16-7 estrogen 
Equilin 
 
474-86-2 Estrogen replacement 
17β-estradiol 
 
50-28-2 estrogen 
Testosterone 
 
58-22-0 androgen 
Mestranol 
 
72-33-3 Ovulation inhibitor 
Equilenin 
 
517-09-9 Estrogen replacement 
 
O
Cl
Cl OH
Cl
 
H3C CH3
HO OH
 
HO
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HO
H
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H
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H H
 
O
H3C
HO
 
HO
H H
H3C
H
OH
 
O
H3C H
H3C
OH
H H
 
O
OH
 
HO
O
CH3
H
31 
 
Name Structure CAS Use 
17α-ethynyl 
Estradiol 
 
57-63-6 Synthetic estrogen 
Coprostane 
 
481-20-9 Fecal steroid 
Progesterone 
 
57-83-0 estrogen 
Estriol 
 
50-27-1 Reproductive hormone 
Coprostan-3-ol 
 
360-68-9 Fecal steroid 
Coprostan-3-one 
 
601-53-6 Fecal steroid 
Cholesterol 
 
57-88-5 Plant/animal steroid 
 
2.2.2 Sample collection and sample treatment 
Samples were collected from three different protected areas in South Florida, Big 
Cypress National Preserve (BCNP), Everglades National Park (ENP) and 
Biscayne National Park (BNP). The sampling sites are shown in figure 3. Soap, 
beverages, sun screen, repellent, caffeinated drinks and pharmaceuticals were 
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not allowed to be used during sampling to minimize potential contamination of 
samples. Water samples were collected in previously combusted glass bottles to 
avoid contamination. Samples were filtered through 0.45 µm before being 
transferred into separatory funnels. The walls of the glass bottles were rinsed 
with methylene chloride to guarantee that all analytes were transferred into the 
separatory funnels. 
 
2.2.3 Extraction method 
Each 1 L water sample was extracted by liquid-liquid extraction (LLE) using a 
separatory funnel equipped with Teflon cap and stopper. Samples were fortified 
with surrogate standards (caffeine-13C3, bisphenol A-d16, estrone-d4, 17β-
estradiol-d5 and progesterone-d9) and extracted three times using 50 mL 
methylene chloride. All the organic layers were dried over anhydrous sodium 
sulfate and collected in a 250 mL flat-bottom round flask. Extracts were 
evaporated to about 10 mL in a water bath at 65 °C, transferred to concentration 
tubes, concentrated to 1 mL under nitrogen gas, transferred into 1.5 mL amber 
vial and brought to dryness using nitrogen gas. 
 
2.2.4 Silylation method 
N,O-bis(trimethysilyl)trifluoroacetamide (BSTFA) (100 μL) was added to each 
amber vial and samples were heated at 60 °C for 45 min in the GC oven. Internal 
standard (chrysene-d12) working solution (100 μL) was added to the sample 
extracts before injection to gas chromatography mass spectrometry. 
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Figure 3. Location of sampling sites 
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2.2.5 GC-MS analysis 
All the chromatographic measurements were performed using a Thermo GC/MS 
system comprised of a Finnigan Trace GC Ultra fitted with an autosampler AS 
3000 and a Finnigan Trace DSQ operated in an EI at 70 eV. Derivatized sample 
extracts (2 μL) were injected into a DB-5MS column (30 m with 0.5 μm film 
thickness and 0.25 mm I.D.) under the splitless mode. The helium flow rate was 
held constant at 1.2 mL/min and the GC oven was programmed from 85 °C (1 
min hold) at a rate of 15 °C /min to 270 °C (1 min hold), then at a rate of 5 °C 
/min to 300 °C (10 mins hold). The transfer line was 280 °C. The MS operated in 
EI mode using selected ion monitoring (SIM) to enhance sensitivity. 
 
2.2.6 Quantification 
Quantification of target compounds was accomplished by isotope dilution. The 
target compound was identified by retention time and ions (usually one 
quantitation ion and one or two confirmation ions). The quantitation ion and 
confirmation ion of target compounds are shown in table 2. The ion ratio was 
monitored to distinguish the matrix interference from the target compounds. In 
each sequence of samples, relative response factor (RRF) was calculated by 
calibration solutions. Seven calibration solutions with concentration of target 
compounds representing 5 ng/L to 1000 ng/L were run before samples. A 
continuous calibration check was also performed after each set of samples to 
assure the instrument’s stability through the run.  
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Table 2. Molecular weight, retention time, quantitation ion and confirmation 
ion of PPCPs 
Name type Molecular weight 
RT 
(min) 
Quantitati
on ion 
Confirm
ation ion 
Confirmat
ion ion 
DEET Analyte 191.27 14.33 190 191 119 
Caffeine-13C3 Surrogate 197.21 17.51 197 196 198 
Caffeine Analyte 194.19 17.51 194 195 109 
Nonylphenol Analyte 220.3 18.08 292 179 180 
Triclosan Analyte 289.54 20.72 360 347 345 
Bisphenol A-d16 Surrogate 244.38 21.55 368 386  
Bisphenol A Analyte 228.29 21.67 357 358 372 
Chrysene-d12 
Internal 
standard 240.37 26.26 240 239 236 
Androsterone Analyte 290.00 26.50 272 271 347 
17α-estradiol Analyte 272.38 28.21 416 285  
Estrone-d4 Surrogate 274.39 28.35 346 347 261 
Estrone Analyte 270.37 28.41 342 218 257 
Equilin Analyte 268.35 28.55 340 341 242 
17β-estradiol-d5 Surrogate 277.42 28.78 421 422 287 
17β-estradiol Analyte 272.38 28.83 416 285  
Testosterone Analyte 288.42 29.23 270 360 226 
Mestranol Analyte 310.43 29.73 227 242 367 
Equilenin Analyte 266.33 29.83 338 339 295 
17α-ethynyl 
estradiol Analyte 296.4 30.48 425 426 285 
Coprostane Analyte 372.67 31.06 217 218 357 
Progesterone-d9 Surrogate 323.52 31.50 323 324 279 
Progesterone Analyte 314.46 31.70 314 272 229 
Estriol Analyte 288.38 31.75 311 345 504 
Coprostan-3-ol Analyte 388.67 35.32 370 355 371 
Coprostan-3-one Analyte 386.65 37.33 231 232 386 
Cholesterol Analyte 386.65 37.55 329 368 458 
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2.3 Results and discussion 
2.3.1 Method development and validation 
2.3.1.1 pH range experiment 
The pH is an important factor that affects the recovery of analytes when analytes 
with different functional groups are presented in the sample. Compounds in 
neutral form are more willing to partition to the organic phase, while in their 
ionized form they prefer to stay in the aqueous phase. The pH was adjusted to 
3.0, 6.0 and 10 to assess recoveries across the pH range. Recoveries of target 
analytes are shown in Figure 4. Recovery did not differ significantly at different 
pH values expect for androsterone, equilin, testosterone, and coprostan-3-ol, 
whose recoveries were lower at pH=10. Therefore, pH was not adjusted for the 
real samples. Additionally, there were many advantages of doing extraction at 
natural pH: ① It simplified sample handling: no extra steps were required to 
remove acid or base; ② The pH is amenable to the derivatization step; ③ It 
eliminated the risk of acidic hydrolysis of susceptible analytes during sample 
preparation. 
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Figure 4. Recovery of PPCPs when extraction at different pH 
 
2.3.1.2 Method validation 
Batch quality assurance and quality control included a method blank, a fortified 
blank, one matrix spike sample and one duplicate sample per set of 20 samples 
or less analysis. Recoveries of the matrix spike were consistent between 
analytes. The duplicate sample agreed within 30% of target compounds except 
for cholesterol. Method detection limits (MDLs) are shown in table 3. Analytes 
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were spiked in DI water at environmental concentrations ranging from 2.00 ng/L 
to 20.0 ng/L) and MDLs were between 0.14 ng/L and 2.61 ng/L, respectively. The 
average recovery of analtyes was 79%. 
 
Table 3. Performance data for PPCPs (linearity, method limit of detection, 
spike level and recovery) 
Analyte Surrogate RRF R2 
Spike 
level 
(ng/L) 
MDL 
(ng/L) 
Recovery 
(%) 
DEET Caffeine-13C3 0.7251 0.9744 2.00 0.24 87 
Caffeine Caffeine-13C3 1.0351 0.9990 2.00 2.61 96 
Nonylphenol Bisphenol A-d16 0.2575 0.9980 2.00 0.47 67 
Triclosan Bisphenol A-d16 0.0918 0.9973 2.00 1.20 145 
Bisphenol A Bisphenol A-d16 1.3781 0.9986 2.00 1.46 89 
Androsterone Estrone-d4 0.5796 0.9973 2.00 0.21 107 
17α-estradiol 17β-Estradiol-d5 1.0726 0.9999 2.00 0.14 90 
Estrone Estrone-d4 1.5556 0.9964 2.00 0.22 81 
Equilin Estrone-d4 0.6110 0.9975 2.00 1.09 60 
17β-estradiol 17β-Estradiol-d5 1.1809 0.9999 2.00 0.18 93 
Testosterone Estrone-d4 0.0526 0.9989 4.00 0.37 64 
Mestranol Estrone-d4 0.2421 0.9914 4.00 2.00 107 
Equilenin Estrone-d4 1.6533 0.9963 2.00 0.33 56 
17α-ethynylestradiol 17β-Estradiol-d5 0.2845 0.9964 4.00 0.65 94 
Coprostane Progesterone-d9 1.5742 0.9994 8.00 0.48 85 
Progesterone Progesterone-d9 2.4044 0.9953 8.00 0.41 83 
Estriol 17β-Estradiol-d5 0.3663 0.9957 2.00 0.29 10b 
Coprostan-3-ol Estrone-d4 1.0304 0.9944 4.00 0.51 45b 
Coprostan-3-one Progesterone-d9 0.6814 0.9974 8.00 1.45 60 
Cholesterol Estrone-d4 0.5336 0.9962 a 150 63 
RRF- relative response factor 
R2-coefficient of determination of a linear regression 
MDL- method detection limit  
a MDL was set at 150 n/L because cholesterol is a common contamination on the glassware   
b recovery of estriol is low because of no proper surrogate for it. 
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2.3.2 Analysis of real samples 
The method was successfully applied to 80 samples from surface water collected 
from three protected areas in South Florida. The detailed description of the 
sampling sites and the concentrations of PPCPs are summarized in table 4. 
Detection frequencies and concentrations of PPCPs are shown in figure 5. 
 
Figure 5. Concentrations and frequencies of detection of selected 
microconstituents in all sampling sites 
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DEET was detected in 55% of sampling sites with concentrations ranging from 
ND to 27.9 ng/L. DEET is the most common active ingredient in insect repellents. 
On the basis of the 1990-1999 estimates, approximately four to seven million 
pounds of DEET are used every year in the U.S. (Cahill et al., 2004). Therefore, 
it is not surprising that DEET is the most frequently detected pollutant in ground 
water in the United States (Barnes et al., 2008). Concentrations as high as 1100 
ng/L have been reported for U.S. streams (Kolpin et al., 2002). Nevertheless, 
concentrations of DEET are usually related to recreational use and not an 
indicator of water quality issues related to wastewater intrusion. 
 
Caffeine was detected in 40% of the sampling sites with concentrations ranging 
from ND to 169 ng/L. Caffeine was one of the most frequently detected 
compounds in this study and results are consistent with previous studies in the 
area (Gardinali and Zhao, 2002; Singh et al., 2010) and other similar areas such 
as the Herault watershed, where caffeine was not completely degraded either in 
the wastewater treatment plant or in river water (Rabiet et al., 2006). Caffeine 
has been associated with coral bleaching at concentrations between 30 × 106 
ng/L and 75 × 106 ng/L (Pollack et al., 2009). Although the concentrations are 
orders of magnitude larger than the concentration of caffeine detected in the 
sampling sites, potential impacts of chronic exposure effect at low concentrations 
and possible additive effect with other chemical pollutants should still be of 
concern. Caffeine was neither detected in the sampling sites in Big Cypress 
National Preserve nor in the sampling sites in the Everglades National Park like 
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SRS3, SRS4, WB1, WB2 and WB3. Caffeine was detected in the sampling sites 
along the canals and in the Biscayne Bay National Park, which are affected by 
human activities. Therefore, caffeine can be used as a valuable indicator of 
human activities.  
Triclosan was detected in 30% of the sampling sites, ranging from ND to 10.9 
ng/L. Triclosan is an antibacterial agent added to detergents and soap formulas. 
The annual production of triclosan exceeded a million pounds in the late 1990s 
(Vanderford et al., 2003). Triclosan is hard to be removed during primary 
clarification, aeration basin and secondary clarification stages of wastewater 
treatment. Concentrations of triclosan from a Louisiana treatment plant effluent 
were between 10 to 21 ng/L, which were similar to the concentrations we 
detected (Boyd et al., 2003). Additionally, triclosan was detected at less than 50 
ng/L in the surface water in South Wales, UK (Thomas and Hilton, 2004) and 
found at 4.2 ng/L in surface water from Hamburg, Germany (Weigel et al., 2004). 
 
Androsterone was detected at only one site at a concentration of 2.44 ng/L 
(C111-2). Few studies included androsterone in their target compounds. 
Nevertheless, androsterone is an important weak androgenic steroid hormone, 
which comes from the metabolism of testosterone. Androsterone was detected in 
14.3 % of U.S. streams at a maximal concentration 214 ng/L and a median 
concentration of 17 ng/L (Kolpin et al., 2002). The source for androsterone in the 
area is unknown. 
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Estrone (E1) was detected in only 4% of the sampling sites at a maximal 
concentration of 5.98 ng/L (BB09). These results are much lower than the 
concentrations detected by Kolpin et al. in U.S. streams (112 ng/L) (Kolpin et al., 
2002). Such high concentrations have not seen in any other studies. The study of 
Edward et al. detected estrone in an agricultural region at a maximal 
concentration of 0.9 ng/L in river waters and 17 ng/L in irrigation canals 
(Kolodziej et al., 2004). Estrone detected in BB09 indicated that leaks from the 
landfill or WWTP area nearby may be affecting the quality of surface water. 
Caffeine, DEET, bisphenol A and coprostan-3-ol were also detected in BB09. 
 
Estradiol was detected at two sampling sites at a maximal concentration of 3.34 
ng/L. By contrast, 17β-estradiol was detected in U.S. streams at a maximal 
concentration of 93 ng/L at 10.0% frequency of detection (Kolpin et al., 2002). 
However, such high concentrations were not seen in other studies. Estradiol was 
detected in spring water in Mexico City at a concentration of 0.17 ng/L (Gibson et 
al., 2007). No 17β-estradiol was detected in surface water in the Mississippi 
River (Boyd et al., 2003), effluents from various WWTPs in Italy (Castiglioni et al., 
2005), or effluents from 12 municipal wastewater treatment plants along the 
Thames River in Canada (Lishman et al., 2006). 
 
Coprostan-3-ol, copostane and coprostan-3-one are metabolites of cholesterol 
generated by fecal bacteria (Jeannot et al., 2002). Cholesterol was detected at 
sampling sites at a maximal concentration of 2736 ng/L. Cholesterol can be 
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produced from both nonanthropogenic and anthropogenic sources (Kolpin et al., 
2002). Therefore, chlolesterol was detected at all sampling sites. Similar 
concentrations also were found in the Danube River (Sebok et al., 2009). 
Coprostan-3-ol was detected in 17% of the sampling sites at a maximal 
concentration of 16.5 ng/L (C111-4). Previously, bacterial indicators were used to 
determine the quality of water and the stress from anthropogenic activities. 
Nucleic acid sequences were detected in 93.3% of coral surface microlayer 
samples from Florida Bay. It indicated the accumulation of entire microorganisms 
in the reef environment may be a risk to public and environmental health (Lipp et 
al., 2002). However, bacteria indicators have their limitations, such as being time-
consuming and lacking specificity. Therefore, chemical indicators of human feces 
were an alternative to identifying human sewage contaminations in water bodies. 
The fecal steroid coprostan-3-ol was first suggested to be an indicator of fecal 
pollution (Glassmeyer et al., 2005). Coprostane was detected only at one 
sampling site (TS1) at a maximal concentration of 13.5 ng/L. Coprostane was 
detected in river samples at 20 ng/L (Jeannot et al., 2002). Coprostan-3-one was 
detected at two sampling sites at a maximal concentration of 6.79 ng/L. 
 
Average concentrations of analytes detected in each sampling site were shown 
in figure 6 using different colors. Average concentrations between ND and 10 
ng/L were displayed in blue color.  Average concentrations between 10 and 25 
ng/L were displayed in green color. Average concentrations between 25 and 50 
ng/L were displayed in yellow color. Average concentrations between 50 and 100 
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ng/L were displayed in red color. Result in figure 6 showed that average 
concentrations in BCNP were lower than the other two protected areas. The 
reason is there are almost no residents in BNP area and human activities in BNP 
are much less than the other two protected areas. 
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Figure 6. Map showing the distribution of average concentrations. ND-10 ng/L, blue dot; 10-25 ng/L, green dot; 25-50 
ng/L, yellow dot; 50-100 ng/L, red dot. 
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In summary, the three most frequently detected compounds were DEET, caffeine 
and triclosan, if we do not consider cholesterol. The greater frequency of 
detection of these three compounds may be derived from their greater annual 
use. Mixture of PPCPs was prevalent during this study because forty three 
percent of sampling sites had more than three target compounds. Research has 
shown that certain chemical combinations can have additive toxic effects to 
organisms (Pomati et al., 2008). Therefore, the toxicity research should not only 
focus on individual compound effect but also the mixture of these compounds. 
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Table 4. Description of sampling sites and concentrations of PPCPs 
STATION 
ID 
STATION 
DESCRIPTOR DEET Caffeine Triclosan 
Androst
erone Estrone 
17β-
estradiol Coprostane 
Coprostan-
3-ol 
Coprosta
n-3-one 
Cholester
ol 
BB01 Biscayne Bay 
ND-
8.87 
ND-
54.1 ND ND ND ND ND ND ND ND-276 
BB02 Biscayne Bay 
ND-
10.2 ND ND ND ND ND ND ND ND ND-418 
BB03 Biscayne Bay 
ND-
25.9 ND ND ND ND ND ND ND ND ND -242 
BB04 Biscayne Bay 
ND-
18.3 ND ND ND ND ND ND ND ND 215-274 
BB05 Biscayne Bay 
ND-
8.76 ND ND ND ND ND ND ND ND ND -312 
BB06 Biscayne Bay 
ND-
6.21 ND ND ND ND ND ND ND -1.32 ND 208-420 
BB07 Biscayne Bay 
3.63-
19.3 
ND-
38.5 ND ND ND ND ND ND ND 342-445 
BB09 Biscayne Bay 
ND-
6.29 
ND-
25.4 ND ND 
ND-
5.98 ND ND ND -12.4 ND 
289-
2337 
BB10 Biscayne Bay 
ND-
9.29 ND ND ND ND ND ND ND ND ND -269 
BB11 Biscayne Bay 
ND-
13.2 
ND-
22.9 ND ND ND ND ND ND ND ND -279 
BB12 Biscayne Bay ND ND ND ND ND ND ND ND ND 321-389 
BICY1 Big Cypress ND ND ND ND ND ND ND ND ND ND 
BICY3 Big Cypress 17.2 ND ND ND ND ND ND ND ND ND 
BICY4 Big Cypress ND ND ND ND ND ND ND 3.16 ND ND 
BICY5 Big Cypress 
ND-
16.8 ND ND ND ND ND ND ND ND ND -423 
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STATION 
ID 
STATION 
DESCRIPTOR DEET Caffeine Triclosan 
Androst
erone Estrone 
17β-
estradiol Coprostane 
Coprostan-
3-ol 
Coprosta
n-3-one 
Cholester
ol 
BICY6 Big Cypress ND ND ND ND ND ND ND ND ND 203-319 
BICY7 Big Cypress ND ND ND ND ND ND ND ND ND ND 
BICY8 Big Cypress ND ND ND ND ND ND ND ND ND ND 
C111-1 C111 Basin ND 22.9 2.66 ND ND 3.34 ND ND ND 545 
C111-2 C111 Basin ND 10.6 4.34 2.44 ND ND ND ND ND 353 
C111-3 C111 Canal ND ND 9.10 ND ND ND ND ND ND ND -434 
C111-4 Highway Creek 
6.71-
17.2 
ND -
35.5 ND ND 
ND-
3.42 ND ND 1.59-16.5 ND 
287-
2736 
E1 East Boundary ND ND ND ND ND ND ND ND ND ND 
E2 East Boundary 12.1 39.6 ND ND ND ND ND ND ND 1561 
E3 East Boundary ND 33.6 ND ND ND ND ND ND ND ND 
E4 East Boundary ND ND 10.9 ND ND ND ND ND ND ND 
E5 East Boundary ND 61.3 ND ND ND ND ND ND ND ND 
E6 East Boundary ND 68.8 ND ND ND ND ND ND ND ND 
E7 East Boundary ND ND 9.66 ND ND ND ND ND ND ND 
FB1 Florida Bay ND ND ND ND ND ND ND ND ND 164 
FB2 Florida Bay 11.5 ND ND ND ND ND ND ND ND 553 
S178 Structure 178 ND 
ND -
18.4 
ND -
1.33 ND ND ND ND ND- 5.46 ND-3.22 309-859 
S18C Structure 18C ND 
63.5-
169 ND ND ND ND ND ND ND 158-274 
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STATION 
ID 
STATION 
DESCRIPTOR DEET Caffeine Triclosan 
Androst
erone Estrone 
17β-
estradiol Coprostane 
Coprostan-
3-ol 
Coprosta
n-3-one 
Cholester
ol 
SRS1 
Shark 
River 
Slough 
6.25 87.0 ND ND ND ND ND ND ND 642 
SRS2 
Shark 
River 
Slough 
23.2 40.8 ND ND ND ND ND ND ND 719 
SRS4 Shark River ND ND ND-1.72 ND ND ND ND ND ND 
ND -
1149 
TS1 Taylor Slough 
3.02-
7.24 
56.7-
108 ND-9.66 ND ND ND 13.5 ND -3.26 ND ND -623 
TS2 Taylor Slough ND 12.1 4.86 ND ND 3.16 ND 6.72 ND 702 
TS3 Taylor Slough ND 15.3 ND ND ND ND ND ND ND 456 
TS4 Florida Bay ND ND ND ND ND ND ND ND ND 183 
TT1 Tamiami Trail 
ND -
10.9 
51.2-
71.5 ND-6.20 ND ND ND ND ND ND 284-367 
TT2 Tamiami Trail ND 54.7 ND ND ND ND ND ND ND 191 
TT3 Tamiami Trail 
11.9-
19.8 ND ND-5.54 ND ND ND ND ND ND 234-568 
TT4 Tamiami Trail 
ND -
26.1 ND ND-6.66 ND ND ND ND ND ND 183-899 
WB1 West Boundary 
ND -
8.91 ND ND ND ND ND ND 3.49-5.20 6.79 150-855 
WB2 West Boundary 
11.6-
27.9 ND ND-2.61 ND ND ND ND ND ND ND -274 
WB3 West Boundary 
ND -
4.37 ND ND-6.84 ND ND ND ND ND ND ND -178 
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2.4 Conclusion 
The present study gave an overview of the occurrence of PPCPs and hormones 
in South Florida surface waters. Although there were a few reports about the 
occurrence of microconstituents in several typical environments in South Florida 
(Gardinali and Zhao, 2002; Singh et al., 2010), it was the first time to report the 
occurrence of PPCPs and hormones in surface waters from Big Cypress National 
Preserve, Everglades National Park and Biscayne National Park.  
 
Pharmaceuticals and personal care products were detected at higher 
concentrations and higher frequencies compared to hormones. Caffeine can be 
used as an indicator of human activities. Potential impact of chronic exposure 
effects of caffeine at detected concentrations is still unknown. In our study, the 
highest detected concentration of estrone (5.98 ng/L detected in BB09) was high 
enough to require further investigation because of the toxicological implications 
for fish and probably other aquatic organisms. Results suggested that leakage 
from the landfill area and WWTP nearby may affect the quality of surface water. 
Results also indicated that future toxicity research should not only focus on the 
effect of individual compounds, but also on the influence of mixtures of 
compounds, since 43% of sampling sites have more than 3 compounds detected. 
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CHAPTER 3 
Detection of PPCPs and hormones in sediment samples using GC-MS 
3.1 Introduction 
Current WWTPs do not completely remove PPCPs from wastewater. Measuring 
the concentration of PPCPs in the influent and effluent of WWTPs is insufficient 
to evaluate the efficiency of removal, because many PPCPs may be incorporated 
into sludge, which is used for landfill or as the fertilizer in agriculture (Jelic et al., 
2009). No matter how the sludge is disposed of, PPCPs may enter the 
environment with the sludge and leach into sediment or soil. Moreover, PPCPs 
could enter surface water by runoff or enter groundwater through leaching from 
leakage. Therefore, it is essential to develop new methods for detection of 
PPCPs in the mineral phases, such as sediment, soil and sludge. By analyzing 
sediment or soil samples from the environment, the fate of PPCPs in the 
environment can be better understood. 
 
The difficulty of sediment or soil sample analysis is because of the low 
concentration of PPCPs and the complex effect of matrices. The low 
concentration of analytes requires extensive extraction techniques and large 
concentration rates of samples. Accelerated solvent extraction (ASE) has 
demonstrated more advantages than Soxhlet extraction on automation, reduced 
extraction time and lower solvent consumption.  Reduction of matrix effects 
requires proper cleanup steps (Löffler and Ternes, 2003; Burkhardt et al., 2005; 
Peng et al., 2006). Currently, SPE is the most widely used as cleanup step for 
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environmental sediment and soil samples (Burkhardt et al., 2005; Peng et al., 
2006; Rice and Mitra, 2007; Xu et al., 2008; Durán-Alvarez et al., 2009). For 
instrument analysis, MS2 or high resolution MS are preferred to decrease the 
interference from matrices (Löffler and Ternes, 2003; Gómez et al., 2007; Jelic et 
al., 2009).  However, single quadrupole is still able to do the quantitation if proper 
cleanup steps are applied (Burkhardt et al., 2005; Rice and Mitra, 2007; Xu et al., 
2008; Durán-Alvarez et al., 2009).  
 
In the present study, a method to simultaneously determine many 
environmentally relevant PPCPs and steroid hormones in sediments and soils 
using ASE-SPE-GC-MS was developed. Recoveries of most analytes were 
adequate even when the matrix became complex at very low spike levels. MDLs 
are low enough to detect the target compounds at environmentally relevant levels.  
 
3.2 Experimental  
3.2.1 Chemicals 
Caffeine was purchased from Fisher Scientific (Suwannee, GA, USA). Naproxen, 
ibuprofen, gemfibrozil, triclosan, bisphenol-A, 4-n-nonylphenol, androsterone, 
estrone, equilin, 17β-estradiol, 17α-estradiol, testosterone, 17α-ethynylestradiol, 
coprostane, progesterone, estriol, coprostane, coprostan-3-ol and coprostan-3-
one were purchased as neat compounds from Sigma-Aldrich (St. Louis, MO, 
USA). Equilenin were purchased as certified standard solutions from Dr. 
Ehrenstorfer (Augsburg, Germany). Surrogate standard caffeine-trimethyl-13C3 
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was purchased from Cambridge Isotope Laboratories Inc (Andover, MA, USA); 
DEET-d7, triclosan-d3, 4-n-nonylphenol-d4, equilin-d4, 17β-estradiol-d5, estrone-
d4, 17α-ethynylestradiol-d4, norgestrel-d6, progesterone-d9 and 5α-cholestan-
3β-ol-d5 were purchased from CDN Isotopes (Pointe-Claire, Quebec, Canada). 
Bisphenol A-d16 was purchased from Sigma-Aldrich (St. Louis, MO, USA). All 
the reference standards were >95% purity. Detailed information of analytes is 
shown in table 5. 
 
Table 5. Name, structure, CAS and intended usage of analytes 
Name Structure CAS Use 
Caffeine 
 
58-08-2 Stimulant 
Nonylphenol 
 
104-40-5 
Product formed 
during process 
phenols 
Triclosan 
 
3380-34-5 antibiotic 
Bisphenol A 
 
80-05-7 Polymer additive 
Ibuprofen 
 
15687-27-1 Analgesics and antiinflamatory 
naproxen 
 
22204-53-1 Analgesics and antiinflamatory 
gemfibrozil 
 
25812-30-0 Liqid regulator 
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Name Structure CAS Use 
Androsterone 
 
53-41-8 androgen 
17α-estradiol 
 
57-91-0 estrogen 
Estrone 
 
53-16-7 estrogen 
Equilin 
 
474-86-2 Estrogen replacement 
17β-estradiol 
 
50-28-2 estrogen 
Testosterone 
 
58-22-0 androgen 
Equilenin 
 
517-09-9 Estrogen replacement 
17α-ethynyl 
Estradiol 
 
57-63-6 Synthetic estrogen 
Coprostane 
 
481-20-9 Fecal steroid 
Progesterone 
 
57-83-0 estrogen 
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Name Structure CAS Use 
Estriol 
 
50-27-1 Reproductive hormone 
Coprostan-3-ol 
 
360-68-9 Fecal steroid 
Coprostan-3-one 
 
601-53-6 Fecal steroid 
 
3.2.2 Sampling 
Reclaimed water used for irrigation was collected directly from a sprinkler system  
using 500 mL PETE bottles and was stored in the freezer at <10 °C. The source 
of reclaimed water used in this study is the Miami-Dade Water and Sewer 
Department North District Wastewater Treatment Plant. The wastewater 
treatment plant was designed to have a flow of 120 million gallons per day (MGD) 
with average daily flow around 112.5 million gallons per day. Pure oxygen 
activated-sludge is used in the WWTP as the main secondary treatment process 
(Kasprzyk-Hordern et al., 2008). Extra filtration and disinfection are applied to 
effluents before release to make the reclaimed water ready for use in irrigation. 
Sediments and soil samples were collected in and near a fresh water pond in FIU 
Biscayan Bay Campus (Figure 7). Soil samples were collected under the 
sprinkler and on the side of the pond. Sediment samples were collected at the 
bottom of the pond.  
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Figure 7. Sampling sites of sediment and soil 
 
3.2.3 Sample preparation 
Samples were extracted using a Dionex ASE 200 accelerated solvent extraction 
system. Extraction cells were filled with 20 g of anhydrous sodium sulfate and 2 
grams of the freeze-dried sediment sample. Blanks consisted of 20 g of sodium 
sulfate. The most efficient solvent tested for extraction was methanol and ASE 
conditions used were as follow: pre-heat (0 min), heating time (5 mins), 60% 
flush, 1 cycle. Temperature was held at 100 °C and pressure was 1500 psi. 
Solvent was evaporated to dryness and samples were reconstituted in 60 mL of 
DI water. NH4OH (60 μL) was added to adjust pH to 10. Oasis MAX cartridges 
(225 mg) were conditioned with 5 mL of methanol followed by 5 mL of DI water 
(pH 10). Samples were loaded to the cartridges at a rate of 1-2 mL/min. The first 
fraction (5 mL of methanol: water 1:1) contained polar analytes. The second 
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fraction (5 mL of acetone and 5 mL of acetone with 4% formic acid) contained the 
steroid hormones. Hormone concentrations are usually lower than 
pharmaceuticals in environmental samples and the fractionation helped to 
decrease the background interferences in the gas chromatograph mass 
spectrometry. Fractions were evaporated to dryness using nitrogen gas. Pyridine 
(100 µL) and BSTFA (50 µL) were added to the residue. Compounds were 
derivatized at 60 °C for 45 minutes and analyzed on a Thermo Trace DSQ 
GC/MS. The procedure is shown in figure 8. 
 
Figure 8. Sample preparation procedure for sediments and soils 
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3.2.4 GC-MS analysis 
All the chromatographic measurements were performed using a Thermo GC/MS 
system comprised of a Finnigan Trace GC Ultra fitted with an autosampler AS 
3000 and a Finnigan Trace DSQ operated in an EI at 70 eV. Derivatized sample 
extracts (2 μL) were injected into a DB-5MS column (30 m with 0.5 μm film 
thickness and 0.25 mm I.D.) under the splitless mode. The helium flow rate was 
held constant at 1.2 mL/min and the GC oven was programmed from 85 °C (1 
min hold) at a rate of 15 °C /min to 270 °C (1 min hold), then at a rate of 5 °C 
/min to 300 °C (10 mins hold). The transfer line was 280 °C. The MS operated in 
EI mode using selected ion monitoring (SIM) to enhance sensitivity. Recoveries 
of PPCPs in different matrices and method detection limits (MDLs) were 
performed for method validation. 
 
3.2.5 Extraction recovery and method detection limit 
Analytes were spiked to sodium sulfate, pre-extracted sediment and sediment to 
check the recovery of method. Fortification concentrations are: caffeine, 
bisphenol A, ibuprofen, gemifibrozil, naproxen, nonylphenol, triclosan, estrone, 
equilin, equilenin androsterone, 17β-estradiol, 17α-estradiol, and estriol were 
spiked at 4.4 ng/g. Testosterone, coprostan-3-ol, 17α-ethynylestradiol were 
spiked at 8.9 ng/g. Progesterone, coprostan-3-one and coprostane were spiked 
at 17.8 ng/g. 
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Method detection limits (MDLs) were determined according to EPA guidelines 
(Ripp, 1996). Eight replicate pre-extracted sediment samples spiked with all 
compounds with concentration ranging from one to eight times of the tested 
detection limit (DL). Standard deviations (SD) were calculated from replicates 
and MDL = 2.998 SD. 
 
3.3 Results and discussion 
3.3.1 Method development and validation 
3.3.1.1 Recovery of analytes from different matrices 
Pharmaceuticals and personal care products and hormones were spiked into 
sodium sulfate, pre-extracted sediments and untreated sediments at very low 
fortification levels. Recoveries of PPCPs are shown in figure 9. Recoveries were 
not affected as the matrix complexity increased even for such low fortification 
levels. With the exception of equilin, naproxen and progesterone the method was 
very reliable for the rest of the compounds. 
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Figure 9. Recoveries of analytes in sodium sulfate, pre-extracted sediment and 
untreated sediment.  
 
3.3.1.2 Method detection limit 
Method detection limits of analytes in sediment and soil are shown in table 6. 
Method detection limits were low but varied among pharmaceuticals and 
hormones. Method detection limits for ibuprofen, gemfibrozil and naproxen were 
1.86 ng/g, 1.96 ng/g and 0.85 ng/g, respectively. The detection limits for estrogen 
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hormones were between 1.27 ng/g and 14.5 ng/g. Faecal steroids’ detection 
limits were between 3.58 ng/g and 15.5 ng/g. 
 
Table 6. MDLs of PPCPs and hormones in sediment 
analytes MDL (ng/g) analytes MDL (ng/g) 
caffeine 1.85 equilin 2.11 
bisphenol A 2.51 equilenin 2.64 
ibuprofen 1.86 androsterone 2.99 
gemfibrozil 1.96 testosterone 8.61 
naproxen 0.85 17α-ethynylestradiol 6.68 
4-n-nonylphenol 3.34 estriol 1.27 
tricolsan 1.35 coprostan-3-ol 5.50 
estrone 2.30 progesterone 14.5 
17β-estradiol 2.05 coprostan-3-one 15.5 
17α-estradiol 1.66 coprostane 3.58 
 
3.3.2 Analysis of real samples 
The detected concentration of PPCPs and hormones are shown in table 7.  
Results of reclaimed water samples are analyzed by online SPE-LC-MS/MS 
method, which is shown in chapter 6.3. Most of analytes were below detection 
limits even though some of analytes were detected in the reclaimed water at 
relatively high concentrations. Results indicated that the higher the logkow value, 
the more possible that the compounds attach to the sediment or soil. Coprostanol 
was detected at sediment from the bottom of ponds but concentrations were 
below detection limit on soil samples from side of pond and under sprinkler. The 
most possible explanation is selective partition combined with degradation, 
probably aided by the microbial activity in the soil, the high temperatures of the 
region and long exposure to sunlight.  
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Table 7. Concentrations of PPCPs in reclaimed water, sediment and soil 
 Logkow Reclaimed water (ng/L) 
Sampling site 
1 
Soil under the 
sprinkler 
(ng/g) 
Sampling site 
2 
Soil on the 
side of the 
pond (ng/g) 
Sampling site 
3 
Sediment at 
the bottom of 
pond (ng/g) 
triclosan 4.76 ND-1035 3.78 4.22 7.66 
caffeine <0 ND-3249 ND ND ND 
bisphenol A 3.3 ND-14306 6.14 ND ND 
gemfibrozil 4.75 ND-4177 ND ND ND 
Coprostan-3-ol 8.2 ND-17197 ND ND 235 
 
3.4 Conclusion 
A robust, reliable and sensitive analytical method was developed for the 
simultaneous determination of many environmentally relevant hormones, steroids 
and pharmaceuticals in sediments and soils. Good recoveries were achieved for 
different matrices except for equilin, coprostanol and coprostanone. Method 
detection limits were low enough to detect at environmentally relevant analysis. 
Compounds with low logkow value are willing to stay in the water and 
compounds with relatively high logkow value are more possible to attach to the 
sediment or soil. Even though some of analytes were detected in the reclaimed 
water at relatively high concentrations, most analytes were below detection limits 
in the sediment and soil samples. The microbial activity in the soil, the high 
temperatures of the region and long exposure to sun light may cause the 
degradation of analyte in the soil samples. 
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CHAPTER 4 
Detection of PPCPs and hormones in aqueous samples using online SPE- 
LC-MS/MS assessing the utility of APPI for non ionizable compounds 
4.1 Introduction 
Because traditional wastewater treatment processes cannot completely remove 
drugs and estrogens from the final effluent of conventional wastewater treatment 
plants (WWTPs), pharmaceuticals and personal care products (PPCPs) could be 
continuously released into the environment in rather large quantities (Esperanza 
et al., 2004). It is particularly important when reuse water is used for irrigation. 
Many PPCPs, also named microconstituents or organic waste indicators, have 
been detected in both effluent of wastewater treatment plants and in the 
receiving surface waters (Jeannot et al., 2002; Boyd et al., 2003; Cahill et al., 
2004; Weigel et al., 2004). Several PPCP residues even when present at trace 
levels may have adverse effects on organisms in particular those with endocrine 
disrupting capability (Ben-Jonathan and Steinmetz, 1998). Research has 
indicated that endocrine disrupting compounds (EDCs) can interact with the 
endocrine system of fish at very low concentrations by long-term exposure (Ben-
Jonathan and Steinmetz, 1998; Pollack et al., 2009). Therefore, it is very 
important to accurately monitor concentrations of PPCPs and EDCs in the 
aquatic environment at environmental relevant concentrations (ng/L). 
 
Gas chromatography mass spectrometry (GC-MS) has been traditionally used to 
detect many PPCPs and EDCs in aquatic matrices in a number of studies (Boyd 
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et al., 2003; Weigel et al., 2004; Lishman et al., 2006; Verenitch et al., 2006; 
Gibson et al., 2007; Gómez et al., 2007; Markman et al., 2007). Gas 
chromatography mass spectrometry is a very widely used and mature technique; 
however, it requires collection of large sample volumes, extensive use of solvent 
for extraction, several evaporation steps and in many cases, derivatization steps 
to make polar compounds amenable to gas chromatography. High performance 
liquid chromatography coupled to mass spectrometry has been shown as a 
valuable alternative for detection of PPCPs and EDCs to overcome the 
drawbacks of GC-MS (Gardinali and Zhao, 2002; Gentili et al., 2002; Ingrand et 
al., 2003; Cahill et al., 2004; Castiglioni et al., 2005; Schlüsener and Bester, 2005; 
Martnez Bueno et al., 2007; Gros et al., 2009; Laven et al., 2009; Huerta-Fontela 
et al., 2010; Jian-lin et al., 2010). Electrospray ionization (ESI), atmospheric 
pressure chemical ionization (APCI) and atmospheric pressure photoionization 
(APPI) are the three most common ion sources coupled with HPLC/UPLC. 
Electrospray ionization however because of its versatility dominates the field of 
environmental analysis at trace level (Hilton and Thomas, 2003; Martnez Bueno 
et al., 2007; Lopez-Serna et al., 2010). 
 
Electrospray ionization and APCI have both been widely used for analysis of 
polar molecules in aqueous environmental samples in many studies (Cahill et al., 
2004; Castiglioni et al., 2005; Gros et al., 2009; Lopez-Serna et al., 2010). 
However, ESI and APCI also have many limitations: 1. Because ionization 
efficiencies are charge affinity dependent, certain classes of compounds cannot 
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be ionized (some steroids, nonpolar compounds like PAHs, etc); 2. Adducts with 
common cations ( Na+ and K+), routinely form during ESI, and these charge-
bearing salt compounds could not only increase the chemical background but 
reduce the analyte signal (Hanold et al., 2004). 3. Target analyte molecules are 
often not ionized because of competition with other compounds with higher 
charge affinity. Therefore, most of the studies using ESI are focused on 
pharmaceuticals, which are readily ionizable by electrospray ionization. Fewer 
studies have tried to detect steroid hormones, which are difficult to ionize by ESI 
or APCI, with marginal results (Jeannot et al., 2002; Ingrand et al., 2003). Not 
surprisingly, several studies often rely on the use of chemical derivatization to 
increase sensitivity, even for LC/MS (Palmgren et al., 2005; Lien et al., 2009; 
Wang and Schnute, 2010).  
 
Atmospheric pressure photoionization is on the basis of the interaction of a 
photon beam created by a high intensity discharge lamp with the vapors of a 
nebulized liquid solution entering the MS source (Marchi et al., 2009). 
Atmospheric pressure photoionization is an ionization technique that has the 
capability to ionize compounds with various polarities while being remarkably 
tolerant of matrix additives (Cai et al., 2005; Viglino et al., 2008). The rapidly 
growing number of publications in this area clearly demonstrates the advantages 
of atmospheric pressure photoionization (Raffaelli and Saba, 2003; Bos et al., 
2006; Marchi et al., 2009). Atmospheric pressure photoionization was introduced 
as a complement of ESI and APCI. Currently, APPI has proven to be a valuable 
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tool for analytes, which are poorly or not ionized by ESI and APCI. Examples of 
the progress were shown in recent studies. For example, Viglino and coworkers 
developed a fully automated online method using LC-APPI-MS/MS to 
simultaneously detect selected natural and synthetic hormones at concentrations 
as low as 5 ng/L (Viglino et al., 2008). Yamanoto et al. compared detection of 
steroidal hormones using ESI and APPI and they found that APPI displayed 
higher sensitivity than ESI for most of the unconjugated steroids examined, with 
much greater sensitivity for testosterone and 4-androstene-3, 17-dione 
(Yamamoto et al., 2006). Itoh and coworker was able to detect 16 common 
polycyclic aromatic hydrocarbons (PAHs) with MDLs as low as 0.79-168 ng/L 
using LC/dopant-assisted (DA) APPI/MS (Itoh et al., 2006). Cai and his 
coworkers demonstrated a robust method to detect 16 priority PAHs in 3.5 min at 
low pictogram using chlorobenzene as the dopant. (Cai et al., 2009). Indeed, 
APPI not only gives superior performance on nonpolar compounds but also 
works well for many analytes which are properly ionized by ESI and APCI. Cai et 
al. suggested that APPI could be considered as a more universal ionization 
method since APPI was able to ionized more compounds, with greater structural 
diversity, than ESI and APCI (Cai et al., 2005). Because of the capacity of APPI 
to ionize compounds with various polarities, it has been successfully applied 
frequently to environmental and pharmaceutical samples (Cai et al., 2005; 
Yamamoto et al., 2006; Viglino et al., 2008; Garcia-Ac et al., 2011). 
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Most sample preparation protocols for the analysis of microconstituents in water 
samples uses off-line extraction as the main sample preparation. Although 
relatively straightforward, the disadvantages of off-line extraction are: lengthy 
extractions, and solvent evaporation and dervatization effects on reproducibility. 
Therefore, there is considerable interest in developing on-line sample extraction 
procedures that mainly overcome the need for the time consuming evaporation 
and reconstitution steps in the off-line procedure. Many recent articles have 
described on-line SPE procedure for detection of EDCs (Segura et al., 2007; 
Viglino et al., 2008; Garcia-Ac et al., 2009; Lien et al., 2009). However, further 
development in environmental monitoring should target simultaneous detection of 
multiple classes of compounds with diverse properties using a combination of on-
line SPE and tandem MS to achieve high sample throughput. 
 
In this work, a novel fully automated on-line preconcentration method coupled to 
HPLC-APPI-MS/MS was developed for a comprehensive list of analytes with 
environmental relevance for water tracking in semi pristine environment. The on-
line procedure was optimized for cleanup efficiency and analyte retention. 
Different ionization methods, including HESI, APCI and APPI, were explored. 
Atmospheric pressure photoionization was evaluated with different dopants 
(acetone, anisole, chlorobenzene and toluene). Statistically determined MDLs for 
analytes in each method were generated to cross-evaluate the method’s 
capability. Reclaimed water is often the released end product of a WWTP 
treatment. As a results of water scarcity, use of reclaimed water for agricultural 
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and landscape irrigation has been become increasing popular. However, the use 
of reclaimed water has received much less attention than WWTP effluent, and 
little is known about the risk of contamination of surface water and groundwater 
by this kind of source (Wang et al., 2005; Kinney et al., 2006). A comprehensive 
method should be capable of analyzing both source (reclaimed water) and the 
receiving water with equal robustness. 
 
4.2 Experimental  
4.2.1 Chemicals 
Caffeine was purchased from Fisher Scientific (Suwannee, GA, USA). 
Acetaminophen, naproxen, carbamazepine, primidone, DEET (N,N-Diethyl-3-
methylbenzamide), triclosan, bisphenol-A, gemfibrozil, androsterone, estrone, 
equilin, 17β-estradiol, testosterone, 17α-ethynylestradiol, coprostane, 
progesterone, estriol, coprostan-3-ol and coprostan-3-one were purchased as 
neat compounds from Sigma-Aldrich (St. Louis, MO, USA). 4-tert-octylphenol 
was from Restek (Bellefonte, PA, USA). Mestranol (ethynylestradiol 3-methyl 
ether) and equilenin were purchased as certified standard solutions from Dr. 
Ehrenstorfer (Augsburg, Germany); Surrogate standard caffeine-trimethyl-13C3 
was purchased from Cambridge Isotope Laboratories Inc (Andover, MA, USA); 
DEET-d7, triclosan-d3, carbamazepine-d10, 4-n-nonylphenol-d4, equilin-d4, 17β-
estradiol-d5, estrone-d4, 17α-ethynylestradiol-d4, norgestrel-d6, progesterone-d9 
and 5α-cholestan-3β-ol-d5 were purchased from CDN Isotopes (Pointe-Claire, 
Quebec, Canada). Bisphenol A-d16 was purchased from Sigma-Aldrich (St. 
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Louis, MO, USA). All the reference standards were >95% purity. Detailed 
information for all analytes is shown in Table 8. Stock solutions were prepared at 
concentrations of 200 μg/mL in methanol and stored below 0 °C in the dark. All 
laboratory materials were either made of glass or Teflon to avoid contamination. 
All glassware used in extraction was cleaned with soap and rinsed with water 
before combustion. Glassware was combusted at 450 °C for at least six hours 
before using it. Teflon materials were washed with DI water, rinsed with methanol, 
acetone, methylene chloride and hexane before use.  
 
4.2.2 Sampling 
Reclaimed water used for irrigation was collected directly from a sprinkler system 
using 500 mL PETE bottles and was stored in the freezer at <10 °C. The source 
of reclaimed water used in this study is the Miami-Dade Water and Sewer 
Department North District Wastewater Treatment Plant. The wastewater 
treatment plant was designed to have a flow of 120 million gallons per day (MGD) 
with average daily flow around 112.5 million gallons per day. Pure oxygen 
activated-sludge is used in the WWTP as the main secondary treatment process 
(Kasprzyk-Hordern et al., 2008). Extra filtration and disinfection are applied to 
effluents before release to make the reclaimed water ready for use in irrigation. 
 
4.2.3 Sample preparation 
Water samples were allowed to reach room temperature, filtered through glass 
fiber filters with a pore size of 0.5 µm without loss of analytes and samples were 
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analyzed within 14 days in order to avoid potential degradation and 
transformation of analytes. No additional sample preparation was required 
beyond the addition of surrogates. 
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Table 8. Information of analytes 
compound CAS Usage/source compound CAS Usage/ source 
acetaminophen 103-90-2 analgesic and anti-inflammatory testosterone 58-22-0 natural hormone 
caffeine 58-08-2 stimulant drug progesterone 57-83-0 natural hormone 
primidone 125-33-7 anticonvulsants androsterone 53-41-8 natural hormone 
estriol 50-27-1 Hormone mestranol 72-33-3 synthetic hormone 
carbamazepine 298-46-4 anticonvulsant coprostan-3-one 601-53-6 fecal sterol 
DEET 134-62-3 insect repellent coprostan-3-ol 360-68-9 fecal sterol 
equilenin 517-09-9 natural hormone bisphenol A 80-05-7 intermediate in synthesis of plastics 
naproxen 22204-53-1 
analgesic and anti-
inflammatory ibuprofen 15687-27-1 
analgesic and anti-
inflammatory 
17α-
ethynylestradiol 57-63-6 synthetic hormone triclosan 3380-34-5 
antibacterial and 
antifungal agent 
equilin 474-86-2 natural hormone 4-tert-octylphenol 27193-28-8 degradation of octylphenolethoxylates 
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compound CAS Usage/source compound CAS Usage/ source 
17β-estradiol 50-28-2 natural hormone gemfibrozil 25812-30-0 Lipid regulator 
estrone 53-16-7 natural hormone     
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4.2.4 Instrumentation 
An EQuan Environmental Quantitation system manufactured by Thermo Fisher 
Scientific was used to preconcentrate microconstituents from reclaimed water. 
The EQuanTM system is based on a dual switching-column system, which 
consists of a sample delivery system, a switching-column array and an LC-
MS/MS system. Its sample delivery system consists of an autosampler 
manufactured by CTC analytics AG (Zwingen, Switzerland) and an Accela 600 
loading pump (Thermo Fisher Scientific, San Jose, CA, USA). Its column-
switching array is composed of a Rheodyne 7750E-205 six-port switching valve 
system made by IDEX (Oak Arbor, WA, USA), a preconcentration column and an 
analytical column. A Thermo Hypersil aQ (20 mm × 2.1 mm, 12 µm particle size) 
was used as the loading column and a Thermo Hypersil Gold (50 mm × 2.1 mm, 
1.9 µm particle size) was used as the analytical column. Mass spectrometry 
analysis was performed using a TSQ Quantum Access triple quadrupole mass 
spectrometer (Thermo Fisher Scientific, San Jose, CA, USA). 
 
4.2.5 On-line SPE setup 
Depending on the expected target analyte concentration, 5 mL or 20 mL samples 
were injected into the sample loop (step 1 in figure 10) and then loaded to the 
preconcentration column at a flow rate of 1 mL/min (step 2 in figure 10). This 
loading rate allowed good overall recoveries of analytes. The preconcentration 
column was washed by 1000 µL of water with varied amount of methanol and 
connected to the analytical column after the valve had switched to the inject 
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position. The loading column and analytical column underwent the same gradient 
in the positive ionization (PI) mode or negative ionization (NI) mode (step 3 in 
figure 10). The gradient details are shown in Table 9. 
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Figure 10. On-line SPE procedure 
 
4.2.6 Mass spectrometry 
Mass spectrometry analysis was performed using a TSQ Quantum Access QqQ 
Mass Spectrometer (Thermo Scientific, San Jose, CA, USA). Quantitation for all 
sources was performed using selected reaction monitoring. Instrument control 
and data acquisition were performed using Xcalibur software (rev. 2.1, Thermo 
Scientific, San Jose, CA, USA). Source parameters for analytes were optimized 
using HESI, APCI and APPI independently. A mobile phase of 0.1% fomic 
acid/MeOH (50:50, v/v) was used for the positive ionization mode and 
water/MeOH (50:50, v/v) was used for the negative ionization mode. Each 
analyte and surrogate was injected to the ion source at a concentration of 10 
μg/mL. Compound-dependent parameters such as tube lens and collision energy 
were optimized to obtain maximum signals. The APPI source was further 
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optimized for the dopants described before. Results are shown in Table 10a, 10b 
and 10c. 
Table 9. Gradient of load pump and analytical pump 
Time 
(min) 
Load Pump Analytical Pump Valve position 
Solvent A 
water 
(%) 
Solvent B 
methanol 
(%) 
Flow 
rate 
(μL 
min-1) 
Solvent B 
methanol 
(%) 
Solvent D 
0.1% FA 
in water 
(%) 
Flow 
rate 
(μL min-
1) 
 
PI mode 
0.0 75 25 1000 10 90 200 Load 
6.0 75 25 1000    Inject 
6.1 0 100 250     
7.0    10 90   
14.0    100 0   
26.0    100 0   
27.0   250 10 90  Load 
27.1 0 100 1000     
28.0 0 100      
28.1 100 0      
33.0 100 0  10 90 200  
NI mode 
 
Solvent A 
water 
(%) 
Solvent B 
methanol 
(%) 
Flow 
rate 
(μL 
min-1) 
Solvent A 
water 
(%) 
Solvent B 
methanol 
(%) 
Flow 
rate 
(μL min-
1) 
 
0.0 25 75 1000 50 50 200 Load 
6.0 25 75 1000    Inject 
6.1 0 100 720     
7.0    50 50   
8.0    0 100   
12.0    0 100   
14.0 0 100 720 50 50   
14.1 0 100 1000    Load 
15.0 0 100      
15.1 100 0      
20.0 100 0  50 50 200  
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Table 10a. Ions of analytes in ESI 
Analyte ESI parameter 
 Precursor ion m/z SRM1 CE1 SRM2 CE2 SRM3 CE3 tube lens 
acetaminophen [M+H]+ 
 
150.0 107.2 22 118.1 33 132.1 24 49 
Caffeine [M+H]+ 195.1 138.2 18 110.2 22 83.3 26 67 
Primidone [M+H]+ 
 
219.1 91.2 28 162.2 12 117.2 23 68 
Estriol [M-H]- 287.1 145.2 41 171.1 37 159.2 40 94 
Carbamazepine [M+H]+ 
 
237.1 194.1 19 192.1 25   61 
DEET [M+H]+ 192.1 91.3 25.0 119.2 11.0 65.3 36.0 72 
Equilenin [M-H]- 265.1 193.1 47 221.1 35 181.1 40 81 
Naproxen [M-H]- 229.0 170.1 18 185.2 11   60 
17α-ethynylestradiol [M-H]- 295.2 145.1 23 143.2 45 267.2 15 99 
Equilin [M-H]- 267.1 143.1 36 115.2 47 145.1 30 70 
17β-estradiol [M-H]- 271.1 145.1 45 146.2 35 158.0 33 79 
estrone  [M-H]- 269.1 145.1 40 159.1 37 143.2 56 78 
Testosterone [M+H]+ 289.2 109.2 25 97.2 25 79.3 39 109 
Androsterone [M+H]+ 291.2 273.2 8 255.2 13 199.1 19 97 
78 
 
Analyte ESI parameter 
Progesterone [M+H]+ 315.2 109.2 25 97.2 24 79.3 41 98 
Mestranol          
coprostan-3-one [M+H]+ 387.3 369.4 11 95.2 30 119.3 32 129 
coprostan-3-ol          
bisphenol A [M-H]- 227.1 212.4 20 133.3 28 158.7 11 94 
Ibuprofen [M-H]- 205.1 161.3 10     51 
Triclosan [M-H]- 286.9 142.1 34 160.9 38 35.4 11 111 
4-tert-octylphenol [M-H]- 205.1 133.1 26 134.1 21 117.1 72 99 
Gemfibrozil [M-H]- 249.1 121.2 20 106.1 49 120.1 44 65 
 
Table 10b. Ions of analytes in APCI 
Analyte APCI parameter 
 Precursor ion m/z SRM1 CE1 SRM2 CE2 SRM3 CE3 tube lens 
Acetaminophen [M+H]+ 152.0 110.1 16 93.1 24 65.3 29 82 
Caffeine [M+H]+ 195.1 138.0 19 110.1 23 123.0 31 87 
Primidone [M+H]+ 219.1 91.2 28 162.0 12 119.1 16 83 
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Analyte APCI parameter 
Estriol [M-H2O+H]+ 271.1 253.0 12 157.0 21 133.0 23 76 
Carbamazepine [M+H]+ 237.0 193.9 19 192.9 33 191.9 24 93 
DEET [M+H]+ 192.1 119.1 17 91.2 28 65.3 43 76 
Equilenin [M+H]+ 267.1 209.0 18 249.0 12 165.0 50 70 
Naproxen [M+H]+ 231.0 184.9 14 170.0 25 141.0 44 91 
17α-ethynylestradiol [M-H2O+H]+ 279.1 133.0 16 159 21.0 105.1 32 78 
Equilin [M+H]+ 269.1 251.0 13 211.0 18 181.0 40 78 
17β-estradiol [M-H2O+H]+ 255.2 159.1 18 133.1 22 144.1 37 76 
estrone  [M+H]+ 271.2 253.0 12 157.0 19 159.0 22 78 
Testosterone [M+H]+ 289.2 97.1 24 109.1 26 253.0 16 83 
Androsterone [M-H2O+H]+ 273.2 255.2 10 91.129 38 105.1 35 90 
Progesterone [M+H]+ 
 
315.2 109.1 27 97.1 25 297.0 14 81 
Mestranol [M-H2O+H]+ 285.2 267.0 14 171.0 19 173.0 23 66 
coprostan-3-one [M+H]+ 387.3 369.3 10 95.12 33 147.0 25 94 
coprostan-3-ol [M-H2O+H]+ 371.3 95.1 30 81.2 31 109.1 27.0 90 
bisphenol A [M-H]- 227.1 211.9 21 133.0 31 210.9 34 88 
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Analyte APCI parameter 
Ibuprofen [M-H]- 205.2 161.2 10     58 
Triclosan [M-Cl-2H]- 250.9 214.9 26 186.9 32.0 159.0 31.0 75 
4-tert-octylphenol [M-H]- 205.1 133.1 29 134.1 21 117.1 64 94 
Gemfibrozil [M+H]+ 251.1 232.8 5 129.0 8 83.2 13 87 
 
Table 10c. Ions of analytes in APPI 
Analyte RT (min) APPI parameter 
  Precursor ion m/z SRM1 CE1 SRM2 CE2 SRM3 CE3 tube lens 
         
Acetaminophen 8.2 [M+H]+ 152.1 110.1 15 65.3 31 93.2 23 100 
Caffeine 11.46 [M+H]+ 195.1 138.1 19 110.2 22 123.1 31 100 
Primidone 12.44 [M+H]+ 219.1 162.1 13 91.2 34 119.1 18 98 
Estriol 13.28 [M-H2O+H]+ 271.1 253.1 12 133 30 159.1 30 75 
Carbamazepine 13.66 [M+H]+ 237.1 194.1 18 192.1 23 179.1 35 87 
DEET 14.09 [M+H]+ 192.1  119.1  17 91.2  31 65.3 43 88 
Equilenin 14.59 [M+H]+ 267.1 209.1 18 249.1 11 165.1 52 93 
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Analyte RT (min) APPI parameter 
Naproxen 14.62 [M-COOH]+ 185.1 170.1 17 141.1 33 115.1 49 84 
17α-ethynylestradiol 14.66 [M-H2O+H]+ 279.1 133.1 17 159 19 105.1 37 82 
Equilin 14.67 [M+H]+ 269.1 251.1 14 211.1 18 181 38 103 
17β-estradiol 14.69 [M-H2O+H]+ 255.1 159 17 133.1 19 144 36 76 
estrone  14.76 [M+H]+ 271.1 2531.1 12 159 21 157 19 90 
Testosterone 15.06 [M+H]+ 289.2 97.1 23 109.1 24 253.2 16 107 
Androsterone 15.96 [M-H2O+H]+ 273.2 255.2 13 105.2 39 161.1 23 104 
Progesterone 15.64 [M+H]+ 315.2 109.1 22 97.1 21 297.3 15 68 
Mestranol 16.18 [M+H]+ 293.2 147.1 18 173.1 21 158.1 34 91 
coprostan-3-one 22.04 [M+H]+ 387.3 369.3 16 95.2  35 109.1 28 104 
coprostan-3-ol 22.09 [M-H2O+H]+ 371.3 95.2 31 81.2 34 109.1 26 103 
bisphenol A 12.14 [M-H]- 227.1 212 22 211 35 133.1 34 87 
Ibuprofen 13.20 [M-H]- 205.1 161.1 11     56 
Triclosan 13.43 [M-Cl-2H]- 250.9 215 22 187 31 159 29 100 
4-tert-octylphenol 13.59 [M-H]- 205.1 133.1 28 134.1 20 117.2 62 98 
Gemfibrozil 13.69 [M-H]- 249.1 121.1 17 127.1 14 106.2 45 73 
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To avoid introducing additional variability, ionization techniques were performed 
using a common Ion MAX source housing (Thermo Scientific, San Jose, CA, 
USA). Source-dependent parameters for optimal HESI detection were as follows: 
capillary temperature (300 °C), vaporizer temperature (350 °C), sheath gas 
pressure (35 arbitrary units), aux gas pressure (5 arbitrary units), ion sweep gas 
pressure (8 arbitrary units) and spray voltage (+4000 V and -3500 V). 
 
Source-dependent parameters for optimal APCI detection were as follows: 
capillary temperature (270 °C), vaporizer temperature (400 °C), sheath gas 
pressure (30 arbitrary units), aux gas pressure (5 arbitrary units), ion sweep gas 
pressure (0 arbitrary units) and discharge current (4 μA) for both positive and 
negative polarity. 
 
The photoionization lamp used for APPI was a Syagen krypton UV lamp which 
emits photons at 10 eV and 10.6 eV (Syagen Technology Inc., Tustin, CA, USA). 
The source-dependent parameters for optimal detection were as follows: 
capillary temperature (270 °C), vaporizer temperature (400 °C), sheath gas 
pressure (30 arbitrary units), aux gas pressure (5 arbitrary units), ion sweep gas 
pressure (0 arbitrary units) and discharge current (0 μA). Four different dopants, 
acetone, anisole, chlorobenzene and toluene, were tested to find the best one for 
the analytes.  
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4.2.7 Matrix effect  
Signal suppression or enhancement effects have been widely reported in the 
literature when complicated matrices are tested in API (Viglino et al., 2008). 
Therefore, matrix effects were evaluated using the following equation 1. 
(%) ( ) 100%RWs RWnsmatrixeffect
DIs
−
= ×                                       (1) 
RWs is the analyte peak area in the spiked reclaimed water, RWns is the analyte 
peak area in the non-spiked reclaimed water and DIs is the analyte peak area in 
DI water spiked with a known amount of analytes. Signal enhancement is 
indicated by matrix effect values more than 100%, while signal suppression is 
indicated by matrix effect values less than 100% (Garcia-Ac et al., 2009). Three 
replicate samples were run to determine the relative standard deviation (RSD). 
Spike level of analytes were four times of the spike level used to calculate MDLs, 
which is shown in table 11. 
 
4.2.8 Extraction recovery and method detection limit 
Analyte recovery was evaluated by measuring 5 mL spiked tap water samples 
since it is more comparable to environmental waters than DI water. The spiked 
level of analytes for method detection limits is shown in table 11. For each 
compound, three different spike levels from low to high were tested to evaluate 
how different spike amounts would affect recovery of compounds. Method 
detection limits (MDLs) were determined according to EPA guidelines (Ripp, 
1996). Eight replicate tap water samples spiked with all compounds with 
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concentration ranging from one to eight times of the tested detection limit (DL). 
Standard deviations (SD) were calculated from replicates and MDL = 2.998 SD. 
MDLs were calculated for 5 mL sample size and 20 mL sample size. 
 
4.2.9 QA/QC 
Blanks were run with each batch to check for potential contamination and assess 
background levels of native analytes. Spiked blanks (LBS) and matrix spikes (MS) 
were also run with each analytical batch to check the recovery of analytes. 
Isotopic dilution was used to increase the precision and accuracy of analytsis. A 
five-point calibration curve was constructed with each batch of 20 or less 
samples to check for linearity and analytical sensitivity. Calibration range is 
shown in table 11. 
 
4.3 Results and discussion 
4.3.1 Online procedure optimization 
Optimization of key parameters is essential in the development of a robust online 
procedure: mobile phase flow rate, sample volume, loading flow rate, wash flow 
rate, wash volume and organic composition of the wash solvent were all tested. 
Based on previous study (Lien et al., 2009), the analytical mobile phase flow was 
set at 200 µL/min to produce better analyte signal strength. 1 mL/min was 
chosen as the optimum loading flow rate since it allowed good overall recoveries 
of analytes and higher flow rates have shown to affect the long-term functioning 
of loading columns (Garcia-Ac et al., 2009). The presence of dissolved organic 
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substances in environmental waters could introduce severe interference and 
make quantitation complicated (Viglino et al., 2008). Thus, a wash step was used 
after the loading step. To avoid introducing pressure change, the washing flow 
rate was kept the same as the loading step (1 mL/min). The amount of washing 
time (0.5 and 1.0 mins) and percentages of methanol (25%, 50%, 75% and 100%) 
were changed for all target compounds using 5 mL sample size. Results from 
this optimization are shown in Figure 11. When washing with a volume of 500 μL 
(0.5 min), all the compounds except acetaminophen were effectively retained on 
the loading column independent of the percentage of methanol used (Figure 11a). 
Acetaminophen is very water soluble and was not well retained on the column 
even after washing with only 500 μL of pure water (recovery was 56% ± 5%). 
Therefore, the Hypersil aQ column is not a good choice to retain acetaminophen. 
When the preconcentration column was washed with a volume of 1000 μL (1.0 
min), caffeine and primidone recoveries decreased for methanol content above 
25% (Figure 11b). Quantification of hormones is also difficult because of the 
organic matter interference background when the wash step was eliminated, but 
it improves significantly after the preconcentration column is washed. Therefore, 
a wash step of 1000 μL water with 25% methanol was finally used because it 
represents the best overall performance for recoveries and sensitivities, except 
for acetaminophen, that is poorly recovered under most conditions tested. In 
negative mode, analytes were retained on the preconcentration column very well 
and 1000 μL water with 75% methanol was used as the wash step.  
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Figure 11. Recovery of analytes during the washing step after loading. (a) 500 
µL wash with increasing methanol composition And (b) 1000 μL wash with 
increasing methanol composition. Asterisk (*) indicates not recovered. Spike 
levels are shown in table 11. 
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4.3.2 Comparisons of different ion sources based on MDLs 
Analytes detected in positive mode were separated into three categories 
according to their chemical functionalities and general properties: the 
pharmaceuticals, the hormones and the sterols. Because MDLs were 
dramatically different between categories, MDLs were compared for compounds 
within each category with 5 mL sample size. The best ionization source was 
determined by direct comparison of the MDLs. Analytes detected in the negative 
ionization mode were separated into a fourth category. In each group, 
compounds were ordered based on the average MDL of the different ionization 
methods. Results are summarized in Figure 12,13 and 14. 
 
4.3.3 Pharmaceuticals and personal care products 
The first three compounds of the six compounds in this category, carbamazepine, 
DEET and caffeine, are easily detected in all ion sources (Figure 12). Previous 
studies indicate that these three compounds are better detected using ESI 
(Castiglioni et al., 2005; Trenholm et al., 2008). Our results indicate that APPI 
with toluene is also an excellent alternative. MDLs for the next three compounds, 
naproxen, acetaminophen and primidone, were higher than the first three 
compounds. For naproxen, acetaminophen and primidone, the best detection 
methods were APPI with toluene (15.4 ng/L), APCI (1.92 ng/L) and APPI with 
toluene (38.3 ng/L), respectively. Despite the fact that ESI and APCI showed 
advantage for certain compounds in the category, APPI with toluene is a good 
overall choice to detect them. 
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Figure 12. MDLs of pharmaceuticals for all ionization mechanisms tested. Note 
the different axes. Asterisk(*) indicates best performance 
 
4.3.4 Hormones 
Ten natural and synthetic hormones were investigated in this category. Seven 
out of ten compounds, testosterone, equilenin, equilin, 17α-ethynylestradiol, 
androsterone, estriol and mestranol, were best detected using APPI with toluene 
(Figure 13). Two out of ten compounds, progesterone, 17β-estradiol were best 
detected using APPI with chlorobenzene. One out of ten compounds, estrone, 
was best detected using APPI with acetone. However, for this category, APPI 
significantly outperformed all other ionization modes. 
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Figure 13. MDLs of hormones for all ionization mechanisms tested  
Testosterone and progesterone behaved slightly differently. The two compounds 
showed overall low detection limits for all ion sources tested. A one way ANOVA 
comparison showed that there was no significant difference between ion sources. 
Equilenin and equilin required presence of dopants to improve the MDLs. The 
best dopant for them was toluene with MDLs of 3.44 ng/L and 7.15 ng/L, 
respectively. 17β-estradiol, 17α-ethynylestradiol (EE2), androsterone and 
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mestranol had similar results. These four analytes were extremely hard to ionize 
in HESI and mestranol even did not yield a signal in HESI. MDLs improved 
slightly when APCI and APPI were used but dramatically decreased when 
dopants were added. Toluene was the best dopant for all of them, except for 
17β-estradiol. Based on the results, it is clear that dopant chemistry and proton 
affinity are important for this compound category. 
 
4.3.5 Sterols and sterones 
Two model compounds were investigated in the sterol category. Sterols showed 
much higher MDLs compared with the other two categories (Figure 14). The 
Conventional ESI method is not well suited to ionize sterols because their highly 
lipophilicity and the lack of multiple polar functional groups. APCI however has 
been successfully used for the detection of sterols. A recent study showed that 
APPI was particularly sensitive for cholesterol, sitosterol and sitostanol 
(Palmgren et al., 2005). Coprostan-3-ol could not be ionized in HESI. APPI, 
however, was much better, and MDLs using chlorobenzene (36.7 ng/L) and 
toluene (43.9 ng/L) were low enough for trace analysis. Coprostan-3-one was 
marginally ionized by HESI with an MDL of 2090 ng/L, but APPI with acetone 
dramatically decreased MDL to 118 ng/L. All these results point out again the 
benefit of using a single ionization method for trace environmental analysis. 
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Figure 14. MDLs of sterols and sterones for all ionization mechanisms tested 
 
4.3.6 Negative ionization mode  
Five compounds were detected in the negative ionization mode: bisphenol A, 
ibuprofen, triclosan, gemfibrozil and 4-tert-octylphenol. All of them were detected 
by HESI, APCI and APPI with dopants. Results are shown in Figure 15.  
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Figure 15. MDLs of analytes in negative mode for all ionization mechanisms 
tested 
 
For bisphenol A, APPI with toluene was the best ionization with an MDL of 6.56 
ng/L. For ibuprofen, both HESI and APCI were better choices. Ibuprofen is a very 
polar and small compound; therefore, Atmospheric pressure photoionization did 
not provide an effective method. Triclosan could not be ionized by HESI. APCI 
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improved the ionization of triclosan yielding an MDL of 126 ng/L. APPI with 
toluene as dopant lowered the MDL by half to 67.9 ng/L. Gemfibrozil was 
detected in the negative ionization mode in all the ion sources except for APCI. 
APPI with toluene was the best ionization method, with an MDL of 36.4 ng/L. The 
best ionization method for 4-tert-octylphenol was APCI with an MDL of 47.3 ng/L.  
 
Three of the compounds were best detected in APPI with toluene as dopant. 
However, for polar compounds like ibuprofen or medium polar compounds like 4-
tert-octylphenol, APPI was not the best choice. This is one of the few examples 
where HESI or APCI outperform the APPI source. 
 
4.3.7 Final choice of dopant 
A key goal of this study was to compare ionization sources and provide an 
overall solution in a single run. APPI with toluene as dopant was the choice 
because it provided the lowest MDLs for most analytes. Our results indicate that 
dopant flow is critical in controlling source stability but does not influence signal 
intensity. Different flows of toluene were tested, ranging from 5 µL/min to 50 
µL/min in a constant mobile phase flow rate of 200 µL/min. Analyte signals did 
not increase as the flow rate of the dopant increased for the positive mode; 
however, analyte signals became more stable when the flow was set at 25 
µL/min. In the negative mode, we observed that the signals of bisphenol A, 
ibuprofen and 4-tert-octylphenol were negatively affected when adding more than 
10 µL/min toluene. Therefore, flow rate was kept under 5 µL/min. Dopants have 
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been used since 1994 to enhance photoionization performance (Marchi et al., 
2009). The ionization mechanism usually depends on the PA of the dopant, 
solvent and analyte. There are two possible mechanisms: charge transfer, 
dominated by electron affinity (EA) and proton transfer. In addition, solvent 
molecules having the right proton affinities actively participate in the reaction to 
enhance the ionization efficiency (Equation 2 and 3). Based on the results shown 
in table 10c, where all the target analytes preferentially produced protonated or 
deprotonated molecular ions, the likely mechanism seen in the APPI source is 
probably dominated chemical ionization by solvent molecules (equation 3) with 
the dopant being used to promote the transfer of energy from krypton lamp to the 
solvent rather than to produce direct ionization of the analytes by proton transfer. 
D•+ + nS → [D-H]• + [Sn + H]+     if  PAS > PA[D-H]•                                                  (2) 
[Sn + H]+ + M → nS + [M+H]+     if  PAM > PAS                                                     (3) 
The IE of four dopants, anisole (8.2 eV), toluene (8.3 eV), chlorobenzene (9.07 
eV) and acetone (9.7 eV), are clearly below the IE provided by the lamp and 
lower than of water (12.6 eV) and methanol (10.8 eV), thus formation of the 
radical cation from the dopants will dominate in the source. The PA of four 
dopants are anisole (839.6 kJ/mol) > acetone (812.0 kJ/mol) > toluene (784.0 
kJ/mol) > chlorobenzene (753.1 kJ/mol) (Marchi et al., 2009). Although PAs for 
the compounds targeted in this study are not available in the literature, it is likely 
that will range above the PAs for both water and methanol. Because most 
analytes formed [M+H]+ ions under the optimized conditions tested, the 
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predominant mechanism for our analytes was likely the reaction of dopant 
photoions with solvent molecules, followed by solvent based ionization of the 
analytes by proton transfer as suggested by previous studies for a water-
methanol-toluene system (Kauppila et al., 2002; Kauppila et al., 2004). Although 
acetone have a high IE, its high PA (812.0 kJ/mol) cause it less effective than 
toluene (784.0 kJ/mol) in proton transfer mechanism. Chlorobenzene has often 
been described as the best APPI dopant. However, in this study, toluene 
generated better results and has the advantage of being less toxic than 
chlorobenzene (Marchi et al., 2009). Therefore, toluene was chosen as the 
dopant for all analytes  
 
4.3.8 Recovery comparison 
Three spike levels (1 × MDL level, 5 × MDL level and 10 × MDL level) were used 
to assess recoveries. A summary of the results are present in Figure 16. Analyte 
recoveries in the positive mode ranged from 70% to 152% when spike levels 
were close to MDLs. The recoveries ranged from 86% to 121% when the spike 
level was increased to the 5 × MDL level and ranged from 79% to 126% when 
spike level was increased to the 10 × MDL level. No significant differences were 
seen between the 3 spiking concentrations (average recovery 105%). Results 
indicated that analytes were retained at the preconcentration column very well. 
When spike levels were close to the detection limit, recoveries were more 
variable than at high spike levels. RSD’s of all the spiked samples were less than 
20%, except testosterone and equilenin that spiked at the MDL level (24% and 
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21%). Recoveries of analytes detected in negative mode were less reproducible 
and clearly affected by the spike levels. Analyte recoveries in the negative mode 
ranged from 44% to 216% except for ibuprofen when spike levels were close to 
MDLs. The recoveries ranged from 76% to 163% when the spike level was 
increased to the 5 × MDL level and ranged from 67% to 155% when spike level 
was increased to the 10×MDL level. There is no difference between the 5 × and 
10 × MDL fortification levels but method performance was less robust at 
concentrations near the MDLs. 
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Figure 16. Recovery of analytes at different spike levels 
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4.3.9 Matrix effects evaluation 
Results in Table 11 indicated that 70% of the analyte’s signals were enhanced 
because of matrix effects in APPI, while 30% of analyte’s signals were 
suppressed because of matrix effects. Two compounds, androsterone and 
ibuprofen, were not detected in the spiked reclaimed water sample because of 
high background interference. Compared to other ionization sources (ESI and 
APCI), APPI is not generally considered susceptible to the matrix effect (Hanold 
et al., 2004). However, results in our study showed otherwise, since signal 
intensity were significantly influenced by matrix for most analytes (127% 
average). For example, the enhancement for mestranol and triclosan were more 
than 200% and suppression of 4-tert-octylphenol was 55%. Enhancement and 
suppression were observed in both positive and negative mode. This is a clearly 
indication that the contribution of the solvent and other ionization producing 
procedure described in equation 2 is likely the controlling factor while the 
participation of the dopant is a secondary process. Results also pointed out that 
the wash procedure was essential in eliminating the interference from 
wastewater samples but was a compromise for early eluting highly-polar 
compounds that are more influenced by rinsing with a stronger organic phase.  
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Table 11. Evaluation of the APPI Matrix effect 
Analyte  matrix effect (%) RSD 
 PI mode 
Caffeine 179  7 
Primidone 131  12 
Estriol 118  1 
carbamazepine 172  4 
DEET 120  11 
Equilenin 70  8 
17α-ethynylestradiol 117  15 
Equilin 95  12 
17β-estradiol 106  13 
Estrone 113  3 
Naproxen 121  15 
Testosterone 113  17 
Progesterone 116  5 
Mestranol 247  7 
coprostan-3-one 69  17 
coprostan-3-ol 96  21 
 NI mode 
bisphenol A 126  8 
Triclosan 222  60 
Gemfibrozil 156  11 
4-tert-octylphenol 55  12 
 
4.3.10 Method validation 
The method was validated by using APPI with toluene as a dopant. Calibration 
range, linearity, spike levels and MDLs of 5 mL and 20 mL are shown in Table 12. 
The linearities of all analytes were above 0.99, except gemfibrozil, triclosan and 
4-tert-octylphenol, which were all detected in the negative ionization mode. DEET 
was commonly detected in the reagent water at a concentration of about 2 ng/L. 
DEET can be transferred via dirty hands or gloves (Capdeville and Budzinski, 
2011). Therefore, 10 ng/L was used as the starting calibration point of DEET and 
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MDLs were corrected to 5.9 ng/L.  When sample size was increased from 5 mL 
to 20 mL, some analytes lost their recovery on column since they were washed 
away at loading procedure. Acetaminophen and caffeine cannot be detected 
when sample size was increased to 20 mL. The MDLs of bisphenol A and 
triclosan of 20 mL were higher than 5 mL because of the recovery lost. Statistical 
MDLs were comparable to previous research (Viglino et al., 2008) for estradiol, 
estrone, 17α-ethinylestradiol and progesterone, however the method reported 
here expanded significantly the list of analytes that could be detected 
simultaneously by APPI. Despite the fact that without using dopant (Viglino et al., 
2008), the improvement for specific compounds like estriol (15 ×) combined with 
the detection of fecal sterols at low ng/L levels constitue an important 
improvement justifying the use of dopant.  
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Table 12. Calibration range, linearity, spike levels and MDLs 
 
calibration 
range(ng/L) linearity 
spike level 
(ng/L) 
MDLs(ng/L) 
5 mL  
MDLs(ng/L) 
20 mL 
acetaminophen 100-800 0.9935 200 9.24  NA 
caffeine 2-2048 0.9946 8 1.51  NA 
primidone 62.5-4000 0.9905 250 38.3  14.9 
estriol 32-1024 0.9905 64 10.5  1.64 
carbamazepine 1-256 0.9927 1 1.18  0.30 
DEET 10-2560 0.9912 10 5.90  2.83 
equilenin 4-1024 0.9985 16 3.44  3.39 
naproxen 80-5120 0.9943 160 15.4  8.45 
17α-
ethynylestradiol 4-1024 0.9903 16 4.22  1.26 
17β-estradiol 4-1024 0.9935 16 8.94  2.57 
equilin 10-1280 0.9939 40 7.15  1.17 
estrone  10-1280 0.9951 20 9.47  1.59 
testosterone 2-1024 0.9916 4 2.87  2.30 
progesterone 10-160 0.9901 10 8.93  1.72 
androsterone 32-512 0.9968 32 10.2  37.0 
mestranol 25-800 0.9902 100 21.3  7.89 
coprostan-3-
one 400-6400 0.9941 1600 182  11.2 
Coprostan-3-ol 200-3200 0.9901 200 43.9  5.44 
bisphenol A 20-5120 0.9925 20 6.56  79.1 
ibuprofen 80-5120 0.9994 80 69.3  NA 
triclosan 25-800 0.9817 100 67.9  115 
4-tert-
octylphenol 30-3840 0.9631 60 108  54.7 
gemfibrozil 40-5120 0.9866 80 36.4  NA 
NA: acetaminophen and caffeine lost recovery when sample size was increased to 20 mL. 
Gemfibrozil and ibuprofen can be detected by HESI method. 
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4.4 Conclusion 
A fully automated online preconcentration HPLC-APPI-MS/MS method for 
simultaneous detection of PPCPs, hormones and sterol steroid was developed. 
Results indicate that APPI produce great ionization capability for a broad range 
of compounds, in particular for ionization efficiency of hormones compared to 
APCI and HESI. The advantages of APPI made it a great alternative for 
consistent detection of trace level organic microconstituents in the environment. 
The online preconcentration method minimized the sample preparation 
procedure, thus producing a reliable and robust method that can be used for 
routine analysis of clean and complex matrix water samples, such as ground, 
surface and reclaimed waters.  
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CHAPTER 5 
Assessing different ionization techniques for the detection of 
pharmaceuticals in aqueous samples using online SPE-LC-MS/MS 
5.1 Introduction 
Liquid chromatography mass spectrometry is one of the fastest growing 
analytical techniques because of its attribution to new application on life science 
and biopharmaceuticals (Hans H, 1998; Hanold et al., 2004; Diaz and Barcelo, 
2005; Hernández et al., 2005; Petrovic et al., 2005; Nunez et al., 2011). Currently, 
ESI and APCI are the most widely used ionization techniques coupled to Liquid 
chromatography mass spectrometry. Electrospray ionization and APCI for 
ionization of polar compounds and have been applied successfully in the 
environmental analysis of aqueous samples (Cahill et al., 2004; Castiglioni et al., 
2005; Martnez Bueno et al., 2007; Gros et al., 2009; Laven et al., 2009; Lopez-
Serna et al., 2010). However, ESI and APCI are not very efficient for ionization of 
nonpolar compounds. A new ionization technique, atmospheric pressure 
photoionization (APPI), has been introduced to mass spectrometry (Robb et al., 
2000). The application and principle of APPI have been reviewed and the rapidly 
growing number of publications in this area clearly demonstrates the advantages 
of APPI (Hanold et al., 2004; Bos et al., 2006). Atmospheric pressure 
photoionization has proven to be a valuable tool for analytes, which are poorly or 
not ionized by ESI and APCI or in the presence of complex analytical condition 
(Itoh et al., 2006; Yamamoto et al., 2006; Viglino et al., 2008; Cai et al., 2009). 
Even though many studies have been conducted to investigate the ability of APPI 
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to detect nonpoplar compounds, very little research has focused on the 
performance of APPI on analytes which are sufficiently ionized by ESI and APCI 
(Cai et al., 2005; Garcia-Ac et al., 2011).  
 
In the present study, first, I developed an online SPE method for accurate and 
reliable detection of 52 pharmaceuticals simultaneously in water samples.  The 
online SPE method minimized the sample preparation procedures, and saves 
solvent, time and labor. Second, I compared the ionization efficiency of two 
ionization techniques (HESI and APPI) on the basis of absolute signal intensity 
and also method detection limits (MDLs). It is the first time to compare the 
efficiency of different ionization techniques based on calculated MDLs, which 
provide a useful tool for comparing analytical methods. 
 
5.2. Experimental 
5.2.1 Chemicals 
Ketoprofen, naproxen, ibuprofen, indomethacin,  mefenamic acid, 
acetaminophen, salicylic acid,  antipyrine, gemfibrozil, bezafibrate, fenofibrate, 
atorvastatin, mevastatin, pravastatin sodium salt hydrate, fluoxetine 
(hydrochloride), paroxetine (maleate), carbamazepine, primidone, ranitidine 
(hydrochloride), diphenhydramine (hydrochloride), cimetidine, atenolol, (±) 
metoprolol (+) tartrate, propranolol, betaxolol (hydrochloride), pindolol, nadolol, 
clenbuterol (hydrochloride), enalapril (maleate), hydrochlorothiazide, lisinopril, 
furosemide, tamoxifen, clotrimazole, glibenclamide were purchased from Sigma-
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Aldrich (Allentown, PA, USA). Diclofenac, propyphenazone, phenylbutazone, 
clofibric acid, famotidine, timolol, salbutamol, metronidazole were purchased 
from Fisher Scientific (Pittsburgh, PA, USA). Codeine, diazepam, lorazepam, 
butalbital, phenobarbital, pentobarbital, were purchased from Cerilliant (Round 
Rock, TX, USA). Loratadine, sotalol (hydrochloride), carazolol (hydrochloride) 
were purchased from Toronto Research Chemicals, Inc. (Ontario, Canada). 
Isotopically labelled compounds, used as surrogates, were diclofenac-d4 
(phenyl-d4), (±)-ibuprofen-d3, N-(4-hydroxyphenyl-d4) acetamide, 2-
hydroxybenzoic-d4 acid, phenylbutazone-d10, clofibric-d4 acid, cimetidine-d3, 
(±)-atenolol-d7, (±)-albuterol-d3, enalaprilat-d5, tamoxifen-d5, clotrimazole-d5, 
norfloxacin-d5 were purchased from C/D/N Isotopes Inc. (Quebec, Canada). 
Diazepam-d5, lorazepam-d4, codeine-d6, phenobarbital-d5, pentobarbital d5 
were purchased from Cerilliant (Round Rock, TX, USA). Mefenamic acid-d3, 
fenirofibrate-d6, atorvastatin-d5 (sodium salt), pravastatin-d3 (sodium salt), rac-
trans paroxetine-d4 (hydrochloride), ranitidine-d6 (hydrochloride), loratadine-d4, 
rac timolol-d5 (maleate), hydrochlorothiazide-13C, d2, furosemide-d5, 
metronidazole-d4, glyburide-d11 were purchased from Toronto Research 
Chemicals, Inc. (Ontario, Canada). The detail information of analytes is shown in 
Table 13. 
 
5.2.2 Sample preparation 
Water samples were filtered through glass fiber filters with a pore size of 0.5 µm. 
Samples were analyzed within 14 days in order to avoid potential degradation 
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and transformation of analytes. pH was adjusted to 2 when sample was analyzed 
in the negative mode. 
 
5.2.3 Instrumentation 
An Environmental Quantition (EQuanTM) system manufactured by Thermo Fisher 
Scientific was used to preconcentrate microconstituents from reclaimed water. 
The EQuanTM system is based on a dual switching-column system, which 
consists of a sample delivery system, a switching-column array and an LC-
MS/MS system. Its sample delivery system consists of an autosampler 
manufactured by CTC analytics AG (Zwingen, Switzerland) and an Accela 600 
loading pump (Thermo Fisher Scientific, San Jose, CA, USA). Its column-
switching array is composed of a Rheodyne 7750E-205 six-port switching valve 
system made by IDEX (Oak Arbor, WA, USA), a preconcentration column and an 
analytical column. A Thermo Hypersil Gold aQ (20 mm × 2.1 mm, 12 µm particle 
size) was used as the loading column and a Thermo Hypersil Gold aQ (50 mm × 
2.1 mm, 1.9 µm particle size) was used as the analytical column. Mass 
spectrometry analysis was performed using a TSQ Quantum Access triple 
quadrupole Mass Spectrometer (Thermo Fisher Scientific, San Jose, CA, USA). 
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Table 13. Information of pharmaceuticals 
GROUP No Name CAS Number Pka log Kow Surrogate 
Analgesics and 
anti-inflammatories 1 Ketoprofen 22071-15-4 5.95 3.12 Ibuprofen-d3 
 2 Naproxen 22204-53-1 4.2 3.18 Ibuprofen-d3 
 3 Ibuprofen 15687-27-1 4.3 3.97 Ibuprofen-d3 
 4 Indomethacin 53-86-1 4.5 4.27 Carbamazepine-d10 
 5 Diclofenac 15307-86-5 4 4.5 Diclofenac-d4 
 6 Mefenamic acid 61-68-7 4.2 5.12 Mefenamic acid-d3 
 7 Acetaminophen 103-90-2 9.51 0.46 Acetaminophen-d4 
 8 Salicylic Acid 69-72-7 2.97 2.26 
2-hydroxybenzoic acid 
d4 
 9 Antipyrin 60-80-0 1.4 0.38 Carbamazepine-d10 
 10 Propyphenazone 479-92-5 4.5 1.94 Phenylbutazone-d10 
 11 Phenylbutazone 50-33-9 4.5 2.5 Phenylbutazone-d10 
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GROUP No Name CAS Number Pka log Kow Surrogate 
 12 Codeine 76-57-3 8.2 1.14 Codeine-d6 
Antihyperlipidemics 
- Lipid Regulators 13 Clofibric Acid 882-09-7 2.84 2.57 Clofibric Acid-d4 
 14 Gemfibrozil 25812-30-0 4.75 4.77 Diclofenac-d4 
 15 Bezafibrate 41859-67-0 3.29 4.25 Fenirofibrate-d6 
 16 Fenofibrate 49562-28-9 5 5.19 Fenirofibrate-d6 
 17 Atorvastatin 134523-00-5 4.5 6.36 Atorvastatin-d5 
 18 Mevastatin 73537-88-3 14.89 3.95 Pravastatin-d3 
 19 Pravastatin 81131-70-6 4.7 3.95 Pravastatin-d3 
Antidepressants 
and anticonvulsants 20 Fluoxetine 54910-89-3 9.5 3.82 Fluoxetine-d6 
 21 Paroxetine 61869-08-7 9.9 3.95 Fluoxetine-d6 
 22 Diazepam 439-14-5 3.3 2.19 Diazepam-d5 
 23 Lorazepam 846-49-1 0.03 2.42 Lorazepam d4 
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GROUP No Name CAS Number Pka log Kow Surrogate 
 24 Carbamazepine 298-46-4 13.9 2.46 Carbamazepine-d10 
 25 Primidone 125-33-7 11.6 0.91 Carbamazepine-d10 
Antihistaminies 26 Famotidine 76824-35-6 6.89 -0.64 Ranitidine-d6 
 27 Ranitidine 66357-35-5 
2.7/8.
2 0.27 Ranitidine-d6 
 28 Cimetidine 51481-61-9 6.8 0.4 Cimetidine-d3 
 29 Loratadine 79794-75-5 5 5.2 Loratadine-d4 
 30 Diphehydramine 88637-37-0 9 3.27 Carbamazepine-d10 
Barbiturates - 
Anticonvulsants 31 Butalbital 77-26-9 12.15 1.87 Phenobarbital-d5 
 32 Phenobarbital 50-06-6 7.4 1.47 Phenobarbital-d5 
 33 Pentobarbital 76-74-4 8 2.1 Phenobarbital-d5 
Beta-blockers -
cardiac arrhythmias 34 Atenolol 29122-68-7 9.6 0.36 Atenolol-d7 
 35 Sotalol 3930-20-9 9.55 0.24 Atenolol-d7 
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GROUP No Name CAS Number Pka log Kow Surrogate 
 36 Metoprolol 37350-58-6 9.7 1.8 Atenolol-d7 
 37 Propranolol 525-66-6 9.49 3 Atenolol-d7 
 38 Timolol 26839-75-8 9.2 1.83 Timolol-d5 maleate 
 39 Betaxolol 63659-18-7 9.4 2.81 Atenolol-d7 
 40 Carazolol 57775-29-8 9.52 3.59 Atenolol-d7 
 41 Pindolol 13523-86-9 8.8 1.75 Atenolol-d7 
 42 Nadolol 42200-33-9 9.67 0.71 Atenolol-d7 
Bronchodilators - 
Beta agonists 43 Salbutamol 18559-94-9 9.3 0.64 Albuterol-d3 
 44 Clenbuterol 37148-27-9 17.84 2 Albuterol-d3 
Antihypertensives 45 Enalapril 75847-73-3 3/5.5 0.07 Enalaprilat-d5 
 46 Hydrochlorothiazide 58-93-5 7.9 -0.1 
Hydrochlorothiazide-
13C, d2 
 47 Lisinopril 83915-83-7 2.5 -1.1 Carbamazepine-d10 
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GROUP No Name CAS Number Pka log Kow Surrogate 
Diuretics 48 Furosemide 54-31-9 2.03 2.03 Furosemide-d5 
Cancer treatment 49 Tamoxifen 10540-29-1 8.85 6.3 Tamoxifen-d5 
Antifungals 50 Metronidazole 443-48-1 2.6 -0.1 Metronidazole-d4 
 51 Clotrimazole 23593-75-1 6.7 1.33 Clotrimazole-d5 
Antidiabetic 52 Glibenclamide 10238-21-8 5.3 2.4 Glyburide-d11 
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5.2.4 Direct injection 
Standard solution (25 µL) at 100 ng/mL was injected to compare the ionization 
efficiency of different techniques. The mobile phase flow rate was 200 µL/min. 
The mobile phase used for HESI positive mode was methanol/acetonitrile (50:50, 
v/v) and 0.1% formic acid in water. The proportion of the organic solvent was 1% 
in the first 2 min, and then organic proportion was increased to 100% in 5 min 
and held for 5 min. After that, organic proportion was decreased to 1% in 2 min 
and held for another 2 min. The mobile phase used for HESI negative mode was 
methanol and water. The proportion of the organic solvent was 1% in the first 2 
min, and then organic proportion was increased to 100% in 5 min and held for 5 
min. After that, organic proportion was decreased to 1% in 2 min and hold for 
another 2 min. The mobile phase used for APPI positive mode was the same as 
HESI positive mode but the gradient was different. The proportion of the organic 
solvent was 10% in the first 2 min, and then organic proportion was increased to 
100% in 5 min and held for 5 min. After that, organic proportion was decreased to 
10% in 2 min and held for another 2 min. The mobile phase used for APPI 
negative mode was methanol and water. The proportion of the organic solvent 
was 10% in the first 2 min, and then organic proportion was increased to 100% in 
5 min and held for 3 min. After that, organic proportion was decreased to 10% in 
2 min and held for another 2 min. 
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5.2.5 On-line SPE  
Water samples (5 mL) were loaded to the preconcentration column at a flow rate 
of 1 mL/min. The preconcentration column was washed by 1000 µL of water and 
connected to the analytical column after the valve had switched to inject position. 
After washing, the loading column and analytical column underwent the same 
gradient in both positive mode and negative mode.  
 
5.2.6 Mass spectrometry 
Mass spectrometry analysis was performed using a TSQ Quantum Access triple 
quadrupole QqQ Mass Spectrometer (Thermo Fisher Scientific, San Jose, CA, 
USA) equipped with an Ion MAX source housing capable of operating HESI and 
APPI. Quantitation for all sources was performed using selected reaction 
monitoring (SRM) mode. Instrument control and data acquisition were performed 
using Xcalibur software (rev. 2.1, Thermo Fisher Scientific, San Jose, CA, USA). 
Source parameters for analytes were optimized using Heated Electrospray 
Ionization (HESI) and Atmospheric Pressure Photoionization (APPI) 
independently using flow injection with a carrier stream of mobile phase. A 
mobile phase of 0.1% fomic acid in water/MeOH (50:50, v/v) was used for 
positive mode and water/MeOH (50:50, v/v) was used for negative mode. Each 
analyte and surrogate was injected to the ion source at a concentration of 10 
μg/mL. Compound-dependent parameters such as tube lens and collision energy 
were optimized to obtain maximum signals in the QqQ system. The precursor ion, 
fragment ions and mass-dependent parameters are listed in table 14. 
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Source-dependent parameters for optimal HESI detection were as follows: 
capillary temperature (350 °C), vaporizer temperature (250 °C), sheath gas 
pressure (30 arbitrary units), aux gas pressure (20 arbitrary units), ion sweep gas 
pressure (5 arbitrary units) and spray voltage (4000 V for positive polarity and 
4000 V for negative polarity). 
 
The photoionization lamp used for APPI was a Syagen 10 eV krypton UV lamp 
(Syagen Technology Inc., Tustin, CA, USA). The source-dependent parameters 
for optimal detection were as follows: capillary temperature (300 °C), vaporizer 
temperature (400 °C), sheath gas pressure (50 arbitrary units), aux gas pressure 
(35 arbitrary units), ion sweep gas pressure (0 arbitrary units), discharge current 
(0 μA). Four different dopants, acetone, anisole, chlorobenzene and toluene, 
were tested to find the best one for the analytes.  
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Table 14. Accurate mass and mass spectrometry parameters of analytes 
 
HESI APPI 
compounds 
precursor 
ion m/z 
tube 
lens SRM1 
CE 
1 SRM2 
CE 
2 SRM3 
CE 
3 precursor ion m/z 
tube 
lens SRM1 
CE 
1 SRM2 
CE 
2 SRM3 
CE 
3 
Ketoprofen [M-H]- 253.1 65 209.1 11 
    
[M+H]+ 255.0 70 209.0 13 105.1 22 77.2 39 
Naproxen [M-H]- 229.0 60 170.1 18 185.2 11 
  
[M+H-H2O-CO]+ 185.1 84 170.1 17 141.1 33 115.1 49 
Ibuprofen [M-H]- 205.1 51 161.3 10 
    
[M-H]- 205.1 161.1 11.0 
     
Indomethacin [M-H]- 356.1 65 312.1 12 297.1 21 282.1 32 [M+H]+ 357.9 61 138.9 20 111.0 43 174.0 12 
Diclofenac [M-H]- 294.0 60 250.0 14 214.0 22 178.1 28 [M+H]+ 295.9 63 213.9 34 249.9 13 277.9 7 
Mefenamic acid [M-H]- 240.1 65 196.1 19 192.1 28 180.1 29 [M-H2O+H]+ 224.0 97 209.0 28 180.0 40 208.0 36 
Acetaminophen [M-H]- 150.0 49 107.2 22 118.1 33 132.1 24 [M+H]+ 152.1 100 110.1 15 65.3 31 93.2 23 
Salicylic Acid [M-H]- 137.1 48 93.1 19 65.2 31 75.2 37 [M-H]- 136.9 47 93.4 20 
    
Antipyrin [M+H]+ 189.1 72 77.2 36 56.3 36 131.1 22 [M+H]+ 189.0 68 77.2 37 131.1 21 146.1 20 
Propyphenazone [M+H]+ 231.1 71 201.1 24 189.1 20 56.3 35 [M+H]+ 231.1 76 189.0 20 146.0 25 77.2 41 
Phenylbutazone [M+H]+ 309.2 71 120.1 19 188.1 15 211.1 16 [M+H]+ 309.1 82 210.9 13 132.2 29 77.3 42 
Codeine [M+H]+ 300.2 86 215.1 25 152.1 65 165.1 42 [M+H]+ 300.0 81 165.0 35 215.0 25 153.0 44 
Clofibric Acid [M-H]- 213.1 56 127.1 19 85.2 12 91.3 47 [M-H]- 213.0 79 127.2 20 85.4 13 
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HESI APPI 
compounds 
precursor 
ion m/z 
tube 
lens SRM1 
CE 
1 SRM2 
CE 
2 SRM3 
CE 
3 precursor ion m/z 
tube 
lens SRM1 
CE 
1 SRM2 
CE 
2 SRM3 
CE 
3 
Gemfibrozil [M-H]- 249.1 65 121.2 20 106.1 49 120.1 44 [M-H]- 249.1 73 121.1 17 127.1 14 106.2 45 
Bezafibrate [M-H]- 360.1 63 274.1 20 154.0 32 85.2 19 [M+H]+ 362.1 71 316.0 13 276.0 13 138.9 25 
Fenofibrate [M+H]+ 361.2 72 233.0 16 139.0 31 121.0 32 [M+H]+ 361.0 73 232.9 16 138.9 30 111.0 50 
Atorvastatin [M+H]+ 559.3 88 440.3 21 250.0 42 276.1 40 [M+H]+ 559.1 84 440.0 21 249.9 41 276.0 45 
Mevastatin [M+H]+ 391.3 74 185.1 14 229.1 13 159.1 26 [M+Na]+ 413.1 94 311.1 21 296.0 26 325.3 23 
Pravastatin [M+Na]+ 447.3 97 327.1 19 309.2 22 
  
[M+Na]+ 447.1 101 327.0 19 309.0 24 429.3 24 
Fluoxetine [M+H]+ 310.1 60 44.3 13 148.1 5 183.1 45 [M+H]+ 310.1 70 44.4 13 148.1 5 259.0 5 
Paroxetine [M+H]+ 330.2 71 192.1 20 70.2 31 135.1 37 [M+H]+ 330.0 88 192.0 20 70.2 33 135.0 34 
Diazepam [M+H]+ 285.1 77 193.1 32 154.1 26 222.1 26 [M+H]+ 285.0 83 193.0 31 222.1 25 257.1 21 
Lorazepam [M+H]+ 321.1 74 275.0 22 303.0 15 229.1 31 [M+H]+ 320.9 76 274.9 20 302.9 14 228.9 29 
Carbamazepine [M+H]+ 237.1 61 194.1 19 192.1 25 
  
[M+H]+ 237.1 87 194.1 18 192.1 23 179.1 35 
primidone [M+H]+ 219.1 68 91.2 28 162.2 12 117.2 23 [M+H]+ 219.1 83 91.2 28 162.0 12 119.1 16 
Famotidine [M+H]+ 338.1 55 189.0 20 259.1 11 155.1 32 [M+H]+ 338.2 68 321.2 12 303.2 11 97.1 20 
Ranitidine [M+H]+ 315.1 65 176.0 18 130.1 25 102.1 34 [M+H]+ 315.0 57 176.0 17 130.0 25 270.0 12 
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HESI APPI 
compounds 
precursor 
ion m/z 
tube 
lens SRM1 
CE 
1 SRM2 
CE 
2 SRM3 
CE 
3 precursor ion m/z 
tube 
lens SRM1 
CE 
1 SRM2 
CE 
2 SRM3 
CE 
3 
Cimetidine [M+H]+ 253.1 67 159.1 14 117.2 16 95.2 29 [M+H]+ 253.0 61 159.0 13 117.1 16 95.1 30 
Loratadine [M+H]+ 383.1 82 337.1 23 267.1 31 259.1 30 [M+H]+ 383.0 86 337.0 22 266.9 31 259.0 31 
diphenhydramine [M+H]+ 256.2 54 167.1 14 165.2 37 152.1 37 [M+H]+ 256.1 51 167.0 15 152.0 33 165.0 44 
Butalbital [M-H]- 223.1 60 180.1 14 42.3 20 85.2 15 [M+H]+ 225.1 70 171.1 12 154.1 13 169.1 14 
Phenobarbital [M-H]- 231.1 61 188.2 14 42.5 15 85.3 15 [M-H]- 231.1 24 188.4 13 42.6 18 
  
Pentobarbital [M-H]- 225.1 60 182.1 15 42.4 20 138.2 19 [M-H]- 225.1 62 182.3 15 
    
Atenolol [M+H]+ 267.2 78 145.1 26 190.1 18 133.1 31 [M+H]+ 267.1 72 145.1 26 190.1 18 225.1 16 
Sotalol [M+H]+ 273.2 77 255.1 11 213.1 18 133.1 27 [M+H]+ 273.1 68 255.1 12 213.1 18 133.1 29 
Metoprolol [M+H]+ 268.2 77 159.1 21 191.1 17 133.1 26 [M+H]+ 268.1 80 116.2 17 191.1 17 159.1 20 
Propranolol [M+H]+ 260.2 78 183.1 17 155.1 25 157.1 20 [M+H]+ 260.1 68 116.2 18 183.0 18 155.1 26 
Timolol [M+H]+ 317.2 84 261.1 16 244.1 21 188.0 25 [M+H]+ 317.1 66 261.0 16 244.0 20 188.0 26 
Betaxolol [M+H]+ 308.2 82 121.1 26 133.1 26 91.1 39 [M+H]+ 308.2 82 116.2 19 98.2 22 72.3 22 
Carazolol [M+H]+ 299.1 70 222.1 19 184.0 25 194.1 29 [M+H]+ 299.1 81 116.2 21 222.0 20 194.1 29 
Pindolol [M+H]+ 249.2 72 116.1 17 172.1 17 144.1 25 [M+H]+ 249.1 66 116.2 17 172.1 17 146.0 19 
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HESI APPI 
compounds 
precursor 
ion m/z 
tube 
lens SRM1 
CE 
1 SRM2 
CE 
2 SRM3 
CE 
3 precursor ion m/z 
tube 
lens SRM1 
CE 
1 SRM2 
CE 
2 SRM3 
CE 
3 
Nadolol [M+H]+ 310.2 73 254.1 17 201.1 22 236.1 19 [M+H]+ 310.1 70 254.1 17 236.1 19 201.0 23 
Salbutamol [M+H]+ 240.2 62 148.1 18 222.1 10 121.1 29 [M+H]+ 240.1 66 148.1 19 166.0 12 222.1 8 
Clenbuterol [M+H]+ 277.1 71 203.0 16 259.1 10 132.1 30 [M+H]+ 277.0 60 202.9 16 259.0 9 132.1 28 
Enalapril [M+H]+ 377.2 74 234.1 19 303.2 17 117.1 36 [M+H]+ 377.1 71 234.1 19 303.1 17 117.1 36 
Hydrochlorothiazide [M-H]- 296.0 78 269.0 20 205.0 23 126.1 33 [M-H]- 295.9 60 269.0 19 205.1 23 126.1 23 
Lisinopril [M+H]+ 406.2 88 84.2 33 246.1 22 309.2 18 [M+H]+ 406.1 78 84.2 31 246.1 19 291.1 8 
Furosemide [M-H]- 328.9 75 285.0 17 204.9 23 126.0 36 [M-H]- 328.9 69 205.0 24 285.2 20 78.2 34 
Tamoxifen [M+H]+ 372.2 84 72.2 23 129.1 26 70.2 36 [M+H]+ 372.1 86 72.3 23 129.1 26 70.3 36 
Metronidazole [M+H]+ 172.1 63 128.1 13 82.2 23 111.1 20 [M+H]+ 172.1 61 128.1 12 82.2 25 111.2 18 
Clotrimazole 
[M-
C3H3N2]+ 277.1 60 165.1 27 199.0 31 242.1 20 [M-C3H3N2]+ 277.0 60 165.0 23 241.0 27 239.0 50 
Glibenclamide [M+H]+ 494.3 70 369.1 14 169.0 33 304.1 25 [M+Na]+ 516.0 101 390.9 19 416.9 19 419.4 19 
 
118 
 
5.2.7 Dopant delivery system 
Dopant was delivered by Fusion Touch 100 syringe pump from Chemyx (Stafford, 
TX, USA). Syringe pump was connected to the auxiliary gas and dopant was 
nebulized to gas phase. The dopant gas delivery system is shown in Figure 17. 
Compared to mixing dopant with mobile phase, this dopant gas delivery system 
increased reaction between dopant and analytes. 
 
Figure 17. Dopant gas delivery system, modified from (Hanold et al., 2004) 
 
5.3 Results and discussion  
5.3.1 Optimization of online SPE procedure 
Water samples (5 mL) were loaded to the preconcentration column at different 
flow rates: 500 μL/min, 1000 μL/min, 1500 μL/min and 2000 μL/min.  Absolute 
recovery of analytes (based on the response only) detected in the positive ion 
mode is shown in Figure 18a and absolute recovery of analytes detected in the 
negative mode is shown in Figure 18b. Loading speed of 2000 μL/min and 1000 
μL/min was chosen for positive mode and negative mode respectively since 
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analytes were recovered most at these two flow rates. In the negative mode, the 
pH of samples was adjusted to 2 to increase the recovery of salicylic acid and 
clofibric acid in the loading column. 
 
In order to reduce matrix effects, a wash step was applied after samples were 
loaded to the preconcentration column. Only water was used to wash the 
preconcentration column because some analytes are very soluble in organic 
solvents. Three different volumes of water (1 mL, 2 mL and 3 mL) were tested in 
both positive mode and negative mode and results are shown in figure 19a and 
figure 19b, respectively. In the positive mode, Metronidazole, lisinopril and 
primidone started to be lost when wash volume was more than 1 mL. Therefore, 
1 mL was chosen as the wash volume in the positive mode. In the negative mode, 
acetaminophen was not retained in the preconcentration column when the wash 
volume was more than 1 mL and the result was consistent with the result shown 
in 4.3.1. Therefore, the Hypersil aQ column is not a good choice to retain 
acetaminophen. Hydrochlorothiazide lost its recovery on the preconcentration 
column when wash volume was more than 1 mL. Thus, 1 mL was also chosen as 
the wash volume in the negative mode. 
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Figure 18a. Absolute recovery of analytes at different load speeds in the positive mode 
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Figure 18b. Absolute recovery of analytes at different load speeds in the negative mode 
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Figure 19a. Absolute recovery of analytes in positive mode with different wash volume 
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Figure 19b. Absolute recovery of analytes in negative mode with different wash volume. Asterisk (*) indicates not 
recovered. 
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5.3.2 Comparison of different API techniques 
5.3.2.1 Comparison based on absolute signal intensity 
Several studies compared the absolute signal intensity of pharmaceuticals using 
different ionization methods (Cai et al., 2005; Garcia-Ac et al., 2011). We 
compared the signal intensity of different ionization methods by direct injection of 
2.5 ng standard compounds. The signal intensity of compound detected in the 
HESI method was treated as 100%. The signal intensity of compounds detected 
in other ionization methods was compared with the HESI method. Results of 
comparison are shown in Table 15. The best ionization method is shown in green. 
For 32 out of 52 compounds, HESI was the best ionization method. 14 out of 52 
compounds were best detected by APPI with toluene as dopant. Only 3 analytes 
were best detected using chlorobenzene as dopant and 3 were best detected in 
APPI with acetone as dopant. Results indicated that HESI was still a very 
effective ionization method for the selected target compounds. For some of the 
compounds usually analyzed in the negative mode in ESI, signal intensity 
increased remarkablely when they were ionized in the positive mode in APPI. 
Ketoprofen ([M-H]- →  [M+H]+), naproxen ([M-H]- →  [M+H-H2O-CO]+), 
indomethacin ([M-H]- → [M+H]+), diclofenac ([M-H]- → [M+H]+), mefenamic acid 
([M-H]- → [M+H-H2O]+), acetaminophen ([M-H]- → [M+H]+) and bezafibrate ([M-
H]- → [M+H]+) were in that case (figure 20). For acetaminophen, signal intensity 
increased 80 times when it was ionized by APPI with toluene as dopant. 
Therefore, APPI with toluene as dopant has two major advantages, firstly, it 
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increases the sensitivity and secondly it avoids the need for positive and negative 
runs for the same sample. 
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Figure 20. Chromatography of compounds in HESI- and APPI+ 
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Table 15. Comparison of analyte responses under different ionization conditions  
  HESI   RSD APPI   RSD 
APPI 
toluene   RSD 
APPI 
acetone   RSD 
APPI 
anisole   RSD 
APPI 
chlor
oben
zene   RSD 
ketoprofen 100 
+
- 10 1 
+
- 8 234 
+
- 8 55 
+
- 5 41 
+
- 9 25 +- 9 
Naproxen 100 
+
- 22 ND 
  
73 
+
- 5 38 
+
- 14 ND 
  
425 +- 11 
Ibuprofen 100 
+
- 13 ND 
  
6 
+
- 8 3 
+
- 16 7 
+
- 2 5 +- 6 
Indometacin 100 
+
- 11 1 
+
- 22 136 
+
- 7 80 
+
- 3 58 
+
- 3 51 +- 5 
Diclofenac 100 
+
- 10 1 
+
- 24 112 
+
- 1 49 
+
- 4 27 
+
- 7 20 +- 13 
Mefenamic acid 100 
+
- 16 8 
+
- 28 228 
+
- 2 168 
+
- 4 67 
+
- 1 53 +- 2 
Acetaminophen  100 
+
- 19 124 
+
- 9 8059 
+
- 9 6682 
+
- 13 1373 
+
- 9 1111 +- 12 
Salycilic Acid 100 
+
- 11 ND 
  
ND 
  
ND 
  
ND 
  
ND 
  
Antipyrin 100 
+
- 5 4 
+
- 20 166 
+
- 19 170 
+
- 5 85 
+
- 23 ND 
  
Propyphenazone 100 
+
- 4 24 
+
- 11 316 
+
- 4 257 
+
- 3 64 
+
- 3 54 +- 12 
Phenylbutazone 100 
+
- 8 1 
+
- 20 115 
+
- 5 54 
+
- 3 19 
+
- 5 13 +- 33 
Codeine 100 
+
- 3 4 
+
- 12 61 
+
- 7 87 
+
- 3 32 
+
- 14 28 +- 17 
Clofibric Acid 100 
+
- 4 ND 
  
8 
+
- 7 5 
+
- 2 11 
+
- 8 13 +- 11 
Gemfibrozil 100 
+
- 15 ND 
  
27 
+
- 2 17 
+
- 5 31 
+
- 2 23 +- 5 
Bezafibrate 100 
+
- 8 1 
+
- 8 67 
+
- 4 49 
+
- 3 13 
+
- 10 9 +- 20 
Fenofibrate 100 
+
- 0 2 
+
- 20 128 
+
- 3 84 
+
- 5 25 
+
- 8 21 +- 14 
Atorvastatin 100 
+
- 5 ND 
+
- 56 3 
+
- 13 3 
+
- 12 1 
+
- 15 1 +- 24 
Mevastatin 100 
+
- 17 14 
+
- 6 5 
+
- 13 4 
+
- 15 2 
+
- 14 2 +- 14 
Pravastatin 100 
+
- 4 ND 
  
10 
+
- 18 ND 
  
ND 
  
ND 
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  HESI   RSD APPI   RSD 
APPI 
toluene   RSD 
APPI 
acetone   RSD 
APPI 
anisole   RSD 
APPI 
chlor
oben
zene   RSD 
Fluoxetine 100 
+
- 3 ND 
+
- 16 6 
+
- 4 4 
+
- 6 1 
+
- 9 1 +- 26 
Paroxetine 100 
+
- 3 4 
+
- 21 24 
+
- 6 19 
+
- 7 5 
+
- 1 5 +- 8 
Diazepam 100 
+
- 4 3 
+
- 18 48 
+
- 3 34 
+
- 4 17 
+
- 1 16 +- 8 
Lorazepam 100 
+
- 1 2 
+
- 18 91 
+
- 3 69 
+
- 13 27 
+
- 7 21 +- 13 
Carbamazepine 100 
+
- 1 1 
+
- 8 32 
+
- 6 31 
+
- 3 8 
+
- 3 6 +- 15 
Primidone 100 
+
- 9 ND 
  
334 
+
- 2 74 
+
- 4 61 
+
- 1 223 +- 1 
Famotidine  100 
+
- 3 ND 
  
ND 
  
380 
+
- 2 138 
+
- 4 110 +- 7 
Ranitidine 100 
+
- 6 2 
+
- 13 84 
+
- 12 83 
+
- 9 11 
+
- 8 9 +- 8 
Cimetidine  100 
+
- 5 9 
+
- 13 336 
+
- 8 418 
+
- 10 72 
+
- 7 59 +- 11 
Loratadine 100 
+
- 2 4 
+
- 18 30 
+
- 4 22 
+
- 5 7 
+
- 2 6 +- 16 
diphenhydramine 100 
+
- 2 ND 
  
5 
+
- 4 3 
+
- 12 1 
+
- 4 1 +- 16 
Butalbital 100 
+
- 15 ND 
  
65 
+
- 8 ND 
  
ND 
  
ND 
  
Phenobarbital 100 
+
- 2 ND 
  
135 
+
- 15 77 
+
- 5 160 
+
- 5 170 +- 23 
Pentobarbital 100 
+
- 25 ND 
  
349 
+
- 15 179 
+
- 21 344 
+
- 8 379 +- 7 
Atenolol 100 
+
- 8 3 
+
- 21 176 
+
- 9 148 
+
- 10 24 
+
- 11 22 +- 12 
Sotalol 100 
+
- 2 5 
+
- 26 228 
+
- 8 202 
+
- 5 36 
+
- 6 31 +- 11 
Metoprolol 100 
+
- 4 3 
+
- 8 15 
+
- 19 13 
+
- 14 2 
+
- 20 2 +- 4 
Propranolol 100 
+
- 4 4 
+
- 27 20 
+
- 10 16 
+
- 15 3 
+
- 11 2 +- 16 
Timolol 100 
+
- 1 2 
+
- 22 16 
+
- 16 12 
+
- 19 3 
+
- 20 2 +- 27 
Betaxolol 100 
+
- 4 19 
+
- 15 72 
+
- 5 59 
+
- 6 14 
+
- 9 14 +- 17 
Carazolol 100 
+
- 5 5 
+
- 42 28 
+
- 8 21 
+
- 14 4 
+
- 20 3 +- 14 
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  HESI   RSD APPI   RSD 
APPI 
toluene   RSD 
APPI 
acetone   RSD 
APPI 
anisole   RSD 
APPI 
chlor
oben
zene   RSD 
Pindolol 100 
+
- 7 12 
+
- 7 445 
+
- 15 383 
+
- 11 61 
+
- 5 45 +- 16 
Nadolol 100 
+
- 3 6 
+
- 8 190 
+
- 6 134 
+
- 12 26 
+
- 9 19 +- 21 
Salbutamol 100 
+
- 2 1 
+
- 24 30 
+
- 11 17 
+
- 17 5 
+
- 4 3 +- 10 
Clenbuterol 100 
+
- 4 ND 
  
14 
+
- 11 9 
+
- 11 2 
+
- 25 1 +- 18 
Enalapril 100 
+
- 3 3 
+
- 17 27 
+
- 12 15 
+
- 10 4 
+
- 11 3 +- 8 
Hydrochlorothiazide 100 
+
- 13 ND 
  
5 
+
- 53 2 
+
- 18 8 
+
- 21 14 +- 11 
Lisinopril 100 
+
- 12 ND 
  
ND 
  
ND 
  
ND 
  
ND 
  
Furosemide 100 
+
- 9 ND 
  
25 
+
- 7 15 
+
- 19 30 
+
- 3 32 +- 8 
Tamoxifen 100 
+
- 2 9 
+
- 24 14 
+
- 2 15 
+
- 4 5 
+
- 1 4 +- 8 
Metronidazole 100 
+
- 3 5 
+
- 8 248 
+
- 18 149 
+
- 11 45 
+
- 17 37 +- 25 
Clotrimazole 100 
+
- 2 7 
+
- 19 20 
+
- 2 11 
+
- 3 22 
+
- 3 21 +- 1 
Glibenclamide 100 
+
- 1 ND     1 
+
- 17 1 
+
- 21 ND     ND     
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5.3.2.2 Comparison based on MDLs 
For further study, we also compared the MDLs of target compounds. Statistically 
determined MDLs using fortified matrix matched samples can be used to 
compare among method and laboratory and truly reflect the performance of the 
detection method. The study only reported the MDLs comparison for compounds 
that were detected in the positive mode in APPI because for compounds 
detected in the negative mode HESI had certainly a better sensitivity. MDLs for 
target compounds under the different ionization methods are shown in Table 16 
and number of compounds with MDLs in 0-5 ng/L, 5-10 ng/L and >10 ng/L range 
are shown in figure 21. For some of the compounds MDLs of APPI were much 
higher than HESI. Take pravastatin for example, MDLs of HESI was 6.9 ng/L 
while MDLs of APPI was more than 500 ng/L. Thus, we still should use HESI as 
ionization method for these compounds. For some compounds like 
propyphenazone, gemfibrozil and fenofibrate etc, calculated MDLs didn’t 
decrease much from HESI to APPI with dopant. Therefore, we can use HESI or 
APPI as the ionization method for these compounds. For compounds that were 
ionized in the negative mode in HESI but the positive mode in APPI, even 
thorough MDLs didn’t decrease much in APPI, a much better background were 
observed in APPI. Take ketoprofen for example, MDLs of HESI and APPI with 
toluene were 10.0 ng/L and 14.7 ng/L, respectively. However, in the negative 
ionization mode of HESI, there were two interference peaks very close to the 
ketoprofen peak. In the positive ionization mode of APPI, there were no 
interference peaks for ketoprofen at all (figure 22). Thus, we used APPI as 
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ionization method for detection of these compounds.  In figure 23, analytes in 
blue cycle is properly to be ionized by HESI and the analytes in the orange cycle 
is properly ionized by APPI, while the analytes in overlapped part of two cycles 
indicated that these analytes can be both ionized by both HESI and APPI. HESI 
is still an ideal ionizatioin technique for polar compounds except for 
acetaminophen. APPI is also a competitive ionization method for many polar 
analytes (overlap part in figure 23).  APPI is an excellent ionization method for 
less polar and nonpolar compounds (analytes in orange cycle from chapter 4). If 
there is a need to detect polar and non-polar com pounds simultaneously, APPI 
will be the best ionization technique. 
 
 
Figure 21. Number of compounds with MDL in 0-5 ng/L, 5-10 ng/L and >10 ng/L 
in HESI and APPI with toluene as dopant 
HESI
0-5 ng/L: 14
5-10 ng/L: 12 
>10 ng/L: 26
APPI with toluene
0-5 ng/L: 0
5-10 ng/L: 5 
>10 ng/L: 47 
132 
 
 
 
Figure 22. Chromatography of ketoprofen in HESI- and APPI+ 
 
Table16. MDLs comparison of different API 
    HESI APPI toluene APPI acetone 
1 ketoprofen 10.0 14.7 250 
2 naproxen 74.0 15.4 15.7 
3 ibuprofen 11.9 NA NA 
4 indomethacine 19.2 8.6 51.0 
5 diclofenac 8.7 9.2 382 
6 mefenamic_acid 2.5 6.0 339 
7 acetaminophen 351 9.24 16.6 
8 salicylic_acid 23.6 NA NA 
9 antipyrine 4.5 148 >250 
10 propyphenazone 5.0 12.3 217 
11 phenylbutazone 147 500 500 
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    HESI APPI toluene APPI acetone 
12 codeine 6.2 354 500 
13 clofibric_acid 23.6 NA NA 
14 gemfibrozil 14.4 36.4 367 
15 bezafibrate 26.0 11.2 24.1 
16 fenofibrate 14.2 21.8 5.1 
17 atorvastatin 6.9 >500 156 
18 mavastatin 75.1 >500 >500 
19 pravstatin 9.0 >500 >500 
20 fluoxetine 12.3 166 388 
21 paroxetine 12.2 235 514 
22 diazepam 1.8 10.9 206 
23 lorazepam 6.4 20.5 31.9 
24 carbamazepine 2.8 19.9 8.5 
25 primidone 28.9 38.3 72.5 
26 famotidine 1.8 >500 >500 
27 ranitidine 3.5 500 500 
28 cimetidine 4.6 154 118 
29 loratadine 5.6 13.0 24.4 
30 diphenhyramine 4.3 33.0 500 
31 butalbital 189 NA NA 
32 phenobarbital 39.7 NA NA 
33 pentobarbital 32.4 NA NA 
34 atenolol 7.0 218 29.6 
35 sotalol 3.5 125 387 
36 metoprolol 13.1 29.6 24.9 
37 propranolol 13.6 22.5 341 
38 timolol 3.9 202 10.5 
39 betaxolol 19.3 224 487 
40 carazolol 10.0 38.2 156 
41 pindolol 10.2 136 152 
42 nadolol 5.7 107 6.9 
43 salbutamol 3.8 357 500 
44 clenbuterol 4.1 15.7 141 
45 enalapril 3.7 6.8 20.3 
46 hydrocholorothiazide 250 NA NA 
47 lisinopril 25.6 >500 >500 
48 furosemide 8.2 NA NA 
49 tamoxifen 42.7 324 500 
50 metronidazole 98.2 >500 >500 
51 clotrimazole 6.3 29.3 140 
52 glibenclamide 22.1 381 >500 
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Figure 23. Analytes that can be ionized in HESI, APPI or both 
 
5.4 Conclusion 
An online-SPE-LC-MS/MS method was developed to detect 52 pharmaceuticals 
simultaneously. The online-SPE method was able to retain target compounds 
very well and interference was reduced by the wash step. HESI and APPI were 
compared by both absolute intensity and MDLs for ionization of 52 
pharmaceuticals. Results indicated that HESI was an ideal ionization technique 
for polar compounds. However, APPI is an alternative ionization technique for 
some polar compounds that were ionized in positive mode.  For simultaneous 
detection of compounds with various polarities, APPI will be a better choice since 
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it showed comparable performance to HESI for some polar compounds and 
excellent performance for less polar or non-polar compounds. 
 
A summary is shown in table 17 on the basis of comparison of methods 
developed in previous chapters for analytes. Proper methods were 
recommended for the detection of analytes. In general, GC/MS is good for 
nonpolar compounds. For less polar compounds, a derivation step is very 
important for the analysis of GC/MS. Heated electrospray ionization of LC/MS is 
appropriate for the detection of polar compounds. APPI with dopant is capable to 
ionize compounds with various polarities.  
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Table 17. Comparison of GC/MS, LC/MS with different ionization sources for analytes 
  GC/MS LC/MS 
 Name   HESI APCI APPI 
APPI 
acetone 
APPI 
anisole 
APPI 
chlorobenzene 
APPI 
toluene 
Ketoprofen 
 
YES 
     
YES 
Naproxen 
 
YES 
     
YES 
Ibuprofen 
 
YES YES 
     
Indomethacin 
 
YES 
     
YES 
Diclofenac 
 
YES 
     
YES 
Mefenamic acid 
 
YES 
     
YES 
Acetaminophen  
  
YES 
    
YES 
Salicylic Acid 
 
YES 
      
Antipyrin 
 
YES 
      
Propyphenazone 
 
YES 
     
YES 
Phenylbutazone 
 
YES 
      
Codeine 
 
YES 
      
Clofibric Acid 
 
YES 
      
Gemfibrozil 
 
YES 
     
YES 
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  GC/MS LC/MS 
 Name   HESI APCI APPI 
APPI 
acetone 
APPI 
anisole 
APPI 
chlorobenzene 
APPI 
toluene 
Bezafibrate 
 
YES 
     
YES 
Fenofibrate 
 
YES 
     
YES 
Atorvastatin 
 
YES 
      
Mevastatin 
 
YES 
      
Pravastatin 
 
YES 
      
Fluoxetine 
 
YES 
      
Paroxetine 
 
YES 
      
Diazepam 
 
YES 
     
YES 
Lorazepam 
 
YES 
     
YES 
Carbamazepine 
 
YES YES YES YES YES YES YES 
Primidone 
 
YES 
     
YES 
Famotidine  
 
YES 
      
Ranitidine  
 
YES 
      
Cimetidine  
 
YES 
      
Loratadine  
 
YES 
     
YES 
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  GC/MS LC/MS 
 Name   HESI APCI APPI 
APPI 
acetone 
APPI 
anisole 
APPI 
chlorobenzene 
APPI 
toluene 
Diphehydramine 
 
YES 
     
YES 
Butalbital 
 
YES 
      
Phenobarbital 
 
YES 
      
Pentobarbital 
 
YES 
      
Atenolol 
 
YES 
      
Sotalol 
 
YES 
      
Metoprolol 
 
YES 
     
YES 
Propranolol 
 
YES 
     
YES 
Timolol 
 
YES 
      
Betaxolol 
 
YES 
      
Carazolol 
 
YES 
      
Pindolol 
 
YES 
      
Nadolol 
 
YES 
      
Salbutamol 
 
YES 
      
Clenbuterol 
 
YES 
     
YES 
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  GC/MS LC/MS 
 Name   HESI APCI APPI 
APPI 
acetone 
APPI 
anisole 
APPI 
chlorobenzene 
APPI 
toluene 
Enalapril 
 
YES 
     
YES 
Hydrochlorothiazide 
 
YES 
      
Lisinopril 
 
YES 
      
Furosemide 
 
YES 
      
Tamoxifen 
 
YES 
      
Metronidazole 
 
YES 
      
Clotrimazole 
 
YES 
      
Glibenclamide 
 
YES 
      
Caffeine YES YES YES YES YES YES YES YES 
Triclosan YES 
      
YES 
Triclocarban 
       
YES 
DEET YES YES YES YES YES YES YES YES 
Bisphenol -A YES YES YES 
    
YES 
4-n-nonylphenol YES 
 
YES 
    
YES 
4-t-octylphenol YES 
      
YES 
140 
 
  GC/MS LC/MS 
 Name   HESI APCI APPI 
APPI 
acetone 
APPI 
anisole 
APPI 
chlorobenzene 
APPI 
toluene 
Androsterone YES 
      
YES 
Estrone (E1) YES 
   
YES 
  
YES 
Equilin YES 
     
YES YES 
Testosterone YES YES YES YES YES YES YES YES 
Equilenin YES 
   
YES 
  
YES 
17-β-Estradiol (E2) YES 
     
YES YES 
17-α-Estradiol YES 
      
YES 
Ethynyl Estradiol (EE2) YES 
     
YES YES 
Progesterone YES 
     
YES YES 
Mestranol YES 
      
YES 
Estriol (E3) YES 
      
YES 
Coprostanol YES 
     
YES YES 
Coprostanone YES 
   
YES 
  
YES 
Coprostane YES 
       
Cholesterol YES               
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CHAPTER 6 
Occurrence of PPCPs in reclaimed water 
6.1 Introduction 
Water stress has become a serious problem worldwide because of the rapid 
population growth on the earth.  Properly managed water resources are critical 
for sustainable development of water supply. In order to improve the 
management efficiency of water resources, treated waters are commonly reused 
worldwide for landscape, agriculture, irrigation, recharging, etc. In the United 
States, treated water has been used in more than 3000 application sites. Over 40 
× 106 m3 of reclaimed water is used in California every year (Wu et al., 2010) (Xu 
et al., 2009).  
 
However, potential adverse effects persist when reusing treated water. It is 
proved that current WWTPs with primary treatment and secondary treatment 
processes could not remove PPCPs completely as PPCPs have been detected 
in the effluent of WWTPs (Deblonde et al., 2011). Tertiary treatments such as 
granular active carbon adsorption, ozonation and catalytic oxidation showed a 
relatively high removal efficiency of PPCPs in the wastewater, but these 
treatments are seldom used in current WWTPs (Yoon et al., 2006; Broséus et al., 
2009; Pisarenko et al.). Therefore, when reusing treated water, PPCPs could 
enter the ecosystem and water supply, which may have potential adverse effects 
to human beings. When treated water is used for irrigation, PPCPs may enter 
surface water by runoff and cause adverse effects on organism in the aqueous 
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environment (Xu et al., 2009). In addition, compounds with strong sorption that 
are recalcitrant to degradation may remain on the surface of the soil and be 
uptaken by plants. Research about uptake of human pharmaceuticals in plants 
grown in soil suggested that compounds introduced by irrigation may be more 
available for plant uptake and translocation than by biosolid application (Wu et al., 
2010). When treated water is used for deep well injection, PPCPs may 
contaminate ground water, which may be used as a source of drinking water. 
Thus, it is essential to monitor the presence of PPCPs in treated water targeted 
for reuse or recharge. 
 
At Florida International University’s Biscayne Bay Campus, treated wastewater 
from the North District WWTP is used for irrigation. The North District WWTP is 
located at NE 154 Street and is east of Biscayne Boulevard, and it receives 
wastewater from the North District of Miami-Dade County. The wastewater 
treatment plant was designed to have a flow of 120 million gallons per day (MGD) 
with average daily flow around 112.5 MGD.  The facilities include screening, grit 
removal, primary sedimentation, activated sludge treatment by oxygenation and 
chlorination. Extra filtration (DynaSand Filtration, Leopold Filtration and Tetra 
filtration) and disinfection are applied to effluents before release to make the 
reclaimed water ready for use in irrigation. The following study monitored the 
reclaimed water between January 2011 and December 2011. 
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6.2 Experimental 
Analyte information is shown in table 18. Sample preparation, online SPE 
procedure and detection method were described in part 4.2 and 5.2. Reclaimed 
water was collected directly from sprinkler system during January 2011 and 
December 2011 at Florida International University, Biscayne Bay Campus. 
 
Table 18. Analytes in reclaimed water samples 
GROUP Name CAS Number 
Analgesics and anti-inflammatories Ketoprofen 22071-15-4 
 
Naproxen 22204-53-1 
 
Ibuprofen 15687-27-1 
 
Indomethacin 53-86-1 
 
Diclofenac 15307-86-5 
 
Mefenamic acid 61-68-7 
 
Acetaminophen  103-90-2 
 
Salicylic Acid 69-72-7 
 
Antipyrin 60-80-0 
 
Propyphenazone 479-92-5 
 
Phenylbutazone 50-33-9 
 
Codeine 76-57-3 
Antihyperlipidemics - Lipid Regulators Clofibric Acid 882-09-7 
 
Gemfibrozil 25812-30-0 
 
Bezafibrate 41859-67-0 
 
Fenofibrate 49562-28-9 
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GROUP Name CAS Number 
 
Atorvastatin 134523-00-5 
 
Mevastatin 73537-88-3 
 
Pravastatin 81131-70-6 
Antidepressants and anticonvulsants Fluoxetine 54910-89-3 
 
Paroxetine 61869-08-7 
 
Diazepam 439-14-5 
 
Lorazepam 846-49-1 
 
Carbamazepine 298-46-4 
 
Primidone 125-33-7 
Antihistaminies Famotidine  76824-35-6 
 
Ranitidine  66357-35-5 
 
Cimetidine  51481-61-9 
 
Loratadine  79794-75-5 
 
Diphehydramine 88637-37-0 
Barbiturates - Anticonvulsants Butalbital 77-26-9 
 
Phenobarbital 50-06-6 
 
Pentobarbital 76-74-4 
Beta-blockers -cardiac arrhythmias Atenolol 29122-68-7 
 
Sotalol 3930-20-9 
 
Metoprolol 37350-58-6 
 
Propranolol 525-66-6 
 
Timolol 26839-75-8 
 
Betaxolol 63659-18-7 
 
Carazolol 57775-29-8 
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GROUP Name CAS Number 
 
Pindolol 13523-86-9 
 
Nadolol 42200-33-9 
Bronchodilators - Beta agonists Salbutamol 18559-94-9 
 
Clenbuterol 37148-27-9 
Antihypertensives Enalapril 75847-73-3 
 
Hydrochlorothiazide 58-93-5 
 
Lisinopril 83915-83-7 
Diuretics Furosemide 54-31-9 
Cancer treatment Tamoxifen 10540-29-1 
Antifungals Metronidazole 443-48-1 
 
Clotrimazole 23593-75-1 
Antidiabetic Glibenclamide 10238-21-8 
Wastewater Indicators Caffeine 58-08-2 
 
Triclosan 3380-34-5 
 
Triclocarban 101-20-2 
 
DEET 134-62-3 
 
Bisphenol -A 80-05-7 
 
4-n-nonylphenol 104-40-5 
 
4-t-octylphenol 27193-28-8 
Hormones Androsterone 53-41-8 
 
Estrone (E1) 53-16-7 
 
Equilin 474-86-2 
 
Testosterone 58-22-0 
 
Equilenin 517-09-9 
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GROUP Name CAS Number 
 
17-β-Estradiol (E2) 50-28-2 
 
Ethynyl Estradiol (EE2) 57-63-6 
 
Progesterone 58-83-0 
 
Mestranol 72-33-3 
 
Estriol (E3) 50-27-1 
Fecal Sterols and sterones Coprostanol 360-68-9 
 
Coprostanone 601-53-6 
 
6.3 Result and discussion 
One or more compounds were found in 100% of the reclaimed water samples. 
The reason for the high detection frequency is that the treatment processes in 
the North District WWTP only include primary and secondary treatments that are 
not designed to remove microconstituents. Even though extra filtration and 
chlorination are applied to effluent, PPCPs and hormones still cannot be 
removed completely. In this one year study period, 33 out of 72 target 
compounds were detected more than once. The detected concentrations of the 
target compounds are shown in figure 24. About 15% of the concentrations were 
more than 1 µg/L and 80% of the high concentrations (>1 µg/L) were derived 
from gemfibrozil, atenolol, caffeine and bisphenol A.  
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Figure 24. Detected concentration ranges for all compounds in reclaimed water 
samples. 
 
Among the high concentration compounds, coprostanol, bisphenol A and DEET 
are the three compounds with detected maximum concentrations that exceeded 
10 µg/L (figure 25). Bisphenol A is known as a weak environmental estrogen, 
more recent research has demonstrated that bisphenol A may be similar to 
estradiol in stimulating some cellular responses (Beverly S, 2011).  DEET’s 
chronic aquatic toxicity data is available for fish (8.42 mg/L), daphnia (5.13 mg/L) 
and algae (9.65 mg/L) (Aronson et al., 2012). The reported observed effect 
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concentrations were hundreds of times higher than the detected concentrations. 
Only two hormones (estrone and estradiol) were detected in the reclaimed water 
samples. The detected concentrations of estrone (50.8 ng/L) and estradiol (58.5 
ng/L) were relatively high compared to lowest observed effect concentration 
(usually few ng/L) (Larsen et al., 2008), but the detection frequency is only 2%. 
Actually, acute toxicity to aquatic organisms is unlikely to occur because acute 
effect concentrations are 100-1000 higher than the detected concentrations in 
the environmental samples. 
 
Figure 25. Maximum concentration and detection frequency of compounds in 
reclaimed water samples 
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In addition, the detection frequency is a critical factor since long-term exposure to 
PPCPs especially compounds with endocrine disruption effects may cause 
problems even though their concentrations are low. The four most frequently 
detected compounds were diphenhydramine (100%), DEET (98%), atenolol 
(98%) and carbamazepine (96%). Diphenhydramine has been reported in water, 
sediment and fish but the effects of diphenhydramine on aquatic organisms is still 
lacking. In the reclaimed water samples, diphenhydramine was detected in all the 
samples all year long with a maximum concentration of 1091 ng/L. A previous 
study indicated that no-observed-effect concentration of diphenhydramine on 
reproduction of D.magna is 0.8 µg/L, while 17% of concentrations detected in 
reclaimed water exceeded 0.8 µg/L and there is no indication of what the effect 
level could be. Atenolol was detected at a maximum concentration of 3761 ng/L 
in 98% of reclaimed water samples. In reproduction test with Daphnia magna, the 
most sensitive no-observed-effect concentration of atenolol was 1.8 mg/L (Küster 
et al., 2009). Winter and his coworker used fathead minnows as test species and 
undertook embryo-larval development (early life stage or ELS) and short-term 
adult reproduction studies. The results of the ELS study showed that NOECgrowth 
and LOECgrowth of atenolol were 3.2 and 10 mg/L, respectively. In the short-term 
reproduction study, NOECreproduction and LOECreproduction  of atenolol were 10 
and >10 mg/L, respectively (Winter et al., 2008). Compared to the toxicity test 
results, the detected concentrations of atenolol in reclaimed water samples are 
much lower than the concentration that will cause chronic effect to fish. 
Carbamazepine is an anticonvulsant pharmaceutical that is commonly found in 
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effluent of WWTPs, surface water and drinking water (Heberer et al., 2002; 
Deblonde et al., 2011). In this study, carbamazepine was detected in 96% of 
reclaimed water samples with a maximum concentration of 173 ng/L. To test the 
chronic effect of carbamazepine, rainbow trout were exposed to three 
concentrations of carbamazepine (1.0 µg/L, 0.2 mg/L and 2.0 mg/L) for 42 days. 
Result indicated that at 2.0 mg/L, both physiological condition status and muscle-
based biomarkers were significantly affected (Li et al., 2009; Li et al., 2010). By 
comparing with toxicity study, the detected concentrations of compounds in the 
reclaimed water were generally lower than the lowest-observed-effect 
concentrations of chronic effects, thus the risk associated with the their 
occurrence was probably minimal.  
 
Although for a single compound, the detected concentrations was lower than the 
lowest-observed-effect concentration, most of the time more than one analytes 
was found in the environmental samples. The resulting additive effects of PPCP 
mixture may cause observed effects to organisms eventually. In the one year 
study, more than one target compounds were found in all reclaimed water 
samples and 13% of reclaimed water samples had a total concentration of > 10 
µg/L. However, the effect and interactions of PPCP mixture in the environmental 
samples is still unclear, and further investigations are required.  
 
To obtain a broader view of the results, target compounds were divided into 15 
groups on the basis of their general application or origins. The percent of 
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detection frequencies of each group are shown in figure 26. The number of 
compounds in the group does not reflect the detection frequency. Most of the 
time, detection frequency was influenced by the usage of compounds and 
removal rate of the WWTPs. Wastewater indicators, β-blockers and 
analgesics/anti-inflammatories were the three most detected groups, which 
covered 67% of detection frequency. The three groups also covered 69% of the 
total concentration (figure 27). Another group that should be of concern is the 
lipid regulator group. Even though the percent of detection frequency is relatively 
low (6%), compounds in the lipid regulator group covered 20% of the total 
concentration.  
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Figure 26. Detection frequency as a percent of different classes in reclaimed 
water samples 
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Figure 27. Percent of total measured concentration for each group of 
compounds in reclaimed water samples 
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6.4 Conclusion 
Methods developed in chapter 4 and 5 were successful applied on 
simultaneously detection of 71 compounds in reclaimed water samples. The 
online SPE method was robust, sensitive and reliable, making it suitable for 
routine analysis of environmental water samples. Reclaimed water samples were 
collected from the sprinkler system for a year-long period in Florida International 
University Biscayne Bay Campus, where reclaimed water was reused for 
irrigation. Analysis results showed that more than one analytes were detected in 
all reclaimed water samples. About 15% of the detected concentrations were 
more than 1 µg/L. Among the detected compounds with high concentrations (>1 
µg/L), coprostanol, bisphenol A and DEET’s maximum concentration exceeded 
10 µg/L. The four most frequently detected compounds were diphenhydramine 
(100%), DEET (98%), atenolol (98%) and carbamazepine (96%). Wastewater 
indicators, β-blockers and analgesics /anti-inflammatories were the three most 
detected groups and these three groups covered 67% of detection frequency and 
69% of the total concentration. The one-year study confirmed that current 
primary treatment, secondary treatment, extra filtration and chlorination in North 
District WWTP could not remove PPCPs completely from effluent. The 
microconstituents were continuously released to the environment through water 
reuse. More seriously, the releasing of microconstituents will continue for a long 
period of time until effective treatment processes are incorporated into the 
WWTPs. Although the detected maximum concentration of a single compound 
may not cause acute effect to organisms and the frequently detected compound 
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may not cause chronic effect at the detected concentrations, it is still uncertain 
that treated water reuse is safe for the environment. The reason is that for all 
reclaimed water samples, more than one compounds was detected and very little 
is known about the combination effect of PPCPs mixture to environmental 
organisms. Therefore, instead of doing experiments about the acute and chronic 
effect of a single compound, more research should focus on the investigation of 
the combination effects of PPCP mixture at environmental relevant 
concentrations. The one-year study of reclaimed water provided lots of critical 
information about compounds that persist in the effluent of WWTPs and their 
environmental concentrations, which are very valuable for toxicity research in the 
future.  
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CHAPTER 7 
Occurrence of PPCPs in drinking water 
7.1 Introduction 
Pharmaceuticals and personal care products have been widely reported in 
wastewater and surface waters worldwide. The occurrence of PPCPs in the 
environment is a partially result of wastewater discharges. Other sources of 
PPCPs in the environmental waters include: runoff from agriculture fields, 
application of veterinary drugs, landfill leachates, etc. Issues concerning the 
quality of drinking water are important because the sources of drinking water 
(surface waters, ground water, etc.) might be impacted by the intrusion of 
wastewaters (Focazio et al., 2008; Fram and Belitz, 2011). The removal 
efficiency of PPCPs in the drinking water treatment plant varies both among 
chemicals and between different processes employed in the treatment plants. 
Advanced technologies such as ozonation (Broséus et al., 2009; Pisarenko et al., 
2012) and granular activated carbon (GAC) (Stackelberg et al., 2007b) can 
remove many compounds, but they cannot eliminate all the contaminations. In 
addition, advanced technologies are not universally applied to the treatment of 
potable supplies, even in developed counties. Consequently, several studies 
have shown the positive detection of PPCPs in the tap water that people are 
drinking (Mompelat et al., 2009). Although it is not clear yet whether drinking 
water containing PPCPs at the detected levels is a risk to humans, drinking water 
will always be a major public concern because it is a direct route for PPCPs  to 
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enter the human body. Therefore, a better understanding of occurrence of 
PPCPs in the drinking water is critical for public health. 
 
The following study summarized results from a comprehensive survey of 
720compounds in 54 tap water samples collected from homes located in the 
Miami-Dade County area. The results provided a preliminary but informative 
assessment of the actual concentrations of PPCPs to which people are exposed 
from drinking water. 
 
7.2 Experimental 
Chemicals, sample preparation, online SPE procedure and detection method 
were described in parts 4.2 and 5.2. Briefly, drinking water samples were loaded 
to the Hypersil Gold aQ preconcentration column and then analytes were back 
flushed to the Hypersil Gold analytical column. Analytes were then separated and 
analyzed by tandem mass spectrometry. Personal care products, steroid 
hormones, sterols and sterones were analyzed with an APPI source, while 
pharmaceuticals were analyzed with the HESI source. Drinking water samples 
were collected from the Miami-Dade area between August and October 2011. 
Information of sampling location is shown in table 19 and figure 28. Water 
samples were collected by volunteers at their place of residence. Samplers were 
instructed to open the water valve, let it run for about five minute and to collect 
the water in a new PET container. Participants were asked to provide an 
approximate location of their home but not a physical address (street crossings 
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only). All samples were immediately frozen or kept refrigerated while transported 
to the lab. 
 
Table 19. Sample name, sampling date and location 
Sample name Sampling date Latitude Longitude 
DW001 8/22/2011 25°46'20.91"N 80°22'6.15"W 
DW002 8/22/2011 26° 1'15.59"N 80° 8'30.79"W 
DW003 8/22/2011 25°54'20.54"N 80° 9'31.89"W 
DW004 8/23/2011 25°57'3.51"N 80° 9'58.40"W 
DW005 8/23/2011 26° 0'45.46"N 80° 9'0.06"W 
DW006 8/23/2011 25°45'34.04"N 80°21'54.13"W 
DW007 8/23/2011 25°52'33.72"N 80° 7'32.80"W 
DW008 8/24/2011 25°33'36.96"N 80°21'4.39"W 
DW009 8/28/2011 25°55'53.30"N 80° 7'30.34"W 
DW010 9/6/2011 25°53'59.72"N 80° 9'0.36"W 
DW011 9/13/2011 25°56'35.70"N 80° 8'21.82"W 
DW012 9/13/2011 25°54'16.94"N 80°11'31.66"W 
DW013 9/13/2011 25°51'49.99"N 80° 7'28.05"W 
DW014 9/13/2011 25°51'4.95"N 80°17'54.93"W 
DW015 9/13/2011 25°46'17.43"N 80°22'19.79"W 
DW016 9/13/2011 25°45'6.11"N 80°12'5.22"W 
DW017 9/13/2011 25°54'31.34"N 80°18'31.18"W 
DW018 9/13/2011 25°45'46.76"N 80°22'53.87"W 
DW019 9/13/2011 25°45'31.28"N 80°21'56.43"W 
DW020 9/13/2011 25°40'11.52"N 80°26'32.74"W 
DW021 9/13/2011 25°45'39.59"N 80°22'34.44"W 
DW022 9/13/2011 25°46'1.62"N 80°22'26.60"W 
DW023 9/13/2011 25°59'33.45"N 80°15'7.17"W 
DW024 9/13/2011 25°45'56.37"N 80°23'46.87"W 
DW025 9/13/2011 25°45'44.44"N 80°12'9.24"W 
DW026 9/13/2011 25°46'58.22"N 80° 8'23.03"W 
DW027 9/13/2011 25°53'50.73"N 80°18'47.40"W 
DW028 9/13/2011 25°46'36.45"N 80°22'27.53"W 
DW029 9/13/2011 25°41'37.49"N 80°21'54.24"W 
DW030 9/13/2011 25°45'44.70"N 80°15'49.34"W 
DW031 9/13/2011 25°46'14.82"N 80°11'51.36"W 
DW032 9/20/2011 25°45'16.06"N 80°13'13.16"W 
DW033 9/29/2011 25°54'14.88"N 80°17'57.88"W 
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Sample name Sampling date Latitude Longitude 
DW034 10/1/2011 25°53'53.45"N 80°13'53.75"W 
DW035 10/1/2011 25°47'0.12"N 80°20'11.02"W 
DW036 10/1/2011 25°48'43.74"N 80°22'12.05"W 
DW037 10/1/2011 25°50'21.18"N 80°22'14.67"W 
DW038 10/1/2011 25°50'24.33"N 80°19'7.10"W 
DW039 10/1/2011 25°53'57.52"N 80°11'39.34"W 
DW040 10/2/2011 26° 7'16.37"N 80°10'47.11"W 
DW041 10/2/2011 25°29'39.38"N 80°24'58.93"W 
DW042 10/2/2011 25°28'39.66"N 80°27'56.37"W 
DW043 10/2/2011 25°40'10.68"N 80°25'57.50"W 
DW044 10/2/2011 25°37'36.85"N 80°24'53.63"W 
DW045 10/2/2011 25°28'44.81"N 80°25'50.04"W 
DW046 10/2/2011 25°33'56.77"N 80°22'56.38"W 
DW047 10/2/2011 25°36'50.11"N 80°18'58.73"W 
DW048 10/2/2011 25°43'2.62"N 80°16'41.26"W 
DW049 10/2/2011 25°38'40.40"N 80°20'19.40"W 
DW050 10/2/2011 25°40'20.88"N 80°19'21.63"W 
DW051 10/16/2011 25°53'6.04"N 80° 9'56.22"W 
DW052 10/16/2011 25°50'49.93"N 80°11'4.68"W 
DW053 10/16/2011 25°47'47.93"N 80°11'23.91"W 
DW054 10/12/2011 25°58'18.44"N 80° 9'12.11"W 
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Figure 28. Map showing the collection sites of drinking water samples 
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7.3 Result and discussion 
The water source for the Miami-Dade County Water and Sewer Department 
(WASD) is the Biscayne Aquifer, which is located just below the surface in South 
Florida. Approximately 330 million gallons per day (mgd) of water are withdrawn 
from the aquifer to meet the needs of the community. There are three water 
treatment facilities in the Miami-Dade County area: the Hialeah and Preston 
Plant, Alexander Orr Plant and the South Dade Water Supply System. The 
Hialeah and Preston plant provides drinking water for residents who live north of 
Flagler Street Up to the Miami-Dade/ Broward line. The Alexander Orr Plant 
serves people who live from Flagler Street to S.W. 248 Street. The South Dade 
Water Supply System serves residents south of S.W. 248 Street. The blue line in 
figure 28 delimits the areas served by different water supply systems. The most 
common water treatment processes are filtration, flocculation and sedimentation, 
and disinfection (URL3).  
 
A total of 15 analytes were detected in the drinking water samples and the 
concentrations are shown in figure 29. At least one analyte was found in 96% of 
the drinking water samples. Compared to the concentrations of analytes detected 
in the reclaimed water or the surface waters, the concentrations detected in the 
drinking water were much lower. Only the concentrations of salicylic acid, 
ibuprofen and DEET were found to be more than 200 ng/L.  The maximum 
concentrations of salicylic acid, ibuprofen and DEET were 521 ng/L, 301 ng/L 
and 290 ng/L, respectively (table 20). The occurrence of PPCPs in the drinking 
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water has been reported in other places in the world. A previous study showed 
that the maximum concentrations of ibuprofen detected in tap water were 3 ng/L, 
0.6, 8.5 and 1350 ng/L in Germany, France, Finland and the USA, respectively 
(Mompelat et al., 2009). The maximum concentration of DEET found in drinking 
water samples in the USA is 63 ng/L (Benotti et al., 2009) and this number is 
significantly lower than maximum value reported in this study (521 ng/L). 
However, DEET is a common environmental contaminant and is very difficult to 
avoid cross-contaminating samples if the compound is present in the sampling 
area (kitchens, bathrooms, etc). 
 
Table 20. Maximum concentration of analytes detected in Miami-Dade area 
and other parts of the world (ng/L) 
 Miami 
Dade 
Finland France Germany USA Canada UK Italy 
ketoprofen 179 8.0a 3.0b      
ibuprofen 301 8.5a 0.6b 3d 1350g   
diclofenac ND  2.5b 35e     
acetaminophen ND  210b      
salicylic_acid 521  19c      
propyphenazone 9.72   240e     
codeine ND    30h    
clofibric_acid 65.1   270f     
gemfibrozil ND     70k   
bezafibrate ND   27d     
fluoxetine 58.4        
paroxetine 65.9        
diazepam ND      10l 23.5m 
carbamazepine 27.8  43.2b  258i 24.0k   
primidone ND   40e     
propranolol 9.58        
betaxolol 24.0        
carazolol 11.2        
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salbutamol 13.1        
metronidazole 178        
clotrimazole 18.5        
Triclosan ND    734g    
DEET 290    63.0j    
a (Vieno et al., 2005)  
b (Togola and Budzinski, 2008)  
c (Vulliet et al., 2011) 
d (Stumpf et al., 1996)        
e (Heberer et al., 2004) 
f (Heberer et al., 1997) 
g (Loraine and Pettigrove, 2006) 
h (Stackelberg et al., 2007b) 
i (Stackelberg et al., 2004) 
j (Benotti et al., 2009) 
k (Tauber, 2003) 
l (Waggot, 1981) 
m (Zuccato et al., 2000) 
 
Figure 29. Concentrations of PPCPs in the drinking water samples collected 
from Miami-Dade County 
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The three most frequently detected compounds were DEET (93%), 
carbamazepine (43%) and salicylic acid (37%) (Figure 30). The high detection 
frequencies of the three compounds indicated that current drinking water 
treatment could not remove them completely from the finished water. In a 
previous study (Stackelberg et al., 2007a), DEET has been reported as one of 
the most persistent compounds during drinking water treatment. Even the 
application of ozone and GAC can only partially remove DEET from the finished 
water. Carbamazepine is another compound that is usually detected in drinking 
water samples. Research indicated that ozone is an efficient way to remove it but 
since the removal rate is not 100%, carbamazepine is still persistent in the 
finished water. DEET and carbamazepine can be used as indictors representing 
potential contamination of PPCPs. Carbamazepine was detected in 40% of the 
tap water samples in the U.S in Benotti’s study and 33% of tap water samples in 
Montreal boroughs in Canada (Garcia-Ac et al., 2009), which is very close to the 
detection frequency of carbamazepine in our study (Benotti et al., 2009). DEET’s 
detection frequency was lower in Benotti’s study (27%) than our study (Benotti et 
al., 2009). Salicylic acid is used as anti-inflammatory drug because of its ability to 
ease aches and pains and reduce fevers. Salicylic acid is also the key ingredient 
in many skin care products, such as soap, cleanser, body wash and cream etc., 
to treat acne, seborrhoeic dermatitis, psoriasis, corns, etc.  Currently, very little 
research is available about the presence of salicylic acid in drinking water. In 
Vulliet’s study, salicylic acid is reported as the most frequently detected 
compounds in the drinking water samples, however, the maximum concentration 
165 
 
(19 ng/L) is much lower than the results in our study. Because salicylic acid was 
detected in the drinking water samples at relatively high concentrations and high 
detection frequencies, future research should focus more on salicylic acid.  
 
 
Figure 30. Maximum concentrations and detection frequencies of PPCPs in 
drinking water samples 
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of analgesics and anti-inflammatories covered 56% of the total concentration 
(figure 31 and 32). The high detection frequency and high detection 
concentration resulted from the large amount of daily use and low removal 
efficiency of drinking water treatment (Benotti et al., 2009).  
 
Figure 31. Detection frequency as percent of different classes in drinking water 
samples 
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Figure 32. Percentage of total concentration of each class in drinking water 
samples 
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In order to understand the spatial distribution of the detection, sampling sites 
were shown in figure 33 as dots and the total concentration was indicated by 
different colors. Grey color represents no analytes detected at the sampling site. 
Blue color represents the total concentration detected at the sampling sites was 
between ND and 10 ng/L. Green color represents the total concentration 
detected at the sampling sites was between 10 and 50 ng/L. Yellow color 
represents the total concentration detected at the sampling sites was between 50 
and 100 ng/L. Orange color represents the total concentration detected at the 
sampling sites was between 100 and 200 ng/L. Red color represents the total 
concentration detected at the sampling sites was between 200 and 500 ng/L. 
Purple color represents the total concentration detected at the sampling sites 
was more than 500 ng/L. The total concentrations were randomly disturbed at the 
samples sites. There is no trend in the relationship of the location of sampling 
sites and total concentrations. Although the total concentrations of three points 
were more than 500 ng/L, the high total concentrations were contributed by 
salicylic acid, which may enter drinking water sample after distribution.  Results 
showed that the drinking water quality were similar in the whole Miami-Dade 
County area, which indicated that similar treatments were applied to source 
water in different drinking water facilities. 
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Figure 33. Distribution of total concentration of analytes in Miami-Dade County 
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Results of drinking water sample can be compared to reclaimed water results. 
Overall, fewer numbers of analytes were detected in the drinking water samples,  
only 15 analytes compared to 33 analytes in reclaimed water samples. The 
detected concentrations of analyte in the drinking water were much lower than 
the detected concentrations in the reclaimed water samples. The three highest 
maximum concentrations in the drinking water samples were 521 ng/L, 301 ng/L 
and 290 ng/L for salicylic acid, ibuprofen and DEET, respectively. While the three 
highest concentrations in reclaimed water for coprostanol, bisphenol A and DEET 
were more than 10,000 ng/L.  In addition, many analytes were detected at 
relatively high average concentration in reclaimed water sample while average 
concentration were close to zero in the drinking water samples (cycled point in 
figure 34). Although, similar compounds were detected in the drinking water 
samples, the detection of frequency is lower compared to reclaimed water 
samples. DEET and carbamazepine were detected in 93% and 37% in drinking 
water samples respectively, while DEET and carbamazepine were detected in 98% 
and 98% of reclaimed water samples, respectively. DEET and carbamazepine 
could be used as the indicator of contamination of PPCPs because their 
persistence in both WWTPs and DWPs. However, more studies are needed to 
establish a potential relationship between reclaimed water and drinking water. 
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Figure 34. Comparison of average concentration of analytes in drinking water 
samples and reclaimed water samples 
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Dade area were analyzed. 15 compounds were detected and more than one 
compound was detected in 93% of samples. The maximum concentration of 
salicylic acid, ibuprofen and DEET were 521 ng/L, 301 ng/L and 290 ng/L, 
respectively. The three most frequently detected compounds were DEET (93%), 
carbamazepine (43%) and salicylic acid (37%). Results indicated that drinking 
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water sources, such as ground water, may be impacted by discharge of 
wastewater, disposal of biosolids from WWTPs or landfilling.  Current drinking 
water treatments cannot prevent certain PPCPs, such as DEET and 
carbamazepine, from entering the drinking water system.  The quality of drinking 
water is a public concern since any compound present in the drinking water 
enters the human body directly. It is the largest threat to human health and long-
term effects (80 years) might occur at a much lower concentration than the 
concentration of therapeutic effects. Adverse effects may be more obvious for 
children, elderly or pregnant women. However, no data are currently available 
regarding the risk because of the long period and difficulty of the research. The 
occurrence of PPCPs in the drinking water is a key issue for water quality. 
Although there are no regulations for PPCPs in drinking water so far, more 
research about the occurrence of PPCPs in the drinking water and more studies 
about the risk of long-term exposure of humans to PPCPs through drinking water 
are highly desirable. 
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CONCLUSIONS 
The overall objective of the study was to detect trace level PPCPs and hormones 
in the South Florida environment (both aqueous phase and solid phase) using 
sensitive and reliable detection methods in order to gain a basic understanding 
on the quality of major environmental compartments with respect to a group of 
important unregulated emergent contaminants. Four methods were successfully 
developed to detect analytes in different matrices, including reclaimed waters, 
surface waters, drinking waters, sediments and soils. By conducting a 
comprehensive evaluation of a large number of environmental samples, we 
confirmed that reclaimed water from a typical secondary treatment WWTP 
routinely introduced a number of PPCPs to the environment at concentrations 
that could range into the µg/L during water reuse applications. In addition, the 
results clearly show that surface waters in South Florida are impacted by several 
PPCPs at trace level. Although contamination is not widespread, there are clear 
indications that wastewater intrusions exist in a number of coastal freshwater and 
saltwater environments. On a positive side, the presence of endocrine disrupting 
chemicals was less prevalent and usually at levels very close to the method 
detection limits so that their potential impacts to biological resources are limited 
both in temporal and geographical extent. Furthermore, some PPCPs were 
detected in drinking water samples from the Miami-Dade County distribution 
system. Concentrations were relatively low and some of the compounds may 
have alternative sources (i.e. salicylic acid) but the presence of low 
concentrations of carbamazepine with relatively high frequency of detection is a 
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conclusive indicator of a connection between wastewater streams and the 
drinking water sources or the distribution system itself. Because the presence of 
these compounds in drinking water constitutes a direct route to human exposure, 
a more detailed survey both in area and time should be conducted. 
 
In summary this study shows that excretion by humans, disposal of unused 
medicine and application of veterinary drugs does cause PPCPs to enter the 
sewage collection systems. Low efficiency of removal in the WWTPs leads to the 
releasing of PPCPs into the environment, in particular in reclaimed water only 
treated to secondary standards. Despite the fact that most PPCPs are not 
acutely toxic, their chronic release at low levels combined with their 
environmental persistence may be cause of potential concern for aquatic 
organisms in receiving waters under the influence of poorly treated wastewaters. 
The presence of PPCPs in drinking water is not novel, however in the case of 
Miami-Dade County where the source for drinking water is the shallow Biscayne 
Aquifer additional studies should be planned to assure that the source remains 
isolated from surface or ground waters influenced by treated or untreated 
wastewater streams. With the increased population growth in South Florida and 
need for water reuse careful consideration should be given to protect the drinking 
water sources from further degradation . 
 
In the future, more effective treatments need to be applied to both WWTPs and 
DWPs to remove PPCPs. Great progress has been accomplished with the use of 
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reverse osmosis and advanced oxidation processes. Until then, or when forced 
by a regulatory framework, the concentrations of PPCPs in wastewater effluents 
targeted for environmental release and drinking water need long term monitoring .  
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